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Active pharmaceutical ingredients (APIs) and their metabolites are 
ubiquitous in the environment and their occurrence in the aquatic environment 
is of growing concern.  However, despite the fact that these may cause harmful 
effects in organisms found within this niche, little is currently known about the 
effects of APIs in the aquatic environment.  Chiral pharmaceuticals are of 
particular concern as the enantiomers may be metabolised differently, with the 
potential for the production of an array of harmful compounds.  There are many 
racemic APIs for treating human and animal conditions, and even in these 
target organisms the pharmacodynamic effects of the enantiomers are not 
always known.  Within recent years the importance of the interactions of these 
compounds within the aquatic environment has been realised and information 
regarding the fate and biodegradation of such environmental pollutants is of 
great importance.  The advent of post-genomic technologies has proved 
advantageous in the study of the effects of these environmental pollutants. 
In this thesis, the effects of a range of chiral APIs, and other 
environmental pollutants, on environmentally relevant microorganisms were 
investigated at the metabolome level.  The effects of chiral APIs were 
investigated in a number of prokaryotic and eukaryotic systems in order to 
provide a comprehensive study of the effects of the APIs in the aquatic 
environment.  FT-IR spectroscopy was employed for metabolic fingerprinting of 
some environmentally relevant bacteria and GC-MS was subsequently 
employed for metabolite profiling of two pseudomonads that had shown 
differential chiral effects with Propranolol.  In addition, FT-IR microspectroscopy 
was employed for the investigation of the phenotypic and localised effects of 
chiral APIs in a eukaryotic system.  Furthermore, the effects of a range of 
environmental pollutants on a complex bacterial community were investigated 
with the use of FT-IR spectroscopy and multivariate analysis.  Initial results 
indicated a large phenotypic response in relation to phenol, and this was further 
explored with a range of ageing experiments and metabolic fingerprinting.  An 
FT-IR peak was found to be characteristic of the phenotypic changes in the 
actively degrading communities and this was likely to be a degradation product 
of phenol, and armed with this knowledge the activated sludge community was 
monitored during the active degradation of phenol with the use of GC-MS. 
The work presented in this thesis has shown for the first time that 
metabolomics allows subtle phenotypes in microorganisms to be revealed when 
they are exposed to chiral forms of APIs which are commonly found in the 
aquatic environment.  Despite these APIs not being designed for any interaction 
with bacteria and aquatic life in general these are significant findings and may 
have implications as more and more APIs become detectable and concentrated 
in the environment due to continued use in man and indeed animals or 
aquaculture.   
 - 17 -  
Declaration 
No portion of the work referred to in the thesis has been submitted in support of an 
application for another degree or qualification of this or any other university or other 
institute of learning. 
 
 
Notes on Copyright: 
i. The author of this thesis (including any appendices and/or schedules to this thesis) 
owns certain copyright or related rights in it (the “Copyright”) and she has given The 
University of Manchester certain rights to use such Copyright, including for 
administrative purposes.  
 
ii. Copies of this thesis, either in full or in extracts and whether in hard or electronic 
copy, may be made only in accordance with the Copyright, Designs and Patents Act 
1988 (as amended) and regulations issued under it or, where appropriate, in 
accordance with licensing agreements which the University has from time to time. This 
page must form part of any such copies made.  
 
iii. The ownership of certain Copyright, patents, designs, trade marks and other 
intellectual property (the “Intellectual Property”) and any reproductions of copyright 
works in the thesis, for example graphs and tables (“Reproductions”), which may be 
described in this thesis, may not be owned by the author and may be owned by third 
parties. Such Intellectual Property and Reproductions cannot and must not be made 
available for use without the prior written permission of the owner(s) of the relevant 
Intellectual Property and/or Reproductions.  
 
iv. Further information on the conditions under which disclosure, publication and 
commercialisation of this thesis, the Copyright and any Intellectual Property and/or 
Reproductions described in it may take place is available in the University IP Policy 
(see http://www.campus.manchester.ac.uk/medialibrary/policies/intellectual-
property.pdf), in any relevant Thesis restriction declarations deposited in the University 
Library, The University Library’s regulations (see 
http://www.manchester.ac.uk/library/aboutus/regulations) and in The University’s policy 
on presentation of Theses. 
 - 18 -  
Acknowledgements 
 
I thank my supervisor, Prof. Roy Goodacre, for his help, guidance and encouragement 
throughout the course of this work.  I also thank all of my friends and colleagues at the 
University of Manchester for their help and support and BBSRC and AstraZeneca for 
funding for this work.   
 
In particular I would like to thank Warwick Dunn for his help and advice and for running 
the GC-MS analyses carried out during the course of this work.  I have had the 
pleasure of working with Cate Winder and Roger Jarvis who I would like to thank for 
sharing their wealth of scientific knowledge with me, great friendship and generally 
keeping me sane throughout this entire process! 
 
Finally, I thank my parents, Margaret and Jeff Wharfe, who have offered me endless 
support (both financially and emotionally), without whom this experience would not 
have been possible.   
 
 
Introduction 
 
An environmental metabolomics investigation of the effects of chiral pharmaceuticals 
and environmental pollutants on microorganisms 
- 19 -   
1 Introduction 
1.1 Pharmaceuticals in the Aquatic Environment 
Active pharmaceutical ingredients (APIs) and their metabolites are ubiquitous in the 
environment (Escher et al., 2005) and the occurrence of APIs in the aquatic 
environment is of growing concern (Fent et al., 2006).  There are a number of routes 
through which APIs and resulting metabolites / degradation products may enter these 
ecosystems (Figure 1.1), and a common avenue is through the excretion of the APIs 
and their metabolites in urine and faeces (Heberer, 2002).  It is known that APIs have 
different rates of metabolism within man.  For example, the β-blocker Propranolol is 
almost completely metabolised within the liver and only 1-4% of an oral dose is 
excreted as the unchanged API and its metabolites.  By contrast, 40-50% of an oral 
dose of Atenolol (also a β-blocker), is excreted as the API or its constituent metabolites 
(Ashton et al., 2004, Carlsson et al., 2006a, Carlsson et al., 2006b).  The subsequent 
degradation of the APIs and their metabolites may also occur at sewage treatment 
plants (STPs); this is usually substrate specific and will vary greatly between APIs.  The 
rate of adsorption to activated sewage sludge during treatment differs between APIs, 
and is dependant on the hydrophobic and electrostatic interactions of the API with the 
particulates and microorganisms, within the activated sewage sludge (Fent et al., 
2006).  Any remaining API and relevant metabolites are diluted into the surface water 
when the effluent is released from the STP.  Hence, many APIs are present in low 
concentrations (ng - µg L-1) in aquatic environments such as rivers, streams and 
estuaries (Escher et al., 2005, Ashton et al., 2004, Carlsson et al., 2006b).  The 
majority of APIs are neither persistent nor highly bioaccumulative; however, the 
continuous release of APIs into the aquatic environment poses a potential risk to 
aquatic organisms even though the concentrations of APIs in receiving waters are quite 
low (Escher et al., 2005).  In addition, concentrations up to 31 mg L-1 have been 
reported in wastewater effluents of API production facilities, and 11 of the APIs 
detected in the effluent were found be present at concentrations >100 µg L-1 (Larsson 
et al., 2007).  Furthermore, the high concentrations of APIs in this effluent were found 
to elicit toxicity effects in the aquatic vertebrate Xenopus tropicalis and a fish species 
(Danio rerio) (Carlsson et al., 2009).   
 
Despite little being known about the effects of APIs in the environment, it must be taken 
into account that they are designed to elicit a specific mode of action in humans 
Introduction 
 
An environmental metabolomics investigation of the effects of chiral pharmaceuticals 
and environmental pollutants on microorganisms 
- 20 -   
(Escher et al., 2005).  Adverse side effects may be encountered in humans at higher 
doses of these APIs, and it can be expected that any beneficial or adverse effect may 
also be observed in aquatic organisms with similar biological functions or receptors.  It 
must also be noted that similar targets may control different metabolic processes in 
different species (Seiler, 2002), and therefore APIs and their metabolites may act 
through additional modes of action in aquatic organisms.  The effects of the APIs may 
be subtle due to the very low concentrations observed in the aquatic environment, and 
as a result these effects may go unnoticed (Escher et al., 2005).  It is also likely that the 
effect of the API will impact on the local population dynamics throughout the whole 
ecosystem, from bacteria up to higher organisms.  To explore the effects of the APIs on 
biological systems a wide range of concentrations should be employed with the 
application of appropriate analytical platforms to profile the complement of biochemical 
components in the cell.  Indeed it is known that APIs could become concentrated in the 
benthic environment of river beds and as bacteria inhabit this niche, this community 
may be exposed to higher levels than expected (Thacker, 2005, Halling-Sørensen et 
al., 1998, Pouliquen et al., 1992). 
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Figure 1.1:  Scheme showing possible sources and pathways for the occurrence of API 
residues in the aquatic environment.  Points outlined in red represent significant aquatic end-
points in the pathways.  Adapted from Heberer et al. (2002). 
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1.1.1 Chiral Pharmaceuticals 
Whilst the effects of APIs in the environment is currently a growing area of research 
there is very little understanding of the environmental effects of chiral pharmaceuticals 
(Fono and Sedlak, 2005, Buser et al., 1999).  A chiral molecule is one that lacks an 
internal plane of symmetry.  The non-superimposable mirror images are termed 
enantiomers and are labelled ‘(R)’ or ‘(S)’ according to a priority system (Cahn Ingold 
Prelog priority rules) based on the atomic number of the molecules substituents.  
Approximately 56% of the APIs currently in use are chiral compounds, 88% of which 
are administered therapeutically as the racemate (i.e., an equal mixture of the two 
enantiomers, represented by the symbol (±)).  The chirality of environmental 
contaminants such as APIs must be taken into consideration in order to understand the 
environmental fate and effects of these compounds fully.   
 
The enantiomers of a chiral API are able to interact differently with other chiral 
compounds such as enzymes, and therefore potentially exert different effects when 
released into the environment (Fono and Sedlak, 2005, Buser et al., 1999, Nikolai et 
al., 2006).  It is widely known that the enantiomers of a chiral API may possess differing 
toxicological and biological effects both from each other, and the racemate (Lees et al., 
2003, Yang et al., 2005).  It has been shown that the (S)- enantiomers of the β-blocking 
agents Atenolol and Propranolol (Figure 1.2) are more potent in man than their 
respective antipodes (Davies, 1990, Pearson et al., 1989, Kurt et al., 1993, Barrett and 
Cullum, 1968) and that a number of the biotransformation pathways for β-blockers are 
stereoselective in humans (Mehvar and Brocks, 2001).  The mode of action of the 
drugs and their enantiomers is not known in prokaryotic systems.  It is therefore 
necessary to enhance our understanding of the fate and biological effects of chiral 
pharmaceuticals on typical microflora from the aquatic environment in order to fully 
appreciate the risks (Huggett et al., 2002).  Of particular interest is the group of APIs 
termed β-blockers as they all contain at least one chiral centre and are generally 
administered therapeutically as the racemate (Mehvar and Brocks, 2001).  In addition, 
they are widely used with approximately 29 and 12 tonnes of Atenolol and Propranolol, 
respectively, consumed each year in the UK.  Furthermore, these APIs have been 
detected in STP effluents and surface waters and are frequently found to be within the 
top 15 most concentrated APIs present within the aquatic environment (Jones et al., 
2002, Ashton et al., 2004, Carlsson et al., 2006a, Carlsson et al., 2006b). 
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The chiral API Propranolol is a non-selective β-adrenergic blocking agent and whilst it 
is known that the (S)- enantiomer exerts the majority of the β-blocking effect, it is 
administered therapeutically as the racemate (Barrett and Cullum, 1968).  Studies 
carried out in cats and on the atrial muscle taken from guinea pigs found the (S)- 
enantiomer to be approximately 100 times more potent and have a longer half-life than 
its respective antipode (Barrett and Cullum, 1968).  In addition, (R)- Propranolol is 
reported to exert membrane stabilising activity (MSA) at therapeutic concentrations 
(Wood, 1984).  The term MSA is employed to describe non-specific interactions that 
may occur between membrane lipid bilayers and lipophilic drugs and chemicals (Roth 
and Seeman, 1971).  These interactions may inhibit membrane permeability to 
electrolytes, through the blockade of sodium fast channels.  MSA may also be used to 
describe the non-specific physical protection of membranes, reports of which include 
red blood cell studies (Langslet, 1970, Seeman and Carl, 1966), and the release of 
lysosomal enzymes (Welman, 1979).  However, studies in which properties of β-
blockers may not be explained by competitive interaction with the adrenergic receptor 
frequently result in such effects being attributed to MSA (Arnim and Welman, 1981, 
Nayler et al., 1980).   
 
Toxicity studies carried out by Kim and co workers in the crustacean Thamnocephalus 
platyurus and a fish species (Oryzias latipes) reported that (±)- Propranolol caused 
acute toxicity in T. platyurus at a concentration of 10.61 µg mL-1 and in O. latipes at a 
concentration of 11.40 µg mL-1.  In addition, toxicity studies have been carried out on a 
range of APIs (including (±)- Propranolol) in the Japanese medaka fish (Oryzias 
latipes) an amphipod (Hyalella azteca) and two crustaceans (Ceriodaphnia dubia and 
Daphnia magna).  It was found that Propranolol caused the greatest effect in the 
organisms studied.  The crustacean C. dubia displayed toxicity responses at a 
concentration of 250 µg mL-1.  Propranolol was the only API investigated which was 
found to cause acute toxicity effects in the Japanese medaka fish.  These effects were 
observed at a concentration of 0.5 µg mL-1 (Huggett et al., 2002).   
 
In contrast to the non-selective β-blocking agent Propranolol, Atenolol is a β1-selective 
blocking agent.  The (S)- enantiomer is reported to posses the majority of the 
pharmacological action in man (Kurt et al., 1993, Pearson et al., 1989).  However, no 
additional action has been reported for either of the enantiomers.  Atenolol is a 
hydrophilic β-blocker and as such does not posses MSA as it does not interact with the 
membrane lipid bilayer (Pearson et al., 1989).  Toxicity studies have shown reported 
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effects on polyp structure of the freshwater cnidarian H. vulgaris at 10 µg mL-1 following 
seven day exposure to the β-blocker (Pascoe et al., 2003).  In addition, reductions in 
heart beat rate and biomass were observed in Daphnia magna following chronic 
exposure to 0.11 µg mL-1 (±)- Atenolol (Fent et al., 2006).  To date, there have been no 
reports on the effects of the pure enantiomers of either Atenolol or Propranolol in 
aquatic organisms and this is an area of environmental concern.   
 
 
(R)-Atenolol (S)-Atenolol
(R)-Propranolol (S)-Propranolol
 
Figure 1.2:  The chemical structures of the chiral β-blocking agents Atenolol and Propranolol. 
 
 
1.1.2 Aromatic Hydrocarbons 
The risks posed to the aquatic environment by aromatic hydrocarbons such as phenol 
and toluene are becoming increasingly apparent and many aromatic hydrocarbons are 
classed as environmental pollutants (Nahar et al., 2000).  Industrial processes such as 
the production of plastics, synthetic fibres and pesticides and the coking process result 
in the production of vast quantities of wastewaters containing aromatic hydrocarbons 
(Abuhamed et al., 2004).  Regulations regarding the discharge of such wastewaters 
are becoming increasingly more stringent worldwide (Lu et al., 2008).   
 
Phenol has been shown to cause toxicity responses in aquatic organisms including 
Daphnia magna, and a range of fish species.  Kühn et al (1989) reported Daphnia 
magna exposed to phenol for 24 h displayed toxicity responses at 10 µg mL-1 and 
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these effects were noted in organisms exposed to only 4 µg mL-1 for 48 h.  The 
reported increase in toxicity of phenol for extended exposure periods is highly relevant 
to aquatic organisms that are likely to be exposed to such pollutants during their entire 
lifespan.  The range of observed toxicity responses in fish include genotoxic, 
immunotoxic, and physiological effects (Hori et al., 2006, Saha et al., 1999, Taysse et 
al., 1995).  In addition, phenol is highly bioaccumulative due to its lipophilic nature and 
environmental concentrations may exceed those previously expected (Hori et al., 
2006).  Furthermore, the toxicity of mixtures of aromatic hydrocarbons such as phenol, 
toluene and benzene has been shown to increase in comparison with the isolated 
chemicals (Abuhamed et al., 2004).  This is of great relevance to the aquatic 
environment, which is likely to contain a variety of chemicals.   
 
 
OHCH3
Benzene Toluene Phenol
 
Figure 1.3:  The chemical structures of the aromatic hydrocarbons benzene, toluene and 
phenol. 
 
 
1.2 Ecotoxicogenomics 
The term genomics encompasses a wide range of scientific disciplines including, 
genome sequencing, assigning gene function to known genes, determination of the 
genome architecture, investigating gene expression at the transcriptome level, protein 
expression at the proteome level and metabolite flux at the metabolome level (Snape et 
al., 2004).  Toxicogenomics combines the disciplines of genomics and toxicology, and 
may be described as the study of genes and their products which play a central role in 
the adaptive responses to abiotic perturbations within biological systems (Nuwaysir et 
al., 1999, Iannaccone, 2001, Rockett and Dix, 1999, Lovett, 2000, Pennie et al., 2000, 
Watanabe, 2007).  This approach enables the further understanding of the underlying 
molecular responses to chemical contaminants (Bradley and Theodorakis, 2002, 
Moore, 2002).  Similarly, the term ecogenomics refers to the application of genomics to 
the field of ecology (Chapman, 2001).  This approach aims to develop further 
understanding of the interactions between organisms in the environment and the 
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interactions between organisms and the environment itself (Snape et al., 2004, Zelikoff, 
1993, Hutchinson et al., 1999, Hutchinson et al., 2003, Harvell et al., 1999, Eggen and 
Suter, 2007).   
 
The term ecotoxicogenomics was first proposed by Snape et al. (2004) to describe the 
integration of the ‘omics technologies, transcriptomics, proteomics and metabolomics 
into the field of ecotoxicology.  This is defined as the study of gene, protein and 
metabolite expression in biological systems that is important in response to 
environmental toxicant exposure (Snape et al., 2004) and aims to understand the key 
mechanisms of toxicity (Poynton and Vulpe, 2009, Poynton et al., 2008, Watanabe and 
Iguchi, 2006).  In addition, ecotoxicogenomics aims to link molecular and cellular 
biomarkers with the higher level population and ecosystem responses; in order to 
predict potential ecological risks for new compounds providing an enhanced 
mechanistic understanding of aquatic ecotoxicology (Snape et al., 2004, Watanabe and 
Iguchi, 2006, Crane et al., 2006).  Environmental contaminants are likely to produce 
genomic responses within an organism (Snape et al., 2004) and within the field of 
biomedicine, it has been shown that exposure to toxicants (such as polycyclic aromatic 
hydrocarbons) almost always results in altered gene expression (Nuwaysir et al., 
1999).  At present, the relationship between genotype and phenotype is poorly 
understood, and the application of functional genomics may provide insight into both 
the genotypic and phenotypic effects of contaminants in the environment (Snape et al., 
2004, Thompson, 1991, Depledge, 1994, Shugart and Theodorakis, 1996, Hood et al., 
2000).   
 
A broad range of gene expression technologies have been developed in order to 
investigate organisms at a genome wide level (Patanjali et al., 1991, Arnheim and 
Erlich, 1992, Schena et al., 1995, Velculescu et al., 1995, Rockett and Dix, 2000, Clark 
et al., 2002).  In addition, methods for the investigation of biological systems at the 
proteome (Gevaert and Vandekerckhove, 2000, Mann et al., 2001) and metabolome 
level (Nicholson et al., 1999, Thomas, 2001, Watkins and German, 2002, Buchholz et 
al., 2002) have also been developed.  However, few of these methods have so far 
been applied to the response of organisms to contaminants in complex environments 
(e.g. sediments or soil).  A key objective for ecotoxicogenomics is the improvement of 
existing, and the development of new, technologies capable of measuring the genome, 
proteome and metabolome profiles for environmental organisms that are exposed to 
numerous perturbations in complex natural environments (Snape et al., 2004).   
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Modern high-density DNA techniques are capable of simultaneously analysing 
thousands of genes and are becoming widely available for both model and non-model 
organisms (Snape et al., 2004, Schena et al., 1995, Rockett and Dix, 2000).  
Application of these techniques allows for the identification of transcripts which are up- 
or down- regulated.  The major advantage of these techniques is the ability to rapidly 
analyse vast numbers of transcripts within a single analysis.  However, such 
techniques are only semi-quantitative as they are dependent on the efficiency of the 
labelling and hybridisation of the individual clones (Snape et al., 2004).  In addition, the 
detection of low copy number transcripts is currently rather difficult (Bartlett, 2001).  
Furthermore, array-based techniques rely on a priori knowledge of the transcripts that 
are likely to be present within a sample in order that gene probes may be designed 
prior to analysis (Clark et al., 2002).   
 
Proteomics is the measurement of the complement of proteins within a biological 
system that are expressed under specific conditions (Snape et al., 2004, Monsinjon 
and Knigge, 2007).  This approach generally employs 2D gel electrophoresis for the 
separation of proteins (firstly by charge and then by size).  However, for peptides or 
protein fragments, high-resolution chromatography techniques such as high 
performance liquid chromatography (HPLC) are more commonly employed.  The 
separation of proteins is then followed by the chemical characterisation of the 
proteome, usually by mass spectrometry which has the sensitivity, selectivity and 
throughput required in order to identify each protein within the proteome (Snape et al., 
2004).  The resultant peptide mass fingerprint (PMF) may then be compared with 
fragment databases in order to provide identification of the proteins (Gevaert and 
Vandekerckhove, 2000, Mann et al., 2001).  Proteomics approaches to ecotoxicology 
investigations, in which measurements of the proteomic response to disease or abiotic 
perturbation during a time course may be required, are both costly and time-
consuming.  A further disadvantage to the application of proteomics to the study of the 
effects of contaminants in environmental populations is the lack of relevant DNA 
sequence information and PMF databases meaning that identification is not possible 
for many of the proteins within a sample (Snape et al., 2004).  However, the continuing 
advances in the DNA sequencing of environmental metagenomic samples and the de 
novo sequencing of protein MS/MS spectra, may provide further insight into the effects 
of contaminants on environmental populations (Maroti et al., 2009, Schulze et al., 2005, 
Venter et al., 2004). 
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Metabolomics is the non-biased identification and quantification of all metabolites within 
an organism or biological system. (Fiehn, 2002, Harrigan and Goodacre, 2003, Oliver 
et al., 1998).  Metabolomics and proteomics approaches possess two clear advantages 
with respect to the analysis of gene function in ecotoxicology studies; the total 
complements of proteins and metabolites change according to the physiological, 
developmental or pathological state of the biological system studied, and are functional 
entities within an organism.  Analysis at the proteomic and metabolomic levels 
therefore enables the characterisation of a biological system at the functional level 
(Raamsdonk, 2001, Snape et al., 2004).  In addition, for many organisms the number 
of metabolites is far fewer than the number of genes or gene products (Raamsdonk, 
2001). 
 
Disease or abiotic effects on gene expression may be detected at the genomic, 
proteomic and metabolomics levels.  However, some environmental contaminants may 
only act at a pharmacological level and will not affect gene regulation and expression 
or protein production, and may therefore only be detected at the metabolome level 
(Lindon et al., 2001b).  Drug induced and other pathophysiological changes result in 
alterations of the ratios, concentrations, binding and fluxes of endogenous 
biochemicals, through direct chemical reaction or binding to key metabolic 
macromolecules.  Sufficiently large disturbances will however, affect the efficient 
functioning of the whole organism and will therefore be reflected in the genome, 
proteome and metabolome (Lindon et al., 2001a). 
 
Functional studies have emphasised analyses at the transcriptomics, proteomic and 
metabolomic levels with a view to a ‘systems biology’ approach of defining the 
phenotype and to identify the linkages between the genotype and phenotype 
(Goodacre et al., 2004, Fiehn, 2002).  The observed response of an organism to toxic 
or other stresses at all three levels gives a comprehensive description of the RNAs, 
proteins and metabolites within the system in response to such stresses.  This 
approach enables analysis of the relevant associations between macromolecules, 
identification of functional linkages, and the production of models that quantitatively 
describe the dynamics of the biological system (Goodacre et al., 2004, Snape et al., 
2004). 
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1.3 Introduction to metabolomics 
In the post-genomic era, the high degree of complexity inherent in the information 
produced by genomic studies has exposed the limitations of solely genomic-based 
investigations.  Recent research has extended to the transcriptome, the proteome; and 
most recently, the metabolome.   
 
The metabolome is the final downstream product of the genome, and has been defined 
as the qualitative and quantitative collection of all low molecular weight molecules 
present in a cell that participate in general metabolic reactions (Dunn et al., 2005, 
Oliver et al., 1998, Harrigan and Goodacre, 2003, Goodacre et al., 2004).  Analysis of 
the metabolome can provide a comprehensive evaluation of the physiological state of 
an organism coupled with unique insights into specific biochemical processes (Oliver et 
al., 1998, Fiehn, 2001, Fiehn, 2002).  The size of the metabolome varies greatly 
depending on the organism studied, for example Saccharomyces cerevisiae contains 
approximately 600 metabolites (Forster et al., 2003) whereas the plant kingdom is 
estimated to have a total of approximately 200,000 metabolites although individual 
species have significantly lower numbers (Fiehn, 2001).  The metabolome is more 
diverse in chemical and physical properties than the genome or the proteome due to 
the greater variations in atomic arrangements (Dunn et al., 2005).  Consequently, 
metabolomic investigations comprise the analyses of an extensive range of chemical 
species, from low molecular weight polar volatiles such as ethanol, to high molecular 
weight polar glucosides, non-polar lipids and inorganic species (Dunn et al., 2005, 
Lahner et al., 2003).  Furthermore, the range of metabolite concentrations present in a 
cell can vary over nine orders of magnitude (pM-mM), making analysis of the 
metabolome significantly more complex than that of the genome or proteome (Dunn et 
al., 2005).   
 
1.3.1 Applications of Metabolomics 
Metabolomics is a complementary technique to the other ‘omics disciplines and is 
perceived as having a number of advantages (Goodacre et al., 2004).  As the final 
downstream product of the genome, the metabolome more accurately reflects the 
activities of the cell at a functional level and changes in the metabolome are amplified 
relative to the proteome or the transcriptome (Urbanczyk-Wochniak, 2003).  In general 
the number of metabolites is lower than the number of genes or gene products 
(Raamsdonk, 2001).  Changes in the quantities of enzymes have significant effects on 
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metabolite concentrations despite having little effect on metabolic fluxes (Raamsdonk, 
2001).  However, some research has found metabolic flux analysis to be very useful for 
understanding biochemical processes in cancer (Boros et al., 2003, Boros et al., 2002, 
Boros et al., 2004, Lane et al., 2009, Fan et al., 2009, Forbes et al., 2006).  In addition, 
there is evidence that metabolic fluxes are regulated by environmental stresses as well 
as gene expression (Johnson et al., 2003), and therefore the measurement of the 
metabolome may be a more sensitive technique to yield information about the 
biological system (Brown et al., 2005, Harrigan and Goodacre, 2003).  Global 
metabolomics approaches have been applied to many different areas of biological and 
clinical study including; clinical diagnosis (Lindon et al., 2003, Nicholls et al., 2001, 
Matsumoto and Kuhara, 1996, Rashed, 2001, Brindle et al., 2002), mode of action 
investigations (Allen et al., 2004, Aranìbar et al., 2001), microbial systems (MacKenzie 
et al., 2008, Smedsgaard and Nielsen, 2005), metabolic engineering studies (Fiehn et 
al., 2000, Weckwerth et al., 2004, Bro and Nielsen, 2004) and environmental stress 
(Viant, 2007, Viant et al., 2003). 
 
1.3.2 Instrumentation Employed in Metabolomics Investigations 
The biochemical status of an organism can be revealed through the qualitative and 
quantitative measurements of its cellular metabolites and these data can be employed 
to both monitor, and determine gene function (Fiehn, 2001, Fiehn, 2002).  The analytes 
studied vary greatly in both concentration and nature and this complexity makes the 
simultaneous profiling of the global metabolome particularly challenging to the 
analytical technologies employed in metabolomics investigations.  At present no single 
analytical technology or extraction method is able to detect every metabolite (Hall, 
2006).  Therefore, a range of targeted extraction procedures and analytical 
technologies are employed (Sumner et al., 2003, Weckwerth, 2003). 
 
A range of terminologies have been applied to the varying metabolomics approaches 
and these are detailed in Table 1.1.  Metabolomics studies may employ a wide range of 
metabolic fingerprinting and profiling methods.  Metabolic fingerprinting methods 
involve the high-throughput analysis of crude samples or simple cellular extracts and 
provide a global metabolite fingerprint.  These techniques are frequently employed in 
the classification or screening of samples (Johnson et al., 2003, Winder et al., 2004, 
Winder et al., 2006).  However, quantification and identification of metabolites is not 
generally carried out in this approach (Dunn et al., 2005).  Fingerprinting methods 
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present an inexpensive means of screening a biological system prior to metabolic 
profiling with more costly techniques (Kaderbhai et al., 2003).  Metabolic profiling 
methods commonly employ hyphenated mass spectrometry (MS) approaches with the 
aim of detecting, identifying and quantifying the metabolites within a biological sample 
(Bino et al., 2004, Dunn et al., 2005).  
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Table 1.1:  Terms and Definitions used in Metabolomics. 
Term Definition 
 
Metabolome 
 
The complete biochemical complement present in an  
organism (Fiehn, 2002, Goodacre et al., 2004). 
 
Metabolomics Non-biased identification and quantification of all metabolites 
within an organism or biological system. Requires the use of 
highly selective and sensitive analytical techniques.   
 
At present, no single analytical technique, or combination of 
techniques can determine all metabolites in microbial, plant or 
mammalian metabolomes (Dunn et al., 2005, Goodacre et al., 
2004, Kell, 2006). 
 
Metabonomics The quantitative analysis of the dynamic multiparametric 
metabolic response of living systems to pathophysiological 
stimuli or genetic modification (Nicholson et al., 1999). 
 
Often used synonymously with metabolomics 
 
Metabolic profiling The identification and quantification of metabolites related 
through similar metabolic pathways or chemistries.   
 
Chromatographic separation is normally employed prior to 
detection. 
 
Targeted 
metabolite analysis 
The quantitative determination of one or a few metabolites 
related to a specific metabolic pathway following extensive 
sample preparation and separation from the sample matrix.   
 
This approach employs chromatographic separation and 
sensitive detection 
 
Metabolic flux 
analysis 
The quantitative monitoring of whole network operation.  MFA 
provides a global perspective on the integrated regulation at 
all levels (including gene expression, enzyme kinetics, and 
allosteric regulation) (Sauer, 2005). 
 
Metabolic 
fingerprinting 
Rapid and high-throughput methods where global metabolite 
profiles are obtained for sample classification or screening.   
 
Analysis is of crude samples or simple cellular extracts.  
Identification and quantification of metabolites is not 
performed.   
 
Metabolic 
footprinting 
The global measurement of metabolites secreted from the 
intracellular complement into the extracellular growth 
medium.   
 
High-throughput method which requires minimal metabolite 
quenching and extraction.  Has been frequently employed in 
microbial metabolomics. 
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1.4 Metabolic Fingerprinting Technologies  
Metabolic fingerprinting is the high-throughput screening of intact samples and cellular 
extracts.  These biochemical fingerprints are usually analysed with chemometrics 
techniques and used to model relationships between samples and to classify them 
according to their origin or biological relevance (Fiehn, 2001).  Metabolic fingerprinting 
provides “biochemical snapshots” of biological samples at a specific time (Dunn et al., 
2005). 
 
One of the popular approaches for metabolic fingerprinting is based on vibrational 
spectroscopy.  These techniques measure the vibrations of bonds within functional 
groups when they interact with electromagnetic (EM) radiation (light).  The two 
vibrational spectroscopy techniques that are used routinely for metabolic fingerprinting 
(or what has been termed disease pattern recognition (Himmelreich et al., 2003, 
Petrich et al., 2000, Staib et al., 2001)) include: Fourier transform infrared (FT-IR) 
spectroscopy, which is based on the absorption of EM radiation; and Raman 
spectroscopy, which is based upon inelastic light scattering (Choo-Smith et al., 2001).  
These vibrational spectroscopy techniques are not as sensitive as mass spectrometry 
or nuclear magnetic resonance (NMR) spectroscopy methods and do not provide 
metabolite identification from complex biological samples, however, they do provide a 
relevant metabolomics tool.  Fourier transform-infrared (FT-IR) spectroscopy is 
currently the most frequently employed technique in metabolic fingerprinting and 
enables the rapid, non-destructive and comparatively inexpensive analysis of complex 
biological systems (Dunn et al., 2005, Kell, 2004, Oliver et al., 1998).  Therefore, FT-IR 
spectroscopy provides a first round screening, or starting point for metabolomic 
analyses, which may direct the focus of more extensive metabolomics studies in 
complementary and more sensitive analytical platforms (Dunn et al., 2005).   
 
 
1.4.1 FT-IR spectroscopy 
Infrared spectrometers have been commercially available since the 1940s; however, 
the technology employed a conventional prism and grating monochromators and each 
wavelength within the IR region had to be measured in succession.  This technology 
therefore, had several drawbacks with respect to analysis time, heat damage, 
sensitivity and reproducibility.  The most significant advances in infrared spectroscopy 
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occurred with development of the interferometer and the introduction of the 
mathematical Fourier transform.  The utilisation of these methods enables the rapid 
and simultaneous analysis of the entire IR spectrum (Banwell and McCash, 1994).  
Consequently, the field of FT-IR spectroscopy has made great strides within recent 
years (Stuart, 1996). 
 
Infrared spectroscopy is based on the various vibrations of the bonds between the 
atoms of a molecule.  Following interrogation with IR light the functional groups within a 
sample absorb the light at specific wavelengths and vibrate in bending, twisting and 
stretching motions thus causing changes in the dipole moment of that bond.  FT-IR 
spectroscopy measures the frequency and intensity of the radiation which is absorbed 
by a sample and the resultant spectrum is therefore representative of these various 
vibrations (Banwell and McCash, 1994).  The determination of such factors may 
provide insight into the chemical composition of a biological sample or allow for the 
identification of an unknown compound (Harrigan and Goodacre, 2003). 
 
The infrared spectrum can be divided into three regions corresponding to 
wavenumbers between 14000 – 4000 cm-1 (near-infrared), 4000 – 400 cm-1 (mid-
infrared) and 400 – 10 cm-1 (far-infrared).  Measurement of the far-infrared (FIR) region 
is more difficult that that of the near- and mid-infrared regions due to the weakness of 
the source employed.  A mercury lamp is most often employed as the source for 
measurement of the FIR; however the signal-to-noise ratio is often higher than that of 
the mid- or near-infrared regions.  Consequently, the majority of infrared applications 
utilise the mid-infrared (MIR) and near-infrared (NIR) regions.  Measurement of the NIR 
region provides information regarding the absorption characteristics of CH, OH and NH 
groups (Belton et al., 1987, Dunn et al., 2005).  The spectra produced from the NIR 
region contain broad features which strongly overlap and therefore require high levels 
of statistical manipulation (Belton et al., 1987).  In contrast, measurement of the MIR 
region gives information regarding the chemical and structural composition of a sample 
which is open to direct interpretation (Griffiths and de Haseth, 2007).  Thus, the use of 
the MIR in metabolomics FT-IR spectroscopy applications is currently favoured 
(Johnson et al., 2003, Johnson et al., 2004, Dunn et al., 2005).  The IR absorption of 
water is particularly strong within the MIR region resulting in the production of broad 
bands in the spectra which may mask the biologically important chemical information.  
These effects may be removed from the FT-IR spectra by post-analysis data 
processing methods, however, the most common approach employed is the drying of 
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samples prior to analysis (Johnson et al., 2003, McGovern et al., 1999, Timmins et al., 
1998, Schuster et al., 2001, Curk et al., 1994).  Alternatively an optics accessory such 
as an attenuated total reflectance (ATR) cell may be employed for the sampling of 
liquids such as plasma or growth media.  It is composed of a crystal such as zinc 
selenide and reduces the absorption of water enabling the direct and non-destructive 
analysis of liquids (Bouhedja et al., 1997, Winder and Goodacre, 2004, Dunn et al., 
2005). 
 
The MIR region may be further broken down into 5 major regions of biological 
significance (Forster et al., 2003).  These regions are termed the fatty acid region 
(3000 – 2800 cm-1), the amide region (1700 – 1500 cm-1) which can be divided into 
bands dominated by amide I and amide II, a region at wavenumbers 1450 - 1200; 1200 
– 1250 cm–1 displaying vibrations from the carboxylic groups of proteins and PO2– of 
phosphodiesters, the polysaccharide region (1200 – 900 cm-1) and the fingerprint 
region (<900 cm-1) which consists of a variety of weak spectral features (Dunn et al., 
2005, Naumann et al., 1996) (See Figure 1.4 for further details).  The characteristics of 
the spectra; the frequency, intensity, number of bands and half widths are distinctive, 
therefore providing a unique fingerprint for the sample (Naumann et al., 1991b). 
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Figure 1.4:  A typical FT-IR absorbance spectrum of Pseudomonas aeruginosa PA14.  The 
major regions of biological interest are highlighted A-E.  Refer to Table 1.2 for further details. 
 
 
 
 
Table 1.2:  Major spectral regions of biological interest. 
 Wavenumber (cm-1) range Dominant Compounds 
A 3000-2800 CHx stretches from fatty acids 
   
B 1700-1500  
   (1700-1600) 
   (1600-1500)   
Proteins 
   C=O from amide I 
   C-N and C-N-H from amide II 
   
C 1450-1200 
 
   (1250-1200) 
Carboxylic groups of proteins, free amino acids, 
polysaccharides 
   P-O from RNA/DNA, phospholipids 
   
D 1200-900 C-O or O-H from polysaccharides 
   
E <900 Unassigned 
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Figure 1.5 highlights the basic components of an FT-IR spectrometer.  Infrared 
radiation emerges from the source, passes through the interferometer to the sample.  
The IR radiation is absorbed by the sample before reaching the detector.  The signal is 
then amplified prior to conversion to a digital form by an analogue to digital converter 
and then transferred to a computer when the Fourier transformation is carried out and 
the data are converted to an IR spectrum (Stuart, 1996). 
 
 
Source Interferometer Sample Detector Amplifier
Analogue/ 
digital 
converter
Computer
 
Figure 1.5:  Flowchart of the components of an FT-IR spectrometer. 
 
 
1.4.1.1 The Infrared Source 
The source of infrared emission in IR spectrometers typically consists of an inert solid 
filament which is electrically heated to incandescence.  The most commonly used mid-
infrared source is the Globar, which is a resistively heated rod constructed of silicon 
carbide (Griffiths and de Haseth, 2007).  In addition, the Nernst glower, which is 
composed of a mixture of refractory oxides, and a tungsten filament is commonly 
employed (Griffiths and de Haseth, 2007).  Following heating of the source to 
incandescence, IR radiation is emitted and directed to a power mirror, which directs the 
IR beam through an aperture resulting in collimation of the beam.  A series of flat 
mirrors then direct the IR beam to the interferometer (Stuart, 1996, Griffiths and de 
Haseth, 2007, Banwell and McCash, 1994). 
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1.4.1.2 The Michelson Interferometer 
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Figure 1.6:  A Michelson interferometer showing planar mirrors and the beamsplitter.  Adapted 
from Stuart (1997).   
 
 
The Michelson interferometer is the basic optical component of the FT-IR spectrometer 
(Figure 1.6) (Stuart, 1996).  It consists of two mirrors, one of which is stationary and the 
other of which can travel in a direction perpendicular to the plane.  The planes of these 
two mirrors are bisected by a semi-reflecting film termed the beamsplitter.  The 
beamsplitter is composed of material which is chosen according to the infrared region 
of investigation.  For the near- or mid-infrared region, an infrared transparent substrate 
such as caesium iodide or potassium bromide is employed.  The substrate is coated 
with germanium or iron oxide, and 50% of the radiation falling onto the beamsplitter is 
reflected by this coating (Stuart, 1996, Banwell and McCash, 1994).   
 
Once the IR beam reaches the interferometer it is directed onto the beamsplitter, the 
coating of which reflects 50% of the beam to the stationary mirror.  The mirror reflects 
the beam back to the beamsplitter, where it has travelled a fixed distance.  The 
remaining 50% of the beam transmits through the beamsplitter to the moving mirror 
where it is reflected back to the beamsplitter and the two IR beams recombine and 
interfere.  The transmitted beam interferes destructively and the reflected beam 
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interferes constructively (Stuart, 1996, Banwell and McCash, 1994).  The spectral 
information is contained within this interference, which is then directed to the detector.  
The moving mirror produces a difference in the optical path between the two mirrors.  It 
therefore has to be aligned in order to enable it to accurately scan distances.  This 
alignment is carried out by a visible helium neon (HeNe) laser which is focused onto 
the corner of the mirror (Stuart, 1996, Griffiths and de Haseth, 2007, Banwell and 
McCash, 1994).   
 
The interferometer enables the simultaneous and rapid analysis of all of the 
frequencies within the infrared spectrum.  The function of the interferometer is to 
produce a novel signal of lower frequency than the original IR signal of a type that the 
detector can recognise.  The resulting variations in beam intensity are then measured 
as a function of path difference.  In FT-IR spectroscopy the spectral resolution is limited 
by the maximum path difference between the two infrared beams and the limiting 
resolution in wavelength (cm-1) is calculated as the reciprocal of the pathlength 
difference (cm).  A key advantage of rapid scanning instruments is the potential 
increase in the signal-to-noise ratio (SNR).  This may be achieved by the collection of a 
number of interferograms which are then signal averaged (referred to as co-adds) by 
the computer.   
 
1.4.1.3 The Infrared Detector 
There are two types of detectors which are most commonly used in the mid-infrared 
region.  The most common detector is a pyroelectric device which incorporates 
deuterated triglycine sulphate (DTGS) in a temperature resistant alkali halide window 
(Stuart, 1996).  These thermal detectors are commonly employed due to their 
sensitivity across the entire infrared range (Banwell and McCash, 1994).  
Photoconductive detectors such as mercury-cadmium-telluride (MCT) are often 
employed in more sensitive applications.  This type of detector contains conductive 
bands in which electrons are readily excited by the absorption of energy from an 
external source such as infrared radiation (Banwell and McCash, 1994).  MCT 
detectors are highly sensitive and have a rapid response compared with DTGS 
detectors, requiring minute levels of excitation energy (Banwell and McCash, 1994).  
Consequently, excitation of electrons within the detector may effected by thermal 
sources other than the infrared radiation and are therefore cooled with liquid nitrogen 
(Griffiths and de Haseth, 2007).   
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1.4.2 FT-IR Microspectroscopy 
FT-IR microspectroscopy, referred to as fast or hyperspectral imaging, is a relatively 
recent development, combining the data obtained from mid-infrared spectroscopy with 
the ability to acquire this data in a spatially resolved manner (Lewis et al., 1995, Snively 
et al., 1999, Treado et al., 1994).  A FT-IR imaging dataset contains both spatial and 
spectral information regarding the sample under investigation.  The typical dimensions 
of a FT-IR imaging dataset range from 64 × 64 to 320 × 256 pixels, within which, each 
pixel contains an infrared spectrum (Snively et al., 1999).  This technique enables 
analysis of the spatial distribution of functional groups which may be connected to 
specific components within a cell or tissue sample (Patel et al., 2008, Lewis et al., 
1995, Beardall et al., 2001, Lasch et al., 2002).   
 
Traditionally FT-IR microscopes were employed to generate chemical maps by a single 
pixel at a time.  In this approach the stage is moved over a raster in order to collect the 
spectrum for each individual pixel to generate a FT-IR map (Lewis et al., 1995).  This 
lengthy technique is both time consuming and limiting in respect to the fidelity of the 
images acquired.  The use of a focal-plane array (FPA) detector significantly reduces 
the acquisition time, thus permitting the measurement of high density chemical maps in 
seconds to minutes (Lewis et al., 1995).  FT-IR imaging currently employs a step-
scanning approach in which the moving mirror waits for the detector read-out prior to 
moving to the next position.  In this approach all of the interferograms are collected 
simultaneously and subsequently transformed into IR spectra.  The instrumentation is 
generally composed of a step-scan FT-IR spectrometer as a light source, a microscope 
with Cassegrainian optics, and an FPA detector (Snively et al., 1999).  The moving 
mirror of the interferometer modulates the light coming from the spectrometer and this 
is translated in order to collect a dataset.  At specific intervals (i.e., retardations), the 
intensity values for all of the pixels are measured, resulting in the collection of a 
complete interferogram for each pixel in the array (Snively et al., 1999).  Subsequent 
Fourier transformation of all of the interferograms produces an array of infrared spectra 
which are spatially resolved (Snively et al., 1999).  The pixel size is diffraction limited 
and therefore the resolution is typically in the 4 - 10 µm range in the mid infrared 
region.  
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1.4.3 Applications of FT-IR spectroscopy 
The principal applications of FT-IR spectroscopy in the study of complex biological 
systems have been in the field of microbiology.  In general FT-IR spectroscopy has 
been applied to biomedical and industrial studies and has previously been used to 
generate informative metabolic fingerprints from biological material (Johnson et al., 
2004, Winder et al., 2007).  Previous studies have also proved its applicability to 
biological systems by successfully demonstrating the discrimination of bacteria to sub-
species level (Winder et al., 2006, Timmins et al., 1998, Naumann et al., 1991a). The 
high-throughput nature of the technique combined with the minimal sample preparation 
has proven the technique ideal for the rapid identification of clinically significant 
bacterial isolates such as, Eubacterium associated with oral infections (Alsberg et al., 
1998), and the differentiation between Candida isolates (Timmins et al., 1998, 
Udelhoven et al., 2000).  FT-IR spectroscopy has also been applied to the field of 
disease pattern recognition (Petrich et al., 2000, Staib et al., 2001) and to the grading 
of lymphoid tumours (Andrus and Strickland, 1998).  In addition, FT-IR spectroscopy 
has been successfully employed to monitor industrial fermentation processes for the 
quantification of metabolite production (McGovern et al., 2002, Schuster et al., 2001).  
The technique has also been employed in the field of plant science, with application to 
the discrimination and classification of plants, including the study of Arabidopsis cell 
wall mutants (Wang et al., 1998, Mouille et al., 2003) and plant responses to abiotic 
stresses (Johnson et al., 2003, Johnson et al., 2004).  In more recent years FT-IR 
spectroscopy has been successfully applied to environmentally relevant investigations 
such as the study of microbial survival during extreme starvation (Barton and Northup, 
2007, Bullen et al., 2008), the discrimination of mycobacteria (Winder et al., 2006) and 
the metabolic effect of salinity in both plant (Johnson et al., 2003) and animal (Bussell 
et al., 2008) species.   
 
The application of FT-IR imaging has been successfully demonstrated in the study of 
biological (Heraud et al., 2005, Kidder et al., 1997, Lewis et al., 1996) and chemical 
(Bhargava et al., 1998, Oh and Koenig, 1998) systems and is popular for the study of 
spatially heterogeneous samples (Snively et al., 1999).  The high spatial resolution now 
available with FT-IR microspectroscopy has allowed investigations of the minute details 
in leaf tissues (Heraud et al., 2007), the classification of malignant gliomas (Krafft et al., 
2007) the study of abiotic perturbations in environmentally relevant microorganisms 
(Patel et al., 2008) and the investigation of single cells to the sub-cellular level (Lasch 
et al., 2002, Giordano et al., 2001).  Furthermore, FT-IR spectroscopy has been 
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successfully applied to the investigation of sub-cellular changes in living algal cells 
induced by nutrient starvation (Heraud et al., 2005).   
 
1.5 Mass Spectrometry 
Mass spectrometry (MS) is a powerful detection method and is widely employed in 
metabolomics investigations.  MS is commonly combined with chromatographic 
techniques such as gas chromatography (GC) and liquid chromatography (LC ) and the 
use of hyphenated-MS instrumentation improves quantification and compound 
identification (Dunn et al., 2005).  Identification of metabolites is possible by spectral 
library matching with standard compounds, interpretation of mass spectra or 
determination of the molecular formula from accurate mass measurements (Dunn et 
al., 2005). 
 
In GC-MS, compounds are separated by GC and then transferred online to a mass 
spectrometer for further separation and detection (Kopka et al., 2004).  The use of GC-
MS combines two highly complementary techniques: GC separates metabolites on the 
basis of polarity and boiling point and is able to separate metabolites that have nearly 
identical mass spectra such as isomers, whilst the fragmentation patterns produced by 
MS can differentiate between co-eluting, but chemically diverse metabolites, which can 
then be identified by database searching (Kopka et al., 2004).  GC-MS is the most 
widely used technology in metabolomics and has been described as the ‘gold’ standard 
(Harrigan and Goodacre, 2003). 
 
1.5.1.1 Metabolite Extraction 
The extraction process should be both non-selective and comprehensive; however, 
each extraction method introduces a level of chemical bias towards a particular group 
of metabolites.  For example metabolites such as carbohydrates have a high solubility 
and are therefore typically extracted in methanol:water.  However, non-polar 
metabolites such as lipids have low solubilities and are therefore typically extracted in 
chloroform.  Consequently, a range of extraction methods may be considered in order 
to obtain a comprehensive metabolite profile from a sample (Soga et al., 2003, Winder 
et al., 2008).    
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1.5.1.2 Derivatisation 
Volatile low-MW metabolites may be sampled and analysed directly.  However, the 
majority of metabolites analysed require chemical derivatisation prior to analysis to 
provide volatility and thermal stability (Roessner et al., 2000, Dunn et al., 2005).  
Derivatisation is a two step process: methoximation is carried out in order to convert 
carbonyl groups to oximes therefore eliminating slow and reversible silylation reactions.  
Trimethylsilylation is then carried out, during which exchangeable protons are replaced 
with trimethylsilyl esters.  The stability of samples is of concern as residual water within 
the samples can result in the breakdown of trimethylsilyl esters.  However, this effect 
can be reduced by extensive sample drying (Dunn and Ellis, 2005).   
 
1.5.1.3 Ionisation and Detection 
Electron impact (EI) ionisation is the most widely used ionisation method for GC-MS as 
it is highly reproducible, and provides molecular ion fragmentation.  This fragmentation 
results in the production of a mass spectrum which is indicative of the metabolites 
structure, therefore aiding the identification of the metabolite (Dunn et al., 2005, Kopka 
et al., 2004).  Typically, three types of detector may be employed in GC-MS couplings, 
and the sensitivity of detection may be influenced by the mass spectrometer employed 
(Dunn et al., 2005).  Mass detection may be conducted by either single quadrupole 
detectors (QUAD), ion-trap technology (TRAP), or time-of-flight detectors (TOF) (Kopka 
et al., 2004).  QUAD detectors may be employed in single ion monitoring mode in order 
to enhance sensitivity.  This method also generally has a wider dynamic range than 
TRAP or TOF instruments.  However, information regarding the metabolites present 
within a sample is required and so this method may introduce bias into metabolic 
profiling studies (Dunn et al., 2005).  TOF detectors do not require such information 
regarding the sample, are high-throughput and can provide good sensitivity (Dunn et 
al., 2005, Kopka et al., 2004). 
 
1.5.1.4 Deconvolution 
The chromatograms produced by GC-MS are complex, containing hundreds of 
metabolite peaks and are further complicated by multiple derivatisation products (Dunn 
and Ellis, 2005).  The application of retention indices (RI) aids metabolite identification 
by the alignment of chromatograms.  Deconvolution software acts by using pure mass 
spectra to define chromatographic peaks, including overlapping peaks.  It also 
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potentially allows reductions in run time, from approximately 60 minutes to less than 15 
minutes (Dunn et al., 2005, Roessner et al., 2000, Weckwerth et al., 2004), as full 
chromatographic separation is not required, and, in many metabolomics analyses, is 
difficult or impossible to achieve (Dunn et al., 2005).  Metabolites are then identified by 
matching their chromatographic retention times and mass-spectral fragmentation 
patterns to known information available in databases (Wagner et al., 2003). 
 
Targeted GC-MS analyses can provide absolute quantification of the level of a given 
metabolite in a concentration range of up to four orders of magnitude, provided that 
appropriate external and internal standardisation have been carried out (Dunn et al., 
2005).  However, each step during extraction, preparation and analysis can introduce 
general and substance-specific losses and these can vary with the biological material.  
Current methods are capable of detecting trisaccharides, steroids, diglycerides and 
some monophosphorylated metabolites (such as glycerol 3-phosphate and glucose 6-
phosphate), but most polyphosphorylated and activated metabolic intermediates are 
presently not accessible to GC-MS analyses.  Another major limitation of GC-MS is that 
many of the peaks are still unidentified.  Some of these unidentified peaks may be 
analytes generated during extraction or by fragmentation in the MS step, but others 
may be significant and even novel metabolites (Kopka et al., 2004).  However the 
development of mass spectral libraries and databases aims to improve the chemical 
identification of these peaks (Allwood et al., 2006, Brown et al., 2009, Kopka et al., 
2005, Wishart et al., 2009).   
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1.6 Multivariate Data Analysis 
Metabolomics experiments generate extensive amounts of multivariate data, and the 
differences between samples are not generally discernable by visual inspection.  In 
addition, only a few of these data points may be required in order to describe the 
problem sufficiently (Goodacre et al., 2004).  It is therefore essential to extract the most 
meaningful elements of these data for the generation of new knowledge in a robust and 
interpretable manner (Goodacre et al., 2004, Eriksson et al., 2004).  Multivariate 
statistical analyses are an important tool for the analysis of complex spectral 
information and are used to extract the maximum information from these datasets.  
Pattern recognition (PR) strategies may be employed for the reduction of the 
complexity of the datasets produced in metabolomics investigations, and in the 
generation and testing of novel hypotheses (Goodacre et al., 2004).  The use of PR 
algorithms may allow the identification and interpretation of non-random behaviour in a 
complex system, which may be obscured by noise or random variations within a 
biological system (Lindon et al., 2001a).  There are a number of different pattern 
recognition strategies employed in the analysis of metabolomic data, many of which 
are based on unsupervised methods such as principal components analysis (PCA) 
(Lindon et al., 2001a, Manly, 1994).  This multivariate approach uses clustering 
methods to assess the similarity in a dataset on the basis of their metabolite profiles 
(Goodacre et al., 2004).  In addition, a number of supervised methods may be 
employed in pattern recognition.  Methods such as discriminant function analysis 
(DFA), principal components regression (PCR), partial least squares regression 
(PLSR), genetic algorithms (GAs) and artificial neural networks (ANNs) seek to 
transform multivariate data extracted from metabolite profiles into something of 
biological interest under the guidance of a “teacher” (Goodacre et al., 2004, Manly, 
1994, Martens and Naes, 1989).  Within these techniques there are two types of data; 
inputs which are explanatory variables, and targets (or outputs).  Supervised learning 
aims to find a “model” in which these data are correctly associated (Goodacre et al., 
2004). 
 
1.6.1 Data Pre-processing 
In metabolomics investigations the multivariate data are generally arranged in a matrix 
in which each row corresponds to a sample and each column corresponds to one 
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variable (e.g. metabolite, or wavenumber).  The matrix, termed X, has N rows 
(samples) and K columns (variables), (Figure 1.7).   
 
K
N
X
 
Figure 1.7:  A visual representation of a dataset or matrix X (input data), employed in 
multivariate analyses.  The dataset X consists of N rows and K columns.  Each row in the matrix 
corresponds to one sample and each column to one variable. 
 
 
Pre-processing of multivariate data prior to statistical analysis is often required in order 
to improve the reproducibility of the data.  The variables within the dataset are often 
mean centred, in which the average of each variable is subtracted.  In addition, the 
variables may be scaled to unit variance such that each variable has an equal chance 
of influencing subsequent statistical analyses.  The pre-processing methods employed 
may be data dependant, and therefore a vast range of methods may be investigated for 
any one experiment.  There are numerous pre-processing methods which may be 
employed in metabolomics data analyses and many of these methods are order-
independent (Goodacre et al., 2007).  The methods most commonly employed in the 
pre-processing of multivariate datasets are detailed in Table 1.3 (Brown et al., 2005, 
Lindon et al., 2001a).   
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Table 1.3:  Methods commonly employed in the pre-processing of multivariate 
datasets.  Adapted from Goodacre et al. (2007). 
Term Description 
 
Normalisation 
 
An operation performed within or across rows in order to make the 
row profiles comparable in size. 
 
Centering An operation performed across the rows in order to translate the 
centre of gravity of the dataset (Keun et al., 2004). 
 
Mean-centering A method which is commonly employed for centering.  Each 
column is expressed in deviations from its mean, across the rows. 
 
Scaling An operation which is performed within a column in order to make 
the column profiles more comparable.  
 
Autoscaling A type of scaling which mean-centres each value of the column 
and then divides the row entries of a column by the standard 
deviation within the column.  
 
Range scaling A scaling method that mean-centres prior to dividing the row 
entries of a column through the range within the column (van den 
Berg et al., 2006).  
 
Pareto scaling A scaling method that mean-centres prior to dividing the row 
entries of a column through the square root of the standard 
deviation within the column.  
 
Transformations 
 
Transformations that linearise or change the scale of the data.  
These could be Log, Square Root, Box-Cox. 
 
Missing Values Data in the table which are not available for analysis. 
 
Outliers Data points which deviate from the distribution of the majority of 
the data.  These data points may be samples, variables or a 
specific combination of both. 
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1.6.2 Principal Component Analysis 
Principal component analysis (PCA; (Jolliffe, 1986, Wold et al., 1987)) is an 
unsupervised multivariate projection method employed as a data reduction strategy in 
which principal components (PCs) are derived that explain the majority of the variance 
within a complex dataset.  The aim of the data compression is to obtain a set of novel 
PCs which describe as much of the variance in the original dataset as possible.  
Reducing the dimensionality of the data allows easier interpretation of the variation 
within a dataset, so that groups, trends and outliers may be identified within the 
samples.  In many cases correlations between variables (e.g. metabolites) occur 
because they change according to some systematic underlying common factor e.g. a 
genetic modification.  PCA has the ability to detect these underlying factors and 
compress the information based upon them.   
 
PCs are new variables which are created from linear combinations of the starting 
variables with the appropriate weighting coefficients (Nicholson et al., 1999).  Each PC 
is orthogonal (uncorrelated) with all the other PCs and consists of one score vector T 
and one loading vector P (Figure 1.8).  The score vector is considered as the new 
variable and the loading vector may be described as the link between the score vector 
and the original variable.  The scores are linear combinations of the original variables 
within the dataset, and the loadings represent the influence (i.e. weighting) of the 
original variables on the scores.   
K
N
X
T
P
 
Figure 1.8:  PCA compresses the information in the data matrix X into scores T and loadings P, 
describing the underlying systematic structures of X
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PCs are commonly calculated using one of two algorithms; the Non-Iterative Partial 
Least Squares (NIPALS) algorithm (Wold, 1966), in which the PCs are calculated 
sequentially; or by Singular Value Decomposition (SVD) (Jolliffe, 1986) in which all of 
the possible PCs are computed in one step.  The length of a PC is termed the 
eigenvalue and is proportional to the amount of variation the PC describes.  The first 
PC contains the greatest variance, with subsequent PCs containing correspondingly 
smaller amounts of variance and at some point the PCs will consist only of data noise 
(Nicholson et al., 1999, Lindon et al., 2001a). 
 
PCA models are both linear and additive; as more PCs are used more of the variance 
within the dataset is explained.  A plot of the first two or three PCs will generally 
provide maximum information content of the data in two dimensions (Jolliffe, 1986, 
Wold et al., 1987).  Thus, PCA offers a rapid method for visualising and comparing the 
variance within a dataset.  Furthermore, PCA is an unsupervised method which does 
not require a priori knowledge of the dataset structure and therefore models the total 
variance within a dataset.   
 
Scores plots may provide insight into the relationships between samples within a 
dataset and can be obtained by plotting the score values for different PCs against each 
other.  In addition outliers within a dataset (i.e. data points which deviate from the 
distribution of the majority of the data.  See Table 1.3) may be identified from PC 
scores plots and removed from the dataset prior to additional analyses.  Plotting the 
corresponding loadings may illustrate the variables responsible for the trends observed 
in these scores plots.   
 
1.6.3 Discriminant Function Analysis 
Discriminant function analysis (DFA; (Manly, 1994)) is a supervised projection method 
which is also known as canonical variates analysis (CVA).  DFA generates a number of 
linear discriminant functions by finding the eigenvalues and eigenvectors of the 
expression: 
 
  W-1B      (Equation 1.1) 
 
Where W is the within group matrix of sums of squares and cross products, and B is 
the between group matrix of sums of squares and cross products. 
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The DFA algorithm cannot analyse datasets which contain colinear variables or too 
many variables, and it is therefore necessary to perform a data compression such as 
PCA, prior to the analysis of a multivariate dataset, and the combination is referred to 
as PC-DFA (Goodacre et al., 1998).  A priori knowledge of class structure is employed 
to achieve the supervision of the algorithm.  Each group of samples is mean centred to 
each of the group means, from which the within group matrix of sums of squares and 
cross products (W) is calculated.  In order to determine the corresponding between 
group matrix (B) the algorithm calculates the difference between W and the total sum of 
squares and cross products.  These matrices are employed by the algorithm in 
Equation 1.1 in order to determine the Fisher (F) ratio (the ratio of between-group to 
within-group variance).  The linear combination of discriminant functions that maximise 
F for the dataset is then sought by the algorithm. 
 
The a priori class structure employed by the DFA algorithm may be based on technical 
experimental replicates, which do not bias analyses designed to observe or model the 
class structure of biological replicates in an experiment (e.g. for the classification of 
unknown microorganisms) (Jarvis and Goodacre, 2004b).  Alternatively, for 
experiments designed to observe or model the class structure according to other 
parameters (e.g. exposure to abiotic perturbation) the a priori class structure may be 
based on the biological replicates (Lopez-Diez et al., 2005).   
 
As DFA is a supervised technique, appropriate validation (Section 1.6.6) methods need 
to be employed in order to ensure that the quality of the data is of a high standard, and 
that the subsequent conclusions drawn from the data are valid.   
 
1.6.4 Principal Component Regression 
Principal component regression (PCR; (Gemperline et al., 1991)) is a supervised linear 
regression method the purpose of which, is to provide an estimation of the values of a 
response variable (Y; e.g. API concentrations) on the basis of selected PCs of the 
explanatory variables (X; e.g. FT-IR spectra).  In this approach PCA is first carried out 
on the dataset and the PC scores are then regressed against the response variables 
(e.g. concentration of abiotic perturbation).   
 
The explanatory variables in multivariate datasets are often highly correlated 
(multicollinearity) and this may lead to the inaccurate estimation of the least squares 
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regression coefficients.  Such difficulties are avoided by decomposition of the data 
matrix (X) into latent variables by PCA, as PCs are uncorrelated.  Furthermore, the use 
of PCs reduces the dimensionality of the regressors as a subset of PCs is typically 
employed in the regression.  This subset usually consists of those PCs which account 
for the highest explained variance within the dataset; however, the PCs which account 
for smaller amounts of variance may also be significant for some analyses (Jolliffe, 
1982).  Moreover as PCA is used it is possible that the largest variation in the data is 
not directly correlated to the Y variable, so alternative regression methods may need to 
be employed. 
 
1.6.5 Partial Least Squares Regression 
The partial least squares regression (PLSR; (Martens and Naes, 1989)) method 
provides another biased (supervised) regression approach with improvements over 
PCR (Geladi and Kowalski, 1986, Höskuldsson, 1995, Wold et al., 2001a, Wold et al., 
2001b, Geladi, 1988, Wold, 1984, Jolliffe, 1986).  It has been shown that PLSR is 
comparable to finding successively linear functions of the predictor variables that have 
maximum covariance with the dependent variables (Jolliffe, 1986, Stone and Brooks, 
1990).  This is reliant upon each of the linear functions being uncorrelated with the 
previous linear functions (Stone and Brooks, 1990).  In contrast to the PCR technique 
which models the variances derived from X, and least squares regression techniques 
which maximise the correlations between Y and X, PLSR combines both correlation 
and variance to model covariance between the predictor matrix (X) and the response 
matrix (Y) (Jolliffe, 1986).  PLSR is particularly useful for the prediction of a set of 
dependent variables from a large set of independent variables, and can deal efficiently 
with multivariate datasets that are highly correlated and contain noise.  PLSR allows 
the relationships between different blocks of data to be derived using modelling with 
“latent variables” which are derived by an iterative procedure.  These latent variables 
are mutually orthogonal (uncorrelated) within each data block and are linear 
combinations of the original variables (Martens and Naes, 1989, Lindon et al., 2001a).   
 
PLSR employs the latent variables (i.e. scores) of X to explain the variance in both X 
and Y (whereas PCA only models the variance in X).  Consequently, the aim is also 
different in the calculation of the latent variables in PLSR and the variance in X which is 
needed to predict the variance in the response variable (Y) is extracted (See Figure 
1.9).  The first score (T1) is calculated by the algorithm in order to maximise the 
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covariance between the T1 score vector and Y.  The weight vector W1 contains the 
influence of the original variable in X on the T1 score.  Information regarding the 
variance described by the T1 score vector is contained in the P1 and C1 loadings of X 
and Y respectively.  The variance explained by the first score vector is removed from 
the X and Y matrices by the subtraction of T1P1 and T1C1 from X and Y resulting in 
the formation of the residuals E and F respectively.  These residuals replace the 
original X and Y, and the method is repeated until the optimal number of components 
has been calculated.   
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Figure 1.9:  PLSR combines both correlation and variance to model covariance between the 
predictor matrix (X) and the response matrix (Y). 
 
 
The number of significant components in a PLSR model can be estimated through the 
use of validation techniques (Wold, 1978).  PLSR models may be validated through 
either internal or external techniques.  Cross validation is commonly used for internal 
validation (Wold, 1978) and may be employed to estimate the number of model 
components and to estimate the predictive capability of the model.  For external 
validation techniques, the PLSR model is used to predict a test set of samples with 
known responses (Y) and the accuracy of the predictions is assessed based upon the 
size of the root mean square error of prediction (RMSEP).  For each response variable 
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in Y a RMSEP value is obtained and is presented in the same units as the response 
(e.g. µg mL-1 for concentration based studies).  In external validation techniques, 
samples that have not been employed to build the model are predicted, therefore 
providing an independent measure of the predictive ability of the model.  Consequently 
external validation is considered the best method for PLSR model validation 
(Broadhurst and Kell, 2006).   
 
1.6.6 Model Validation 
As highlighted for PLSR, model validation is an essential step in multivariate data 
analysis.  It is carried out in order to ensure that the quality of the model is of a high 
standard, and that the subsequent conclusions drawn from the data are valid.  Without 
the application of appropriate model validation techniques, models may over-fit the 
data, finding relationships between the data and the dependent variables that do not 
hold for subsequent analyses (Picard and Cook, 1984); that is to say, there is a lack of 
generalisation.   
 
A common method of validation is to split the data into three sets; a training set which 
is used for training the model, a validation set which is used to avoid over training of 
the data, and a test set which is used to test the ability of the model to generalise.  
Careful consideration should be taken when splitting the data as the groups should 
represent the spread of the variance within the dataset (Brown et al., 2005, Picard and 
Berk, 1990).  For techniques such as PCR, PC-DFA and PLSR the models are 
generated using the training dataset and the test set is then projected into the same 
ordinate space.  The optimum number of latent variables or PCs may then be selected 
for the model where the validation data falls within the bounds of the training and test 
datasets (Handl et al., 2005, Kaderbhai et al., 2003). 
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1.7 Research Objectives 
There are a number of classes of environmental pollutants of which APIs - with specific 
focus on those which contain a chiral centre - are just one.  Within recent years the 
importance of the interactions of these compounds within the aquatic environment has 
been realised (Escher et al., 2005, Fent et al., 2006, Heberer, 2002).  Information 
regarding the fate and biodegradation of such environmental pollutants is now required.  
 
The intention of this study is to investigate the effects of chiral APIs and other 
environmental pollutants on the metabolome(s) of environmentally relevant 
microorganisms (both axenic cultures and communities) and the metabolic pathways in 
which these pollutants undergo degradation.  The effects of these pollutants will be 
tested in both prokaryotic and eukaryotic systems, and a variety of technologies will be 
employed, including FT-IR spectroscopy and GC-MS.  The chemical analyses of these 
systems will be combined with multivariate analysis methods in order to model the 
metabolic effect of chiral APIs and other environmental pollutants on microbial species.   
 
A combination of multivariate methods will be employed for the effective analysis of the 
analytical data obtained, in order to provide classification of the samples.  In addition it 
is intended that the spectral and chromatographic regions important in the 
discrimination and quantification of the metabolic effects may be identified in order to 
fully appreciate the effects of the pollutants on the microbial systems.  Furthermore, 
any possible degradation products will be identified.  
 
In particular the environmental metabolomics investigation presented here will 
investigate the following areas; 
 
1. The growth dynamics of a range of environmentally relevant bacterial species 
will be monitored following exposure to a range of concentrations of the chiral 
APIs Atenolol and Propranolol.  FT-IR spectroscopy - combined with the 
relevant multivariate analysis methods - will be employed as a metabolic 
fingerprinting tool in order to monitor any phenotypic effects exerted on the 
bacterial species at a range of concentrations and enantiomeric ratios.  In 
addition, GC-MS will be employed for metabolic profiling of the observed of 
chiral specific effects. 
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2. The potential chiral specific effects of the APIs Atenolol and Propranolol will be 
investigated in a eukaryotic system.  FT-IR microspectroscopy will be employed 
in order to monitor the general phenotypic effects and more specific localised 
effects of a range of enantiomeric ratios of the APIs at a given concentration in 
the green alga Micrasterias hardyi.  In addition a wide range of multivariate 
analysis methods will be employed to interrogate the hyperspectral data. 
 
3. The phenotypic effects of the chiral APIs Atenolol and Propranolol and the 
aromatic hydrocarbons toluene and phenol on a complex activated sludge 
community will be investigated.  FT-IR spectroscopy will be employed as a 
phenotypic fingerprinting technique in order to model the phenotypic differences 
in the community following exposure to the various environmental 
contaminants.  In addition, any possible degradation of these compounds will 
be monitored with the use of HPLC or a colorimetric assay. 
 
4. Biochemical changes in the activated sludge community will be monitored 
during the degradation of phenol over a 48 h period through the use of FT-IR 
spectroscopy.  In addition the phenotypic effect of storing the activated sludge 
for extended periods of time (without added phenol), will be determined by FT-
IR analysis in order to understand the ability of this microbial community to 
degrade phenol.  In addition, GC-MS will be employed for metabolic profiling of 
the activated sludge community in order to monitor the changes in the meta-
metabolome during the active degradation of phenol. 
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The work presented in this chapter has been published: 
 
E. S. Wharfe, C. L. Winder, R. M. Jarvis and R. Goodacre (2010) Monitoring the Effects 
of Chiral Pharmaceuticals on Aquatic Microorganisms by Metabolic Fingerprinting.  
Applied and Environmental Microbiology 76, 2075-2085. 
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2.1 Abstract 
The effects of the chiral pharmaceuticals Atenolol and Propranolol on Pseudomonas 
putida, Pseudomonas aeruginosa, Micrococcus luteus, and Blastomonas natatoria 
were investigated.  The growth dynamics of exposed cultures were monitored using a 
Bioscreen instrument.  In addition, Fourier-transform infrared (FT-IR) spectroscopy with 
appropriate chemometrics and high-performance liquid chromatography (HPLC) were 
employed in order to investigate the phenotypic changes and possible degradation of 
the drugs in exposed cultures.  For the majority of the bacteria studied there was not a 
statistically significant difference in the organism’s phenotype when it was exposed to 
the different enantiomers or mixtures of enantiomers.  In contrast, the pseudomonads 
appeared to respond differently to Propranolol, and the two enantiomers had different 
effects on the cellular phenotype.  Furthermore, GC-MS metabolic profiling results 
corresponded with these findings, implying that there were different metabolic 
responses in the organisms when they were exposed to the different enantiomers.  We 
suggest that our findings may indicate that there are widespread effects on aquatic 
communities in which active pharmaceutical ingredients are present. 
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2.2 Introduction 
Active pharmaceutical ingredients (APIs) and their metabolites are ubiquitous in the 
environment (Escher et al., 2005), and the occurrence of APIs in the aquatic 
environment is of growing concern (Fent et al., 2006).  There are a number of routes 
through which APIs and resulting metabolites / degradation products may enter these 
ecosystems, and a common avenue is through the excretion of the APIs and their 
metabolites in urine and faeces.  It is known that APIs have different rates of 
metabolism within man.  For example, the β-blocker Propranolol is almost completely 
metabolised within the liver and only 1-4% of an oral dose is excreted as the 
unchanged API and its metabolites.  By contrast, 40-50% of an oral dose of Atenolol 
(also a β-blocker), is excreted as the API or its constituent metabolites (Ashton et al., 
2004, Carlsson et al., 2006a, Carlsson et al., 2006b).  The subsequent degradation of 
the APIs and their metabolites may also occur at sewage treatment plants (STPs); this 
is usually substrate specific and will vary greatly between APIs.  The rate of adsorption 
to activated sewage sludge during treatment differs between APIs, and is dependant 
on the hydrophobic and electrostatic interactions of the API with the particulates and 
microorganisms within the activated sewage sludge (Fent et al., 2006).  Any remaining 
API and relevant metabolites are diluted into the surface water when the effluent is 
released from the STP.  Hence, many APIs are present in low concentrations (ng - µg 
L-1) in aquatic environments such as rivers, streams and estuaries (Escher et al., 2005, 
Ashton et al., 2004, Carlsson et al., 2006b).  The majority of APIs are neither persistent 
nor highly bioaccumulative; however, the continuous release of APIs into the aquatic 
environment poses a potential risk to aquatic organisms even though the 
concentrations of APIs in receiving waters are quite low (Escher et al., 2005).  
 
Despite little being known about the effects of APIs in the environment, it must be taken 
into account that they are designed to elicit a specific mode of action in humans 
(Escher et al., 2005).  Adverse side effects may be encountered in humans at higher 
doses of these APIs and it can be expected that any beneficial or adverse effect may 
also be observed in aquatic organisms with similar biological functions or receptors.  It 
must also be noted that similar targets may control different metabolic processes in 
different species (Seiler, 2002) and therefore APIs and their metabolites may act 
through additional modes of action in aquatic organisms.  The effects of the APIs may 
be subtle due to the very low concentrations observed in the aquatic environment and 
as a result these effects may go unnoticed (Escher et al., 2005).  It is also likely that the 
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effect of the API will impact on the local population dynamics throughout the whole 
ecosystem, from bacteria up to higher organisms.  To explore the effects of the APIs on 
biological systems a wide range of concentrations should be employed with the 
application of appropriate analytical platforms to profile the complement of biochemical 
components in the cell.  Indeed it is known that APIs could become concentrated in the 
benthic environment of river beds and as bacteria inhabit this niche this community 
may be exposed to higher levels than expected (Thacker, 2005, Halling-Sørensen et 
al., 1998, Pouliquen et al., 1992). 
 
Whilst the effects of APIs in the environment is currently a growing area of research 
there is very little understanding of the environmental effects of chiral pharmaceuticals 
(Fono and Sedlak, 2005, Buser et al., 1999).  A chiral molecule is one that lacks an 
internal plane of symmetry.  The non-superimposable mirror images are termed 
enantiomers and are labelled ‘(R)’ or ‘(S)’ according to a priority system (Cahn Ingold 
Prelog priority rules) based on the atomic number of the molecules substituents.  
Approximately 56% of the APIs currently in use are chiral compounds, 88% of which 
are administered therapeutically as the racemate (i.e. an equal mixture of the two 
enantiomers, represented by the symbol (±)).  The chirality of environmental 
contaminants such as APIs must be taken into consideration in order to fully 
understand the environmental fate and effects of these compounds.  The enantiomers 
of a chiral API are able to interact differently with other chiral compounds such as 
enzymes, and therefore potentially exert different effects when released into the 
environment (Fono and Sedlak, 2005, Buser et al., 1999, Nikolai et al., 2006).  It is 
widely known that the enantiomers of a chiral API may possess differing toxicological 
and biological effects both from each other, and the racemate (an equal mixture of the 
two enantiomers) (Lees et al., 2003, Yang et al., 2005).  It has been shown that the (S)- 
enantiomers of the β-blocking agents Atenolol and Propranolol are more potent in man 
than their respective antipodes (Davies, 1990, Pearson et al., 1989, Kurt et al., 1993, 
Barrett and Cullum, 1968) and that a number of the biotransformation pathways for β-
blockers are stereoselective in humans (Mehvar and Brocks, 2001).  The mode of 
action of the drugs and their enantiomers is not known in prokaryotic systems.  It is 
therefore necessary to enhance our understanding of the fate and biological effects of 
chiral pharmaceuticals on typical microflora from the aquatic environment in order to 
fully appreciate the risks (Huggett et al., 2002).  Of particular interest is the group of 
APIs termed β-blockers as they all contain at least one chiral centre and are generally 
administered therapeutically as the racemate (Mehvar and Brocks, 2001).  In addition, 
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they are widely used with approximately 29 and 12 tonnes of Atenolol and Propranolol 
respectively consumed each year in the UK (Ashton et al., 2004, Carlsson et al., 
2006a, Carlsson et al., 2006b). 
 
In order to explore the effect of the APIs on biological systems we employed Fourier-
transform infrared (FT-IR) spectroscopy, this is a phenotyping technique which has 
previously been used to generate metabolic fingerprints from bacteria (Johnson et al., 
2004, Winder et al., 2007).  Previous studies have proved successful in the 
discrimination of bacteria to sub-species level (Winder et al., 2006, Timmins et al., 
1998, Naumann et al., 1991a) through the detection of subtle changes in the 
biochemical phenotype of the bacteria and the use of FT-IR coupled with suitable 
chemometrics to allow the physiological assessment of bioprocesses has been 
demonstrated.  In addition, the combination of FT-IR and trajectory analysis has proved 
successful in the identification of metabolic changes in fermentations (Johnson et al., 
2004).  FT-IR is an automated high-throughput technique (10-60 s per sample is 
typical); requiring minimal sample preparation, and this makes it relatively inexpensive.  
It is therefore an ideal screening method to explore the effect of the APIs on a number 
of bacterial systems. 
 
In this study the chiral specific metabolism of the β1 – selective adrenergic blocking 
agent Atenolol and the non-selective β-adrenergic blocking agent Propranolol by a 
range of environmental microorganisms was investigated (Ternes, 1998, Fono and 
Sedlak, 2005, Roberts and Thomas, 2006).  FT-IR spectroscopy was employed to 
monitor biochemical changes in the spectral fingerprint of the whole bacterial cells 
during the growth of these microorganisms in the presence of the selected APIs.  The 
fate of the API was monitored with chiral HPLC, enabling quantification of the 
enantiomers.  In addition, GC-MS was employed in order to monitor the changes in the 
metabolite profiles of two pseudomonads following exposure to a range of enantiomeric 
ratios of Propranolol.  
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2.3 Materials and methods 
2.3.1 Cultivation of Bacteria 
In order to monitor the effects of the chosen APIs within the aquatic environment a 
variety of microorganisms were selected for investigation.  All of the microorganisms 
employed within this study have been reported to be commonly found within the 
aquatic environment, and are amenable to growth in the laboratory.  Four bacteria were 
selected for this study, Pseudomonas putida KT2440 which has been known to inhabit 
freshwater streams and activated sewage sludge (John and White, 1998, Martínez-
Bueno et al., 2002), P. aeruginosa PA14 which is commonly isolated from freshwater 
streams (Tan et al., 1999), and Micrococcus luteus 2.13 (Rickard et al., 2000), and 
Blastomonas natatoria 2.1 (Sly and Cahill, 1997, Rickard et al., 2000) which have been 
isolated from freshwater biofilms.  The bacteria were cultured in R2A medium 
(Reasoner and Geldreich, 1985) at 15 °C for 24 h, 200 r.p.m. in a Multitron (INFORS 
HT, Switzerland) orbital shaker unless otherwise stated.  The pure enantiomers (i.e. 
(R)- and (S)-) of both Atenolol and Propranolol (as hydrochloride) were purchased from 
Sigma-Aldrich Company Limited, (Poole, Dorset, U.K.).   
 
2.3.2 Screening of microorganisms for growth in the presence of APIs 
The growth of the bacteria was monitored (at 600 nm using a Bioscreen 
spectrophotometer (Labsystems, Basingstoke, U.K.)) for each microorganism at a 
range of concentrations (10-130 µg mL-1) of each enantiomer of the API and the 
racemate.  The data collected from these investigations were used to calculate the 
specific growth and death rates (this is when the rate of cell death or lysis exceeds the 
rate of growth so that a decrease is observed in the turbidity of the culture (Rice and 
Bayles, 2003)) from the exponential phases using the following equation: 
 
( )10 10
2 1
log OD2-log OD1
µ=2.303
t -t
 
Where: log10OD1 = log10 value of OD reading at time point 1 
 log10OD2 = log10 value of OD reading at time point 2 
 t1 = time point 1 and t2 = time point 2 
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The growth rate data (vide infra) was used to select a reduced range of concentrations 
for further investigation; this was based on identifiable difference in growth rate, but 
which did not result in cell death. 
 
2.3.3 Batch growth 
Bacterial cultures were exposed in triplicate to a range of concentrations of the chosen 
API, the pure enantiomers and a range of enantiomeric mixtures were used (see Table 
2.1).  An aliquot (1 mL) of sterile water was added to an additional set of bacterial 
samples to act as a control.  Samples were maintained at 15 °C, 200 r.p.m. in a 
Multitron orbital shaker for 24 h.  Aliquots (2 mL) were taken in triplicate from each flask 
and centrifuged (5 min, 0 °C, 16089 g) to harvest the biomass.  The supernatant and 
pelleted biomass was stored at -80 °C for further analysis. 
 
Table 2.1:  Microorganisms and conditions for batch growth. 
Microorganism 
 
API 
 
Concentration of API (µg mL-1) 
 
Growth 
Temperature 
(°C) 
Incubation 
Period (h) 
P. putida KT2440 Propranolol (±): 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120 15 24 
     
 
Propranolol 
 
50 µg mL-1 of (R) : (S) in the following ratios: 
(0, 25:75, 50:50 75:25 100) 
 
15 24 
 Atenolol (±), (R), (S): 90, 100, 110, 120, 130 15 24 
     
P. aeruginosa PA14 Propranolol (±), (R), (S): 40, 50, 60, 70, 80 15 48 
     
 
Propranolol 
 
50 µg mL-1 of (R) : (S) in the following ratios: 
(0, 25:75, 50:50 75:25 100) 
 
15 48 
 Atenolol (±), (R), (S): 40, 50, 60, 70, 80 15 48 
     
M.  luteus 2.13 Propranolol (±), (R), (S): 40, 50 15 336 
     
B.  natatoria 2.1 Propranolol (±), (R), (S): 40, 50 15 336 
 
 
2.3.4 Quantitative analysis of API concentration with HPLC 
Concentrations of Atenolol and Propranolol were determined by HPLC (Agilent 1100 
series).  The supernatant samples were allowed to thaw at room temperature and were 
filtered (0.22 µm, MilliporeTM) in order to remove any microbial cells remaining in the 
medium.  Aliquots (25 µL) were injected onto the HPLC column in a random order.  
Each sample was injected three times during the analysis, resulting in three analytical 
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replicates for each biological sample.  The HPLC system was equipped with a 
Chirobiotic V2 column (250 mm × 4.6 mm i.d.), particle size 5 µm (ASTEC, Whippany, 
NY, USA) and a UV detector operating at a wavelength of 230 nm.  The column was 
eluted with an isocratic mixture of methanol and water (90:10, v/v) and 1.0% 
triethylamine acetate (TEAA) buffer, pH 5.0.  The pH of the buffer was adjusted with 
acetic acid prior to the addition of methanol.  The measurements were carried out a 25 
± 1 °C at a flow rate of 1 mL min-1 (Bosakova et al., 2005).  
 
2.3.5 FT-IR spectroscopy 
A 96-well zinc selenide (ZnSe) plate was cleaned by rinsing with 2-propanol and 
deionised water (three times) and allowed to dry at room temperature (Winder et al., 
2006, Harrigan et al., 2004).  The cell pellets stored at -80 °C were allowed to thaw at 
room temperature and washed in order to remove any traces of residual API.  Ice cold 
sterile water (2 mL) was added to each sample and gently vortexed.  The samples 
were centrifuged for 10 min (0 °C, 16089 g), and the supernatant was discarded; this 
cycle was repeated 3 times.  A final aliquot of 100 µL sterile water was added to each 
sample and the solution was vortexed.  Aliquots (20 µL) of each resuspended sample 
were applied to the ZnSe plate and oven dried at 50 °C for 10 min.  Drying was used to 
minimise any signal arising from the absorption of water in the mid-IR region, which 
would mask the biologically important chemical information in the spectra.  Three 
replicates of each of the samples were randomly applied to the ZnSe plates and 
triplicate spectra were obtained from different positions of each well, a total of nine 
spectra (so called technical replicates) were collected per sample.  The plate was 
loaded onto a motorised microplate module HTS-XT under computer control by the 
OPUS software version 4 (Winder et al., 2006).  Spectra were collected using an 
Equinox 55 FT-IR spectrometer (Bruker Optics Ltd), in transmission mode using a 
deuterated triglycine sulphate (DTGS) detector over the wavelength range of 4000-600 
cm-1 and with a resolution of 4 cm-1.  64 spectra were co-added to improve the signal-
to-noise ratio.  The spectra are displayed in terms of absorbance (see Figure 2.1 for 
typical example spectra). 
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Figure 2.1:  Typical processed FT-IR spectra for Pseudomonas aeruginosa PA14 exposed to 
80 µg mL-1 (R), (S), and (±)- Propranolol.  Additional control samples are included which were 
not exposed to Propranolol.  The spectra are offset for clarity. 
 
 
2.3.6 FT-IR Spectral pre-processing 
The ASCII data were imported into Matlab version 7.1 (The MathWorks, Inc., Natick, 
MA, USA) and as an initial step spectral regions which are dominated by CO2 
vibrations arising from the atmosphere (2403 – 2272 cm-1 and 683 – 656 cm-1) were 
removed and filled with a linear trend. The spectra were corrected using extended 
multiplicative scatter correction (EMSC) which normalises and smoothes the spectra by 
application of a polynomial smoothing function (Martens et al., 2003).  These pre-
processed spectra were used for subsequent multivariate analyses. 
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2.3.7 Metabolite profiling with GC-MS 
In order to quench metabolism, culture samples (20 mL) were plunged rapidly into an 
equal volume of 60% aqueous methanol solution (−48 °C).  The quenched biomass 
was centrifuged for 10 min (3000 g, −9 °C) and the supernatant was removed.  The 
biomass pellets were stored at −80 °C for further analysis (Winder et al., 2008).  
 
For metabolite extraction, the biomass pellets were suspended in 550 µL of 80% 
aqueous methanol solution (−48 °C), frozen in liquid nitrogen, and allowed to thaw on 
dry ice.  The freeze thaw cycle was carried out three times in order to permeabilise the 
cells and allow leakage of the metabolites into the supernatant.  The suspensions were 
centrifuged for 7 min (16,060g, −9 °C) and the supernatant was retained and stored on 
dry ice.  An additional aliquot (550 µL) of 80% aqueous methanol solution was added 
to the biomass pellet and the procedure was repeated.  The second aliquot of the 
supernatant was combined with the first and the sample was stored on dry ice for 
further analysis (Winder et al., 2008).  In order to prepare the metabolite extracts for 
GC-MS analysis, aliquots (1 mL) of each extract was spiked with 100 µL of internal 
standard solution (0.19 mg mL-1 succinic-d4 acid, 0.27 mg mL-1 malonic-d2 acid, 0.22 
mg mL-1 glycine-d5 in HPLC-grade water) and lyophilised (HETO VR MAXI vacuum 
centrifuge attached to a HETO CT/DW 60E cooling trap; Thermo Life Sciences, 
Basingstoke, U.K.) (Winder et al., 2008).   
 
Samples were subsequently derivatised in two stages.  An aliquot (40 µL) 20 mg mL-1 
O-methylhydroxylamine solution in pyridine was added and heated at 40 °C for 80 min 
followed by addition of 40 µL of MSTFA (N-acetyl-N-(trimethylsilyl)-trifluoroacetamide) 
and heating at 40 °C for 80 min.  A retention index solution was added for 
chromatographic alignment (20 µL, 0.6 mg mL-1 C10/C12/C15/C19/C22 n-alkanes).  
 
The gas chromatography time-of-flight mass spectrometry (GC-TOF-MS) method used 
to analyse the metabolites has been shown to be suitable for detection and semi-
quantification of a wide range of metabolite classes as detailed in available mass 
spectral / retention index libraries (Kopka et al., 2005) or genome-scale reconstructions 
of metabolic networks (Feist et al., 2007).  Samples were analysed in a random order 
employing GC-TOF-MS (Agilent 6890 GC coupled to a LECO Pegasus III TOF mass 
spectrometer) and using the optimal settings determined previously for yeast analysis 
(O'Hagan et al., 2004).  The raw data were processed using LECO ChromaTof v2.12 
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and its associated chromatographic deconvolution algorithm, with the baseline set at 
1.0, data point averaging of 3, and average peak width of 2.5.  A reference database 
was prepared which incorporated the mass spectrum and retention index of all 
metabolite peaks detected in a random selection of samples in order to allow the 
detection of all metabolites present.  Each metabolite peak in the reference database 
was searched for in each sample, and if matched, the peak area was reported and the 
response ratio relative to the internal standard was calculated (Winder et al., 2008).   
 
2.3.8 Multivariate Analysis  
Multivariate analysis followed a protocol developed previously (Goodacre et al., 1998, 
Alsberg et al., 1998).  Principal components analysis (PCA) is an unsupervised method 
for reducing the dimensionality of multivariate data whilst preserving the variance.  This 
transformation was performed prior to canonical variates analysis (CVA).  CVA is a 
supervised learning method that seeks to minimise within group variance whilst 
maximising between group variance, and can be used in conjunction with PCA to 
discriminate between groups on the basis of retained principal components (PCs), 
given a priori knowledge of group membership of the spectral replicates (Manly, 1994, 
Winder et al., 2004).  In this study, PC-CVA models were constructed with a priori 
knowledge of the biological replicates.  In order to make sure these models were not 
over- or under-trained, validation was performed using the method of full cross-
validation, where two of the biological replicates were used for model training with the 
third projected into the model for cluster validation purposes (Jarvis and Goodacre, 
2004a).  Finally, CVA also allows statistical significance to be displayed on the scores 
plots and circles were used to represent the 95% χ2 confidence region constructed 
around each group mean based upon the χ2 distribution with two degrees of freedom 
(Krzanowski, 1988). 
 
Partial least squares (PLS (Martens and Naes, 1989)) regression is a multivariate 
linear regression method which allows the quantitative relationship between different 
variables (i.e., API concentration and FT-IR spectra) to be modelled, and can deal 
efficiently with datasets that are highly correlated.  In this study, PLS regression was 
employed to predict the API concentration values from the FT-IR data.  As for PC-CVA, 
the regression models were calibrated with two of the three biological replicates and 
the third replicate was used as an independent test set to validate the model and 
establish whether the models could generalise. 
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2.4 Results and Discussion 
2.4.1 The effect of the chiral APIs on the bacterial growth rates 
A number of aquatic microorganisms were exposed to the chiral APIs Atenolol and 
Propranolol, and growth rates, death rates and maximum optical density (OD) were 
determined to monitor the effect of the APIs on culture progression (see Figure 2.2 for 
examples of 0, 10, 50, 90 and 130 µg mL-1 for (R)-, (S)- and the racemic mix).  Slight 
variations were observed in the specific growth rates within the Pseudomonas species 
exposed to varying concentrations (10-130 µg mL-1) of (R)-, (S)- and (±)- Propranolol.  
There was a considerable difference in the growth rates observed between species, 
and a marked effect was observed in P. aeruginosa PA14 exposed to Propranolol.  By 
contrast, minimal changes were detected in the growth rates, death rates or maximum 
amount of biomass of both organisms exposed to 10-130 µg mL-1 of (R)-, (S)- and (±)-
Atenolol.   
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Figure 2.2:  Specific growth rate data for Pseudomonas putida KT2440 and P. aeruginosa 
PA14 exposed to 0-130 µg mL-1 of Propranolol or Atenolol.  Maximum OD (600 nm) and 
“specific death rates” are also shown.  Data are averaged from 5 biological replicates and error 
bars show standard deviation. 
Monitoring the effect of chiral pharmaceuticals on aquatic microorganisms by metabolic 
fingerprinting and metabolite profiling 
 
An environmental metabolomics investigation of the effects of chiral pharmaceuticals 
and environmental pollutants on microorganisms 
- 68 -   
An interesting effect was observed for P. aeruginosa PA14 exposed to both of the 
Propranolol enantiomers and the racemate.  At concentrations of 50-70 µg mL-1 there 
appeared to be no death of the microbial cells.  By contrast, for cells exposed to 10-40 
and 80-130 µg mL-1 the death rate was equivalent to that from the control cells.  This is 
likely to be due to the lower concentrations (<40 µg mL-1) of Propranolol having very 
little effect on metabolism so cells quickly reach stationary and death phases, higher 
concentrations (>80 µg mL-1) having a negative impact on metabolism and killing cells 
(as also seen in the final turbidity measurements being significantly lower than control 
cells), whilst the intermediate concentrations (50-70 µg mL-1) might slow growth but the 
cells have not yet entered the death phase.  Inspection of the growth curves indicated a 
second phase of growth several hours into the stationary phase.  Whilst this may be 
indicative of the utilisation of a secondary carbon source this was not observed in the 
control cultures and as such is not the likely explanation.  The biomass of the culture 
decreased as the concentration of the API increased and thus the original carbon 
source was potentially not depleted at the onset of stationary phase.  Whilst at the 
higher concentrations of Propranolol a slight increase in the biomass was immediately 
followed by a noticeable decrease in the OD of the culture (death phase) the maximum 
biomass was severely inhibited by the presence of the API.  Our observations would 
suggest that a differential effect is exerted by the API depending on the concentration 
applied.  At lower concentrations the growth trend is unaffected by the API, and at high 
concentrations a death is observed during the growth period.  However, at intermediate 
concentrations the production of biomass is extended throughout the growth period 
(the onset of death phase may be observed if the growth was monitored for extended 
periods).  The APIs were not metabolised during the growth (Table 2.2) and we would 
hypothesise that the intermediate concentrations of Propranolol were either affecting 
the transport of nutrients into the cell or the rate of metabolism.   
 
 
Table 2.2:  Quantification of Propranolol from HPLC data for bacterial cells exposed to 
varying ratios of (R)- and (S)- Propranolol at 50µg mL-1. 
Ratio of Enantiomers (R:S)b 
75:25 50:50 25:75 
 
Microorganism or 
Medium 
100% 
(R) (R) (S) (R) (S) (R) (S) 
100% 
(S) 
Mediuma 49.6 (1.3) 36.9 (1.2) 11.3 (1.4) 23.8 (1.6) 24.3 (1.2) 11.6 (0.8) 37.2 (1.5) 48.4 (2.1) 
P.  putida KT2440 48.9 (1.7) 37.1 (0.9) 12.3 (1.1) 24.3 (0.8) 24.7 (1.1) 12.1 (0.7) 36.8 (1.4) 48.8 (1.8) 
P. aeruginosa PA14 48.2 (1.9) 36.7 (1.4) 11.9 (1.8) 23.9 (1.9) 24.6 (1.0) 11.9 (1.5) 37.0 (0.9) 49.3 (1.5) 
a Control experiments (labelled medium) were performed to determine the experimental effect on the drug concentration 
(i.e., loss of API during incubation in growth medium). 
b The values are averages for five measurements. The values in parentheses are standard deviations. 
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It can be clearly noted in the growth rate data for the Propranolol exposed cells that the 
specific growth rate decreases as the concentration of the API increases.  This trend is 
also observed in the maximum optical density data and death rates for both 
pseudomonads.  Our findings indicate that Propranolol has considerably different 
affects on the two Pseudomonas species.  These findings are rather surprising as 
these species are genetically closely related.  Estimates show that greater similarity 
(60% of the predicted coding sequences) is shown between the two pseudomonads 
than any other completed microbial genomes to date (Nelson et al., 2002).  In addition, 
comparative genome analysis has shown that 85% of the P. putida KT2440 genome 
has homologues in the P. aeruginosa PAO1 genome (Stover et al., 2000).    
 
The toxicity effects of the APIs observed here in aquatic organisms have been 
previously reported.  Toxicity studies carried out by Kim and co workers in the 
crustacean Thamnocephalus platyurus and a fish species (Oryzias latipes) reported 
that Propranolol caused acute toxicity in T. platyurus at a concentration of 10.61 µg mL-
1
 and in O. latipes at a concentration of 11.40 µg mL-1.  In contrast to the results 
presented here, they found that Atenolol did not cause toxicity effects in the aquatic 
organisms at the concentrations used (<100 µg mL-1) (Carlsson et al., 2009).  In 
addition, toxicity studies have been carried out on a range of APIs (including 
Propranolol) in the Japanese medaka fish (Oryzias latipes) an amphipod (Hyalella 
azteca) and two crustaceans (Ceriodaphnia dubia and Daphnia magna).  It was found 
that Propranolol caused the greatest effect in the organisms studied.  The crustacean 
C. dubia displayed toxicity responses at a concentration of 0.25 µg mL-1.  Propranolol 
was the only API investigated which was found to cause acute toxicity effects in the 
Japanese medaka fish.  These effects were observed at a concentration of 0.5 µg mL-1 
(Huggett et al., 2002). 
 
Previous studies have suggested that β-blockers would not affect microbes due to the 
absence of the API receptors within microbial organisms (Jones et al., 2002, CSTEE, 
2001).  However, in another study conducted by our group we reported that (±)- 
Propranolol significantly reduced the lipid storage components of the algae 
Micrasterias hardyi 649/15 and caused a marked reduction in the cellular protein 
content (Patel et al., 2008).  In addition, the findings from the metabolic fingerprinting 
suggested that the phenotype was altered during exposure to the API (Patel et al., 
2008).  To our knowledge no further studies have been carried out on the metabolic 
effect of Propranolol within aquatic microorganisms.   
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The effects on the growth dynamics of the bacteria are likely to reflect changes in the 
metabolic potential of these cells and this quantitative drug effect was explored further 
using FT-IR spectroscopy and P. putida KT2440 exposed to (±)- Propranolol. 
 
2.4.2 Quantitative effects of APIs on bacteria measured using FT-IR 
spectroscopy 
In order to asses any possible quantitative effects of Propranolol on the phenotype of 
P. putida KT2440 we employed partial least squares (PLS) regression analysis to 
investigate whether the effect on the phenotype as measured using FT-IR 
spectroscopy was directly proportional to the concentration of API applied (Figure 2.3).  
A clear linear relationship was observed between the concentration of (±)- Propranolol 
to which the P. putida KT2440 cells had been exposed to and the metabolic fingerprint.  
In addition, we were able to predict the concentration of Propranolol to which the 
bacterial cells had been exposed with an accuracy of 95.45%.  This is perhaps not 
surprising as the inhibitory effect of the Propranolol on the cells was proportional to the 
concentration of API.  This was a clear phenotypic effect as we were unable to collect a 
spectrum of Propranolol at these concentrations using FT-IR spectroscopy.  We also 
performed PLS regression on the profiles of P. aeruginosa PA14 exposed to the 
intermediate concentrations of Propranolol, to determine if the secondary growth effect 
was proportional to the concentration of API applied (data not shown).  Under these 
conditions it was not possible to generate a correlation between drug exposure 
concentration and the FT-IR data.  Therefore, the presence of the drug may have led to 
more complex biochemical perturbations in the organisms that we are unable to model 
using PLSR.   
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Figure 2.3:  Partial least squares regression model for Pseudomonas putida KT2440 exposed 
to varying concentrations (0 – 100 µg mL-1 in steps of 10 µg mL-1) of (±)- Propranolol.  The 
model was trained with FT-IR data using two of the biological replicates and validated using the 
third biological replicate.  The PLSR model was built using 10 factors. 
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2.4.3 Quantitative analysis of API concentration with HPLC 
Chiral HPLC analysis was performed to quantify the amount of the enantiomers 
remaining at the end of the growth period.  The analysis was targeted to explore the 
effects observed in the growth rate data.  In addition, control experiments were 
performed to determine the experimental effect on the drug concentration; i.e., the loss 
of API during incubation in growth medium.  To determine the effect of the enantiomers 
on the growth of the pseudomonads a range of ratios of Propranolol were employed at 
50 µg mL-1.  The findings of the HPLC analysis (Table 2.2) demonstrated that neither of 
the enantiomers were degraded during the batch growth.  In addition, the 
pseudomonads were exposed to a range of concentrations of the API Atenolol (Table 
2.3), the concentrations selected were chosen from the findings of the growth rate data.  
There was no notable indication of API degradation during the growth of these bacteria. 
 
 
Table 2.3:  Quantification of Atenolol from HPLC data for bacterial cells exposed to 
varying ratios of (R)- and (S)- Atenolol at a range of concentrations. 
HPLC Quantification 
Racemate Pure Enantiomers Microorganism or Medium 
Concentration 
(µg mL-1) (R) (S) Total (R) (S) 
Medium* 80 38.7 (1.9) 39.1 (1.6) 77.8 (3.5) 79.0 (1.4) 78.2 (2.6) 
  
     
P. putida KT2440 90 42.1 (1.8) 43.8 (1.2) 85.9 (3.0) 88.9 (2.1) 88.7 (2.6) 
 100 48.3 (1.9) 47.8 (2.4) 96.1 (4.3) 99.3 (1.9) 98.8 (2.2) 
 110 53.9 (1.8) 54.2 (1.1) 108.1 (2.9) 108.7 (2.6) 109.3 (1.4) 
 120 59.4 (1.3) 58.7 (1.8) 118.1 (3.1) 118.9 (2.4) 119.6 (1.2) 
 130 62.9 (2.3) 63.8 (1.4) 126.7 (3.7) 129.7 (1.8) 128.9 (1.9) 
  
     
40 18.6 (1.5) 19.1 (1.2) 37.7 (2.7) 39.7 (1.5) 38.5 (2.1) P. aeruginosa 
PA14 50 23.8 (1.6) 22.9 (2.2) 46.7 (3.8) 47.6 (4.2) 49.3 (1.6) 
 60 29.2 (1.3) 28.6 (2.1) 57.8 (3.4) 58.4 (1.9) 59.1 (1.7) 
 70 32.9 (2.6) 33.5 (1.4) 66.4 (4.0) 68.9 (1.8) 68.7 (2.2) 
 80 39.2 (1.7) 38.8 (2.3) 78.0 (4.0) 79.9 (1.3) 78.6 (1.9) 
 
 
2.4.4 Effects of chiral APIs on FT-IR metabolic fingerprints  
In order to investigate whether there were any chiral specific phenotypic changes on 
the various aquatic bacteria, a single drug concentration in which there was no 
observable difference in growth rate between the enantiomers was chosen for 
investigation. 
 
During the investigation into the chiral API specific effects on microorganisms the four 
bacteria were exposed to a number of drug concentrations (detailed in Table 2.1).  A 
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summary of the statistically significant differences between the drug enantiomers, 
enantiomeric ratios, or the racemate is shown in Table 2.4. 
 
 
Table 2.4:  The concentration of Propranolol and Atenolol at which a significant effect 
on the bacterial phenotype was observed using FT-IR spectroscopy. 
Concentration of observed effect * Microorganism 
 Propranolol Atenolol 
P.  putida KT2440 50µg mL-1 > 130µg mL-1 
P.  aeruginosa PA14 50µg mL-1 > 80µg mL-1 
M.  luteus 2.13 50µg mL-1 ND 
B.  natatoria 2.1 40 and 50µg mL-1 ND 
* Effects are deemed significant in PC-CVA plots based on confidence regions being statistically different at the 95% χ2 
limit. This is to say at the concentration given, below this all bacteria had an equivalent phenotype (overlapping clusters) 
and above this there was clear differentiation. 
ND; not determined as Propranolol appeared to produce the most notable effects during earlier experiments. 
 
 
PC-CVA was carried out in order to investigate any chiral specific effects on the 
microorganisms as determined by FT-IR spectroscopy.  The distance between samples 
plotted on a PC-CVA scores plot represents the degree of similarity or dissimilarity 
between those samples.  A smaller distance indicates greater similarity and a larger 
distance would indicate that there are greater differences between samples.  Loading 
plots provide an indication of which regions of the spectrum are used to define these 
patterns of separation, which allows for meaningful biochemical interpretation of the 
results.  FT-IR analysis demonstrates that each of the Propranolol enantiomers exerts 
a metabolic effect on the microbial cells of P. aeruginosa PA14 at 80 µg mL-1 (Figure 
2.4a) compared to the control.  It can clearly be observed in the PC-CVA scores plot 
that the control samples separate across PC-CV 1, which accounts for the greatest 
variance within the data according to the putative class assignment, and as discussed 
above this finding was perhaps not surprising given the effect the of the API on the 
bacterial growth dynamics (Figure 2.2).  In addition, the samples exposed to (±)- 
Propranolol are clearly separate from those exposed to each of the enantiomers ((R)- 
and (S)-), which in this analysis show no separation across the first two PC-CV scores.  
As described above, 2 of the 3 biological replicates were used for calibration (shown in 
black) and the 3rd projected into the model (grey font).  The majority of these projected 
data are grouped with the appropriate calibration samples indicating that the separation 
displayed in the model was valid.  Moreover, the 95% confidence intervals for the 
groups are also plotted showing that for 3 of the groups there is a distinct separation in 
CVA scores space.  The analysis demonstrated that the microbial cells exposed to both 
(R)- and (S)- Propranolol cluster together in this analysis, indicating that there was no 
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metabolic difference in the microbial cells exposed to each of the pure enantiomers.  It 
was very surprising to observe that the cultures exposed to the racemate formed a 
distinct cluster separate from the cultures exposed to the pure enantiomers or control 
samples in the CVA space.  The loadings plot (Figure 2.4b) indicates that very specific 
changes in the metabolic fingerprint of the microbial cells account for the patterns of 
separation observed between the control and drug exposed samples in the scores plot.  
The major chemical changes arise in the protein (1681 – 1629 cm-1) and carbohydrate 
(1155 – 999 cm-1) regions of the FT-IR spectrum, with a less pronounced contribution 
from lipid species (2951 – 2845 cm-1) changing in the same direction as the 
carbohydrates.  To further investigate the effect on the biochemical components of the 
cell between the racemate and enantiomers, we calculated difference spectra (for 
example the metabolic fingerprint of the (R)- enantiomer was divided by that of the 
racemate) for each combination of interest.  This data was then used to determine the 
relative changes in the lipid and amide components of the cells with respect to the API 
exposure.  Inspection of the difference spectra (Figure 2.5) revealed that the bacterial 
cells exposed to the racemate contained lower levels of amides and higher levels of 
lipid compared to those exposed to either of the enantiomers.  This suggests that the 
racemate exerts less of a metabolic effect on the bacterial cells, and this is supported 
by the PC-CVA scores plot in which the racemate lies between the control and the 
enantiomer exposed cells across PC-CV 1.  As discussed above, HPLC analysis 
suggests that degradation or a significant uptake of the API does not occur within the 
microbial cells.  Therefore, it is unlikely that the increase in proteins observed in the FT-
IR spectra of Propranolol exposed cells is due to the expression of enzymes in order to 
metabolise the API.  It is more probable that this effect is due to the expression of an 
efflux system to remove the API from the bacterial cell.  In addition, Propranolol is a 
lipophilic API which is known to interact with cell membranes of mammalian cells and 
the observed reduction of lipids in exposed cells is likely to be due to interactions of the 
API with the bacterial cell membrane.  Propranolol is routinely administered to man as 
the racemate. The (S)- enantiomer accounts for the majority of the β-blocking effect, 
while the (R)- has a predominantly membrane stabilising effect (Barrett and Cullum, 
1968, Potter and Sweetland, 1967, Hanna and Evans, 2000, Walle et al., 1984).  One 
can hypothesise that the reason the racemate (±) was different compared to either of 
the enantiomers is because of the difference in the physical properties between the 
racemate and enantiomers (Chickos et al., 1981, Secor, 1963). 
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Figure 2.4:  PC-CVA scores (LHS) and loadings (RHS) plots performed on FT-IR data for 
Pseudomonas aeruginosa PA14 exposed to 80µg mL-1 (R)-, (S)- and (±)- Propranolol (a and b), 
P. putida KT2440 exposed to varying ratios of 50 µg mL-1 (R), (S)- Propranolol (c and d), and P. 
aeruginosa PA14 exposed to 80µg mL-1 (R)-, (S)- and (±)- Atenolol (e and f).  In the scores plots 
points shown in black represent the 2 biological replicates used to train the PC-CVA models.  
Points shown in grey represent the third biological replicate which was used to validate the PC-
CVA model.  Blue circles represent the 95% confidence interval about the group centroid, and 
green circles the 95% confidence region about the group sample population.  In the loadings 
plots the loadings for PC-CV 1 is represented in red and PC-CV 2 in blue.  Points C, M, R and S 
represent control, racemic mixture, (R)- and (S)- respectively.  The enantiomeric ratios 75:25 
and 25:75, (R) : (S) are represented by R:s and r:S respectively.  
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Figure 2.5:  FT-IR difference spectra for Pseudomonas aeruginosa PA14 exposed to 80 µg mL-
1
 Propranolol.  The average FT-IR spectrum for control samples divided by the average 
spectrum for the pure enantiomers ((R)- and (S)-) is shown in (a.).  The average FT-IR spectrum 
for the pure enantiomers divided by the average spectrum for the bacterial cells exposed to the 
racemate is shown in (b.). 
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To explore the chiral specific effect noted in earlier experiments further the 
pseudomonads were exposed to varying ratios of 50 µg mL-1 (R) : (S)- Propranolol.  
The results of the chemometric analysis of the FT-IR spectra again illustrated a 
metabolic difference in the microbial cells exposed to varying ratios of (R)-, and (S)- 
Propranolol from the control samples (data not shown) and these controls were 
removed prior to PC-CVA so that only chiral specific changes were observed.  The 
results of this PC-CVA are shown in Figure 2.4c where P. putida KT2440 exposed to 
50 µg mL-1 (±)- Propranolol (racemate, labelled R:S) are recovered on the left hand 
side of this plot and the 25:75 mixture (r:S) as well as the pure enantiomers are located 
on the right hand side.  The 75:25 (R:s) mixture falls between these two groups.  The 
clear separation of P. putida KT2440 exposed to the racemate supports the earlier 
observations on the effect of Propranolol on the metabolic fingerprints of P. aeruginosa 
PA14. 
 
By contrast, there was no phenotypic variation observed in the metabolic fingerprints of 
the samples exposed to the (R)-, (S)- and (±)- Atenolol (Figure 2.4e and f) as the 95% 
χ2 confidence regions overlap.  The analysis clearly illustrates that no discrimination 
was observed between the three conditions.  This result differs from the analysis of P. 
aeruginosa PA14 exposed to Propranolol (Figure 2.4a) and indicates that Atenolol 
does not have a chiral specific metabolic effect on P. aeruginosa PA14.  
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Figure 2.6:  PC-CVA scores (LHS) and loadings (RHS) plots performed on FT-IR data for 
Blastomonas natatoria 2.1 exposed to 40 and 50µg mL-1 (R), (S) and (±)- Propranolol (a and b) 
and Micrococcus luteus 2.13 exposed to 50µg mL-1 (R), (S) and (±)- Propranolol.  In the scores 
plots points shown in black represent the 2 biological replicates used to train the PC-CVA 
models.  Points shown in grey represent the third biological replicate which was used to validate 
the PC-CVA model.  Blue circles represent the 95% confidence interval about the group 
centroid, and green circles the 95% confidence region about the group sample population.  In 
the loadings plots the loadings for PC-CV 1 is represented in red and PC-CV 2 in blue.  Points 
M, R and S represent the racemic mixture (±), (R)- and (S)- respectively. 
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Due to the chiral specific effects observed in the pseudomonads when exposed to 
Propranolol, two additional bacteria were selected to investigate the effects of 
Propranolol.  Propranolol had a very noticeable metabolic effect on B. natatoria 2.1 at 
40 and 50 µg mL-1 (Figure 2.6a and b) and on M. luteus 2.13 at 50 µg mL-1 (Figure 2.6c 
and d).  The greatest difference observed in these analyses was between the control 
and API exposed samples.  To investigate the more subtle differences between the 
cultures exposed to the different enantiomers and the racemate the control samples 
were removed from the analysis.  B. natatoria 2.1 samples in the PC-CVA scores plot 
are separated across the 1st CV with respect to the enantiomers. The (S)- and (R)- 
enantiomers are clearly separated in the CVA space, with the racemate located 
between them.  A concentration effect was also observed in the metabolic fingerprints 
across PC-CV 2.  This is in contrast to the chiral specific effects for this API on the two 
pseudomonads, in which the greatest variation was noted between the cells exposed to 
the racemate and the enantiomers.  The loadings data for B. natatoria 2.1 indicate the 
major chemical changes arise in the lipid (2936 – 2851 cm-1) region of the FT-IR 
spectrum and at wavenumbers 1748 – 1654 cm-1.  Vibrations in this region may be 
attributed to the C=O stretching of esters and carboxylic acids, however this region is 
dominated by amide I.  The FT-IR difference spectra (Figure 2.7) demonstrate that 
cells exposed to (S)- Propranolol contained lower levels of lipids but higher levels of 
amide and carbohydrate compared to those exposed to the (R)- enantiomer.  This 
suggests that (S)- Propranolol exerts a greater biological effect on the bacterial cells.  
The effect of the API on the M. luteus 2.13 and B. natatoria 2.1 is perhaps more 
predictable as the differing metabolic effects of the enantiomers is linearly additive.  
The difference in phenotypic effect following exposure to Propranolol compared to the 
pseudomonads is likely to be a consequence of the metabolic differences between the 
bacteria.   
 
To our knowledge, the β-blockers Atenolol and Propranolol have not previously been 
studied for chiral specific effects within microbial systems.  Nevertheless, the effects of 
APIs within these systems are highly relevant, as microorganisms populate the lower 
trophic levels within foodwebs.  Therefore, differences in the population dynamics could 
represent a significant effect on the whole of the freshwater community (Jones et al., 
2002). 
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Figure 2.7:  FT-IR difference spectra for Blastomonas natatoria exposed to 40 and 50 µg mL-1 
Propranolol.  The average FT-IR spectrum for samples exposed to 40 µg mL-1 divided by the 
average spectrum for samples exposed to 50 µg mL-1 Propranolol is shown in (a.).  The average 
FT-IR spectrum for bacterial cells exposed to (R)- Propranolol divided by the average spectrum 
for the bacterial cells exposed to the (S)- enantiomer is shown in (b.). 
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2.4.5 Effects of the chiral API Propranolol on selected pseudomonas 
analysed by GC-MS 
In order to investigate the potential chiral specific effects of Propranolol on the two 
pseudomonads, GC-MS was employed for metabolic profiling of the bacterial 
metabolomes following exposure to a range of enantiomeric ratios of (R) : (S)- 
Propranolol at 50 µg mL-1.  The multivariate analysis method PC-DFA was employed in 
order to visualise the trends within the bacterial metabolic profiles in response to the 
varying enantiomeric ratios.  Figure 2.8 shows the PC-DFA scores plot (PC-DF 1 vs. 
PC-DF 2) constructed from the GC-MS profiles of both pseudomonads following 
exposure to the varying enantiomeric ratios of Propranolol and the control samples.  
PC-DF 1 accounts for the greatest variation within the dataset, and this appeared to be 
due to the biological differences between the two species (P. aeruginosa PA14 and P. 
putida KT2440).  The samples appeared to display some separation across PC-DF 2 
according to the enantiomeric ratio of Propranolol to which the bacteria had been 
exposed.   
 
In order to explore the differential metabolic effect further, PC-DFA was carried out on 
the data for each of the pseudomonads separately.  A notable chiral specific effect was 
observed in the metabolic profile for P. aeruginosa PA14 (Figure 2.9) and the samples 
formed distinct clusters according to the enantiomeric ratio of Propranolol to which the 
cells had been exposed.  The samples exposed to the racemate appeared to display 
the greatest difference in comparison with the control samples according to the GC-MS 
data, and this finding corresponded with the earlier FT-IR spectroscopy analysis 
(Figure 2.4).  However, it was not possible to differentiate between the pure 
enantiomers with FT-IR spectroscopy.  By contrast, this GC-MS analysis demonstrated 
a notable difference in the metabolic response to the enantiomers, which showed a 
clear separation across PC-DF 2 (Figure 2.9).  In addition, the remaining enantiomeric 
ratios (75:25 and 27:75 (R) : (S)- Propranolol) also appeared to form distinct clusters, 
suggesting that all of the various enantiomeric ratios exerted differing metabolic effects 
on the bacterial cultures.   
 
Figure 2.10 shows the PC-DFA scores plot for the GC-MS metabolome data of P. 
putida KT2440 following exposure to the enantiomeric ratios of Propranolol and the 
control cultures.  It can be clearly observed that the greatest variation within the dataset 
was between the control and Propranolol exposed cells.  The control samples were 
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therefore removed from the analysis in order to investigate more subtle metabolic 
responses to the enantiomeric ratios within the bacterial cells (Figure 2.11).  As 
observed for P. aeruginosa PA14, the bacterial cells appeared to display differing 
metabolic responses according to the enantiomeric ratios.  Cultures exposed to the 
pure enantiomers displayed distinct clusters from the remaining samples.  Previous 
analyses of P. putida KT2440 exposed to Propranolol were not able to differentiate fully 
between the experimental conditions based on the FT-IR spectra (Figure 2.4c).  
However, distinct clusters were observed for each of the enantiomeric ratios in the PC-
DFA of the metabolic profile data (with the exception of one possible outlier labelled r:S 
which appeared to co-cluster with the racemate exposed cultures, labelled R:S).  
These findings indicated that differential effects were exerted on P. putida KT2440 
when exposed to the enantiomeric ratios and corresponded with the findings for the 
closely related bacterial species, P. aeruginosa PA14.   
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Figure 2.8:  PC-DFA scores plots performed on GC-MS metabolome profiles from 
Pseudomonas aeruginosa PA14 and P. putida KT2440 exposed to varying enantiomeric ratios 
of 50 µg mL-1 (R) : (S)- Propranolol.  The model was constructed using 20 PCs.  Points A and P 
represent P. aeruginosa PA14 and P. putida KT2440 samples respectively.  The enantiomeric 
ratios 100:0, 75:25, 50:50 25:75 and 0:100, (R) : (S)- Propranolol are represented by R, R:s, 
R:S, r:S and S respectively.  Control samples are represented by Con.     
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Figure 2.9:  PC-DFA scores plots performed on the GC-MS metabolome profiles from 
Pseudomonas aeruginosa PA14 exposed to varying ratios of 50 µg mL-1 (R) : (S)- Propranolol.  
The model was constructed using 15 PCs.  The enantiomeric ratios 100:0, 75:25, 50:50 25:75 
and 0:100, (R) : (S)- Propranolol are represented by R, R:s, R:S, r:S and S respectively.  
Control samples are represented by Con.   
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Figure 2.10:  PC-DFA scores plots performed on the GC-MS metabolome profiles from 
Pseudomonas putida KT2440 exposed to varying ratios of 50 µg mL-1 (R) : (S)- Propranolol.  
The model was constructed using 10 PCs.  The enantiomeric ratios 100:0, 75:25, 50:50 25:75 
25:75 and 0:100, (R) : (S)- Propranolol are represented by R, R:s, R:S, r:S and S respectively.  
Control samples are represented by Con.   
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Figure 2.11:  PC-DFA scores plots performed on the GC-MS metabolome profiles from 
Pseudomonas putida KT2440 exposed to varying ratios of 50 µg mL-1 (R) : (S)- Propranolol.  
The model was constructed using 13 PCs.  The enantiomeric ratios 100:0, 75:25, 50:50 25:75 
25:75 and 0:100, (R) : (S)- Propranolol are represented by R, R:s, R:S, r:S and S respectively.  
The control samples were removed for this analysis.   
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The Lilliefors test for normality was carried out on the GC-MS profiling data in order to 
assess whether the data followed a normal distribution (Lilliefors, 1967).  The profiling 
data was not found to be normally distributed and therefore appropriate non-parametric 
tests were employed for subsequent analysis of the data.  The Friedman test is a non-
parametric two-way analysis of variance which does not make assumptions regarding 
the distribution of the data (Theodorsson-Norheim, 1987).  A number of pair wise 
comparisons (p <0.02) were carried out on the GC-MS profiling data in order to 
determine the significant changes in metabolites within the pseudomonads following 
exposure to the API in comparison with the control samples.  Table 2.5 and Table 2.7 
summarise the metabolites which displayed a significant difference compared to the 
control cultures in P. aeruginosa PA14 and P. putida KT2440 respectively.  A total of 
34 metabolites were found to change significantly in P. aeruginosa PA14 following 
exposure to the pure enantiomers or the racemate in comparison with the control 
cultures.  Unfortunately, identification was only possible for 12 of these metabolites by 
means of matching to authentic standards by retention time and mass spectrum or by 
mass spectrum only (Winder et al., 2008).  Comparison of the P. putida KT2440 
metabolic profiles following exposure with the control cultures revealed significant 
changes in 29 of the observed metabolites, of which 16 were identified.   
 
The univariate data analysis of the P. putida KT2440 metabolic profile revealed 
significant reductions in the levels of fatty acids such as myristic acid, hexadecanoic 
acid and octadecanoic acid in cultures exposed to (S)- Propranolol.  By contrast, the 
pure (S)- enantiomer appeared to exert a different metabolic effect in P. aeruginosa 
PA14, and levels of octadecanoic acid were significantly higher in cultures exposed to 
the enantiomer compared to the control cultures.  These findings supported the earlier 
hypotheses that Propranolol exerts a metabolic effect on the lipid components within 
the pseudomonads and in addition, the API appeared to exert differing metabolic 
effects in the two species.  Furthermore, levels of the phospholipid head group 
ethanolamine, commonly found in bacterial cell membranes, was significantly 
increased in P. aeruginosa PA14 cultures exposed to (±)- Propranolol.  By contrast, P. 
putida cultures exposed to (S)- and (±)- Propranolol displayed lower levels of glycerol-
3-phosphate; a component of glycerophospholipids and cultures exposed to the (S)- 
enantiomer displayed lower levels of N-acetylglucosamine, which is a component of the 
peptidoglycan bacterial cell wall.  These results suggest that (S)- and (±)- Propranolol 
exerted an enhanced metabolic effect on the bacterial cell membrane and cell wall in P. 
putida KT2440 in comparison to the (R)- enantiomer.  In addition, these findings 
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indicate that the API exerts a greater effect on the cell membranes in P. putida KT2440 
than in the closely related P. aeruginosa PA14.   
 
A number of amino acids including valine, leucine, isoleucine and tyrosine were 
significantly reduced in P. putida KT2440 following exposure to (S)- Propranolol.  In 
addition, glutamic acid / pyroglutamic acid was reduced in (R)- exposed cultures.  A 
reduction in valine was also observed in the P. aeruginosa PA14 cultures exposed to 
(R)- Propranolol and the racemate and an increase in tryptophan was observed 
following exposure to the racemate.  However, no other significant changes in amino 
acids were observed in the metabolic profiles of P. aeruginosa PA14.  A number of 
intermediates in the urea cycle (citrulline, ornithine and xanthine) were found to 
increase significantly in P. aeruginosa PA14 following exposure to (±)- Propranolol.  
However, no notable difference was observed for these metabolites in the metabolic 
profile of P. putida KT2440 providing further evidence of the different metabolic effects 
of Propranolol in the two pseudomonad species.   
 
Kruskal-Wallis univariate data analysis (Kruskal and Wallis, 1952) was employed in 
order to determine any significant changes in the metabolite profiles of the 
pseudomonads following exposure to the pure enantiomers and the racemate.  The 
Venn diagrams in Figure 2.12 and Figure 2.13 provide a summary of the numbers of 
metabolites displaying a significant change between the experimental conditions for P. 
aeruginosa PA14 and P. putida KT2440 respectively (p <0.02), and Table 2.6 and 
Table 2.8 provide identifications for these metabolites.  The univariate analyses 
indicated that only one metabolite displayed a significant difference in the metabolic 
profiles of P. aeruginosa PA14 exposed to (R)- and (S)- Propranolol.  However, it was 
not possible to identify this metabolite.  By contrast, 5 metabolites displayed significant 
differences in the P. putida KT2440 cultures exposed to the pure enantiomers, of which 
the amino acids tyrosine and tryptophan and the disaccharide trehalose were identified.  
Further inspection of the data revealed significantly lower levels of all of the metabolites 
in the (S)- exposed cultures compared to the (R)- enantiomer, suggesting that (S)- 
Propranolol exerts an enhanced metabolic effect on P. putida KT2440.  These findings 
suggest that (S)- Propranolol exerts an enhanced metabolic effect on P. putida KT2440 
and this is not perhaps surprising as the (S)- enantiomer exerts the majority of the 
intended β-blocking activity in man (Barrett and Cullum, 1968, Hanna and Evans, 2000, 
Potter and Sweetland, 1967, Walle et al., 1984).   
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Comparison of the cultures exposed to (R)- or (±)- Propranolol revealed significant 
changes in a number of metabolites in the metabolic profile of P. aeruginosa PA14 
(Figure 2.12).  The racemate appeared to have a greater metabolic effect on the 
glycolysis intermediate, Fructose-6-phosphate, whilst the (R)- enantiomer appeared to 
exert the greatest effect on gluconolactone.  In contrast, only one metabolite was 
identified as significantly different between the (R)- and (±)- Propranolol exposed 
cultures of P. putida KT2440 in the metabolic profile data (Figure 2.13).  Unfortunately 
it was not possible to identify this metabolite.  In addition, comparison of the metabolic 
profiles of the pseudomonads exposed to (S)- Propranolol or the racemate revealed 
reductions in the levels of glucose-6-phosphate in the P. putida KT2440 metabolic 
profile of the (S)- exposed cultures.  By contrast, P. aeruginosa PA14 cultures 
displayed lower levels of lactose following exposure to the racemate.  An additional two 
metabolites were identified as significantly different for this comparison and inspection 
of the data revealed significant reductions in the levels of these metabolites following 
exposure to the racemate in comparison to the (S)- enantiomer, however it was not 
possible to identify them from the retention time and mass spectra.  These results 
suggest that (±)- Propranolol exerts a greater effect on the P. aeruginosa PA14 
metabolic profile than (S)- Propranolol, whereas the pure (S)- enantiomer appeared to 
exhibit a greater metabolic effect in P. putida KT2440. 
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Table 2.5:  Metabolites found to be significantly altered in Pseudomonas aeruginosa 
PA14 following exposure to (R)-, (S)- or (±)- Propranolol.  Metabolites are listed in 
order of significance (highest first) according to the Friedman test. * 
Metabolite R ± S 
Valined    
Amined    
Tryptophand    
2-hydroxyglutarated    
Octadecanoic acidd    
Hexadecanoic acidd    
Ethanolamined    
Citrullined    
Nicotinamided    
Ornithined    
Xanthinep    
Myristic acidd    
Unknown peak (24)    
Unknown peak (163)    
Unknown peak (69)    
Unknown peak (93)    
Unknown peak (134)    
Unknown peak (190)    
Unknown peak (181)    
Unknown peak (8)    
Unknown peak (91)    
Unknown peak (195)    
Unknown peak (182)    
Unknown peak (108)    
Unknown peak (172)    
Unknown peak (5)    
Unknown peak (159)    
Unknown peak (206)    
Unknown peak (29)    
Unknown peak (135)    
Unknown peak (137)    
Unknown peak (62)    
Unknown peak (129)    
Unknown peak (143)    
* Green points represent a significant increase and red points represent a significant decrease in the 
metabolites identified in the Friedman test (p<0.02). 
d
 represents definitive identification by means of matching to authentic standard by retention time and 
mass spectrum.  p represents putative identification by mass spectrum only.  For the unknown peaks 
the database identifier is provided in parentheses.  
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Figure 2.12:  Venn diagram illustrating the number of metabolites identified as significantly 
different in Pseudomonas aeruginosa PA14 following exposure to (R)- , (S)- and (±)- 
Propranolol exposed cultures.  Identification of the metabolites from each section is detailed in 
Table 2.6. 
 
 
 
 
Table 2.6:  Identification of the metabolites displaying significant differences in 
Pseudomonas aeruginosa PA14 following exposure to (R)- , (S)- and (±)- Propranolol, 
illustrated in the Venn diagram.  Columns A-K refer to the different sections of the Venn 
diagram. 
A C I 
Tryptophand Unknown peak (1) Aminep 
2-hydroxyglutarated D Unknown peak (1) 
Ethanolaminep Valined J 
Citrullined Unknown peaks (3) Lactosed 
Nicotinamided E Unknown peaks (2) 
Ornithined 
Glycerate-3-phosphate / 
glycerol-3-phosphatep 
K 
Xanthinep Aminep Octadecanoic acidd 
Unknown peaks (11) F Unknown peaks (2) 
B Unknown peaks (3)  
Gluconolactonep G  
Fructose-6-phosphated  Unknown peaks (2)  
Unknown peaks (4)   
d
 represents definitive identification by means of matching to authentic standard by retention 
time and mass spectrum.  p represents putative identification by mass spectrum only.   
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Table 2.7:  Metabolites found to be significantly altered in Pseudomonas putida 
KT2440 following exposure to (R)-, (S)- or (±)- Propranolol.  Metabolites are listed in 
order of significance (highest first) according to the Friedman test. * 
Metabolite R ± S 
Glycerol-3-phosphated    
Citric acidd    
Myristic acidd    
5-aminovaleric acidd    
N-acetylglucosaminep     
Leucined     
Isoleucined     
Tyrosined     
Hexadecanoic acidd     
Citrullined    
Lysined     
Aminep    
Glutamic / pyroglutamic acidd     
Octadecanoic acidd    
Gluconolactonep    
Valined    
Unknown peak (158)    
Unknown peak (181)    
Unknown peak (163)    
Unknown peak (182)    
Unknown peak (94)    
Unknown peak (91)    
Unknown peak (48)    
Unknown peak (28)    
Unknown peak (76)    
Unknown peak (116)    
Unknown peak (183)    
Unknown peak (200)    
Unknown peak (111)    
* Green points represent a significant increase and red points represent a significant decrease in the 
metabolites identified in the Friedman test (p<0.02). 
d
 represents definitive identification by means of matching to authentic standard by retention time and 
mass spectrum.  p represents putative identification by mass spectrum only.  For the unknown peaks 
the database identifier is provided in parentheses.  
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Figure 2.13:  Venn diagram illustrating the number of metabolites identified as significantly 
different in Pseudomonas putida KT2440 following exposure to (R)- , (S)- and (±)- Propranolol.  
Identification of the metabolites from each section is detailed in Table 2.8. 
 
 
 
 
Table 2.8:  Identification of the metabolites displaying significant differences in 
Pseudomonas putida KT2440 following exposure to (R)- , (S)- and (±)- Propranolol, 
illustrated in the Venn diagram.  Columns A-K refer to the different sections of the Venn 
diagram. 
A F I 
Unknown peaks (3) Valined N-acetylglucosaminep 
B Glycerol-3-phosphated Octadecanoic acidd 
Unknown peak (1) Lysined J 
C Aminep Glucose-6-phosphated 
Tyrosined Unknown peaks (3) K 
Tryptophand G Leucined 
Trehalosed Glutamic / pyroglutamic acidd Isoleucined 
S-adenosylmethionine p Gluconolactonep Glycerol-3-phosphated 
Unknown peak (1) Unknown peaks (2) Citric acidd 
D H Myristic acidd 
5-aminovaleric acidd Unknown peak (1) Tyrosined 
Unknown peaks (2)  Hexadecanoic acidd 
  Unknown peak (1) 
d
 represents definitive identification by means of matching to authentic standard by retention 
time and mass spectrum.  p represents putative identification by mass spectrum only.   
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2.5 Conclusions 
It was clearly observed from the growth data that Propranolol had a biological effect on 
all the microorganisms studied. At the higher concentrations tested the growth was 
retarded and in most cases the death rate was increased, with associated changes 
observed in the metabolic fingerprints.  The loadings plots from the PC-CVA of API 
dosed and unexposed P. aeruginosa PA14 cells (Figure 2.4b) indicated that 
Propranolol exerts a widespread effect on the bacterial cells and this finding was also 
observed in the other bacteria studied.  The results from the HPLC analysis showed 
that the API was not degraded during the growth period and this suggests that the 
observed changes in the multivariate analysis of the metabolic fingerprints were not 
due to degradation of the API but more likely to be a secondary effect of the drug.  
Despite the genetic similarity of the two pseudomonads studied, our findings show that 
Propranolol exerted a different effect in the two species.  In contrast, the growth data 
showed that an effect was not observed in the Atenolol exposed cultures and this 
finding was reflected in the multivariate analyses of the bacterial fingerprints (Figure 
2.4e).  
 
All four aquatic bacteria were exposed to the enantiomers of Propranolol at 
concentrations in which there was no difference observed in the growth rates.  The FT-
IR analysis revealed that Propranolol affected both the lipid and protein content of the 
bacterial cells.  We hypothesise that this is likely due to the interaction of the APIs with 
the microbial cell walls.  A more predictable effect on the metabolic fingerprints was 
noted during the exposure of B. natatoria 2.1 and M. luteus 2.13 to the Propranolol in 
which the racemate fell between the (R)- and (S)- enantiomers in the PC-CVA.  Rather 
surprisingly the most significant effect on the two pseudomonads was with the 
racemate, whilst the enantiomers had identical effects on the phenotype of the cells.  It 
is possible that the physical properties of the racemate were significantly different from 
the (R)- and (S)- enantiomers and this was reflected in how the cells responded to 
exposure to the API. 
 
Multivariate analysis of the metabolite profile data from GC-MS of the two 
pseudomonads following exposure to a range of enantiomeric ratios of (R) : (S)- 
Propranolol revealed notable chiral specific effects in both P. aeruginosa PA14 and P. 
putida KT2440.  The analysis revealed that it was possible to differentiate between all 
of the various enantiomeric ratios and indicated that differential metabolic effects were 
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exerted on the bacterial cells according to the enantiomeric ratios to which they had 
been exposed.  In addition, significant reductions in a number of fatty acids were 
observed in P. putida KT2440 following exposure to the pure (S)- enantiomer and 
components from the bacterial cell membrane and cells wall were significantly reduced.  
The findings indicated that (S)- and (±)- Propranolol exerted an enhanced metabolic 
effect on P. putida KT2440 in comparison with the (R)- enantiomer.  Furthermore, 
significant changes were observed in a number of intermediates of the urea cycle in P. 
aeruginosa PA14 cultures exposed to (±)- Propranolol.  No significant changes were 
observed for these metabolites in P. putida KT2440, providing further evidence of a 
different metabolic effect in the two closely related pseudomonads.   
 
In conclusion it has been shown that chiral specific effects do occur in bacteria which 
may have implications for environmental ecosystems as these APIs are regularly found 
in the aquatic environment.  We believe FT-IR spectroscopy with appropriate 
chemometrics to be a very powerful method for investigating the phenotype and 
metabolic differences that APIs have when they interact with the bacterial cell.   
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3.1 Abstract 
Pharmaceuticals are an emerging class of environmental contaminants.  Active 
pharmaceutical ingredients (APIs) and their metabolites are ubiquitous in the 
environment and a number of APIs have been detected in wastewaters due to 
excretion of the API following medicinal and veterinary use.  Despite the low 
concentrations detected (ng - µg L-1), the presence of APIs in the aquatic environment 
is of great concern due to the potential for causing undesirable ecological effects.  In 
addition, the enantiomers of chiral APIs may possess differing toxicological and 
biological effects both from each other, and the racemate (an equal mixture of the two 
enantiomers).  It is therefore necessary to enhance our understanding of the fate and 
biological effects of chiral pharmaceuticals in the aquatic environment.  Of particular 
interest is the group of chiral APIs termed β-blockers as they all contain at least one 
chiral centre and are generally administered as the racemate.  In this investigation FT-
IR microspectroscopy was employed to investigate the chirality specific effects of the 
enantiomeric ratios of the β-blockers Atenolol and Propranolol on the total cellular 
fingerprints of the green algae Micrasterias hardyi.  In addition, the spatially localised 
effects of the APIs and their enantiomer ratios on the biochemical components of the 
algal cells were also investigated.  No notable difference was observed in M. hardyi 
exposed to Atenolol compared to the control samples.  By contrast, a phenotypic effect 
on the algal cells was observed when exposed to Propranolol.  A clear difference was 
observed in the FT-IR spectra of the algal cells exposed to 30 µg mL-1 Propranolol at 
all of the enantiomeric ratios and a dominant peak was observed in the FT-IR spectra 
at wavenumbers 1500 - 1200cm-1 which was not observed in cells exposed to (R)- 
Propranolol or the enantiomer.  Inspection of the photomicrographs and functional 
group maps revealed that the algal cells exposed to (R)- and (±)- Propranolol were 
particularly affected by the API.  The greatest reduction in the amide region of the FT-
IR spectra was observed in cells exposed to the racemate.  However, it was not 
possible to determine any specific localised effects in the algal cells relating to the 
cellular components.  Analysis of both the lipid rich and amide I rich areas of the algal 
cells did not reveal significantly different responses from those observed throughout the 
cell.  It is therefore likely that Propranolol exerts a general effect on the whole algal cell.  
This investigation illustrates the power of spatial metabolic fingerprinting with FT-IR 
microspectroscopy for the study of abiotic stresses on complex biological species. 
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3.2 Introduction 
Pharmaceuticals are an emerging class of environmental contaminants (Fent et al., 
2006).  Active pharmaceutical ingredients (APIs) and their metabolites are ubiquitous in 
the environment and a number of APIs have been detected in wastewaters due to 
excretion of the API following medicinal and veterinary use (Escher et al., 2005).  In 
addition, the incomplete removal of these compounds during the wastewater treatment 
processes has led to the presence of many APIs such as antibiotics, estrogens, non-
steroidal anti-inflammatories, and β-blockers in aquatic environments such as rivers 
streams and estuaries (Fent et al., 2006, Escher et al., 2005, Ashton et al., 2004, 
Carlsson et al., 2006b).  Despite the low concentrations detected (ng - µg L-1), the 
presence of APIs in the aquatic environment is of great concern due to the potential for 
causing undesirable ecological effects (Huggett et al., 2002, Kümmerer, 2009, 
Kümmerer et al., 2000).    
 
Although little is known about the effects of APIs in the environment, it must be taken 
into account that they are designed to elicit a specific mode of action in humans 
(Escher et al., 2005) and it can be expected that any beneficial or adverse effect may 
also be observed in aquatic organisms with similar biological functions or receptors.  It 
must also be noted that similar targets may control different metabolic processes in 
different species (Seiler, 2002), and therefore APIs and their metabolites may act 
through additional modes of action in aquatic organisms.  The effects of APIs may be 
rather subtle due to the very low concentrations observed in the aquatic environment, 
and as a result these effects may go unnoticed (Escher et al., 2005).  In addition, it is 
likely that the effect of the API will impact on the local population dynamics throughout 
the whole ecosystem, from bacteria up to higher organisms.   
 
The chirality of environmental contaminants such as APIs must be taken into 
consideration in order to understand fully the environmental fate and effects of these 
compounds.  The enantiomers of a chiral API are able to interact differently with other 
chiral compounds such as enzymes, and therefore potentially exert different effects 
when released into the environment (Fono and Sedlak, 2005, Buser et al., 1999, 
Nikolai et al., 2006).  In addition, the enantiomers of a chiral API may possess differing 
toxicological and biological effects both from each other, and the racemate (an equal 
mixture of the two enantiomers) (Lees et al., 2003, Yang et al., 2005).  It is therefore 
necessary to enhance our understanding of the fate and biological effects of chiral 
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pharmaceuticals in the aquatic environment in order to appreciate the risks fully 
(Huggett et al., 2002).  Of particular interest is the group of APIs termed β-blockers as 
they all contain at least one chiral centre and are generally administered as the 
racemate (Mehvar and Brocks, 2001).  In addition, they are widely used; with 
approximately 29 and 12 tonnes of Atenolol and Propranolol respectively taken each 
year in the UK (Ashton et al., 2004, Carlsson et al., 2006a, Carlsson et al., 2006b). 
 
It is difficult to determine the total effect of APIs in the environment as little information 
on the ecotoxicological effects of pharmaceuticals on both aquatic and terrestrial 
organisms is currently available.  The effect of APIs on aquatic organisms is 
considered particularly important as they are exposed to these compounds via 
wastewater residues during their entire lifespan (Fent et al., 2006).  Microalgae account 
for approximately 50% of total planetary primary productivity and are the major primary 
producers in most aquatic ecosystems (Beardall et al., 2001, Heraud et al., 2005, 
Shelly et al., 2002).  These photosynthetic, unicellular organisms are known to produce 
hydrogen and lipids under stress conditions and have also been used as biomarkers of 
contamination in aquatic environments (Torres et al., 2008).  In addition, it is known 
that algae play an important role in the dispersal, chemical transformation and 
bioaccumulation of many APIs (Bopp and Lettieri, 2007, Kowalewska, 1999, Lei et al., 
2002, Murray et al., 2003, Okay et al., 2000, Todd et al., 2002, Wang et al., 1998).  
Microalgal cells have been reported to display reorganisation of the composition of 
macromolecular components in response to alterations in available nutrients within 
their environment.  This effect has been accurately determined using FT-IR 
microspectroscopy (Beardall et al., 2001, Giordano et al., 2001, Heraud et al., 2005).  
 
As discussed above (Section 1.4.1, page 33) FT-IR spectroscopy is a rapid, 
reagentless and non-destructive technique, facilitating the identification of functional 
chemical groups and polar bonds within a biological sample through the generation of a 
spectral “fingerprint” (Stuart, 1996, Goodacre et al., 1998, Winder et al., 2004, 
Naumann et al., 1994).  FT-IR spectroscopy has previously been used to generate 
informative metabolic fingerprints from biological material (Johnson et al., 2004, Winder 
et al., 2007).  Previous studies have also proved its applicability to biological systems 
by successfully demonstrating the discrimination of bacteria to sub-species level 
(Winder et al., 2006, Timmins et al., 1998, Naumann et al., 1991a).  In addition, the 
combination of FT-IR and trajectory analysis has proved successful in the identification 
of metabolic changes in natural multi-organism fermentations (Johnson et al., 2004).  
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The integration of FT-IR spectroscopy with microscopic imaging techniques enables 
analysis of the spatial distribution of the functional groups which may be connected to 
specific components within the cell or tissue sample (Patel et al., 2008, Lewis et al., 
1995, Beardall et al., 2001, Lasch et al., 2002).  
 
Previous studies investigated the phenotypic effects of the β-blockers Atenolol and 
Propranolol on a number of prokaryotes commonly found in the aquatic environment 
(Chapter 2).  The aim of the present study was to explore both the phenotypic and 
spatial effects of these APIs in a eukaryotic system.  The green alga Micrasterias 
hardyi was selected for investigation following exposure to Atenolol and Propranolol; 
both of which have been found in effluent from wastewater treatment plants and in 
surface water of freshwater streams.  The Micrasterias cells were exposed to a range 
of enantiomeric ratios at a fixed concentration of either Atenolol or Propranolol and 
analysed using FT-IR microspectroscopy.  Through the comparison of both phenotypic 
and physiological changes, this investigation attempted to understand the effects 
exerted on the algal cells by these chiral APIs. 
Monitoring the phenotypic and spatial effect of chiral pharmaceuticals on green algae 
using FT-IR microspectroscopy 
 
An environmental metabolomics investigation of the effects of chiral pharmaceuticals 
and environmental pollutants on microorganisms 
- 99 -   
3.3 Materials and methods 
3.3.1 Culture conditions 
Micrasterias hardyi strain CCAP 649/15 was purchased from Culture Collection of 
Algae and Protozoa (Dunstaffnage Marine Laboratory, Oban, U.K.). M. hardyi was 
cultured in Jaworski’s Medium (JM, (Thomkins et al., 1995)) at 15 °C for 8 w, 60 r.p.m. 
in a Multitron (INFORS HT, Switzerland) orbital shaker, under photo periods of 12 h 
light and 12 h dark.  Nine stock solutions (200 mL) were prepared as detailed in Table 
3.1 and an aliquot (1 mL) of each stock solution was combined in 1 L of water and 
autoclaved (121 °C, 45 min, 15 psi).   
 
M. hardyi was exposed to Propranolol and Atenolol individually at a variety of 
enantiomeric ratios (100:0, 75:25, 50:50, 25:75 and 0:100 (R):(S) ) in triplicate at a 
concentration of 30 µg mL-1, with additional control flasks that did not contain any API.  
The concentration selected for investigation has been shown previously to exert 
phenotypic effects in M. hardyi (Patel et al., 2008); however, the phenotypic effects of 
Atenolol have not been reported for M. hardyi.  Following growth, aliquots (20 mL) were 
taken from each flask and centrifuged at a low speed (3,080 g, 4 °C, 40 min) using a 
Jouan CR 322 (Thermo scientific) to harvest the algal cells without causing damage to 
the cellular structure.  The biomass was resuspended in sterile distilled water (20 mL) 
and this washing process was carried out a total of 3 times in order to remove any 
residual API.  A final aliquot (100 µL) of sterile distilled H2O was added to the algal cells 
and this suspension was used for FT-IR microspectroscopic imaging.  
 
Table 3.1:  Stock solutions required for Jaworski’s medium and their components. 
Stock  g 200 mL-1 
1 Ca(NO3)2·4H2O 4.0 
2 KH2PO4 2.48 
3 MgSO4·7H2O 10.0 
4 NaHCO3 3.18 
5 EDTA FeNa 0.45 
 EDTA Na2 0.45 
6 H3BO3 0.496 
 MnCl2·4H2O 0.278 
 (NH4)6Mo7O24·4H2O 0.20 
7 Cyanocobalamin 0.008 
 Thiamine HCl 0.008 
 Biotin 0.008 
8 NaNO3 16.0 
9 NaHPO4·12H2O 7.2 
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3.3.2 FT-IR microspectroscopic imaging 
Aliquots (20 µL) of each resuspended sample were applied onto CaF2 disks (Crystran 
Ltd, Dorset, U.K.), and air dried prior to analysis.  Drying was used to avoid absorption 
of water in the mid-IR region which may mask biologically important chemical 
information in the spectra.  The spectra were collected in transmission mode using an 
Equinox 55 module step scan Fourier transform spectrometer coupled to a Hyperion 
3000 microscope (Bruker optics Ltd).  The microscope was equipped with a 64 × 64 
liquid nitrogen cooled mercury cadmium telluride focal plane array (MCT FPA) detector, 
which allows the simultaneous acquisition of spectral data from a 267 µm × 267 µm 
area when employing a ×15 objective lens.  The FT-IR spectral maps were collected 
over the wavelength range of 4000-900 cm-1 with a spectral resolution of 8 cm-1.  The 
data acquisition time was approximately 25 min for sample and 25 min for background 
measurements (Patel et al., 2008, Lasch et al., 2002).   
 
Spectral data were collected using routines within the OPUS 4.0 IR imaging software 
(Bruker Optics).  The ratio of the sample and background datasets was taken to 
generate transmittance images of each algal sample.  The spectral images were 
converted to absorbance within the OPUS software and exported as ASCII files 
 
3.3.3 Data analysis 
The ASCII data were imported into Matlab version 7.1 (The MathWorks, Inc., Natick, 
MA, USA) and a number of in-house algorithms were used in order to explore the 
spectral data (see Figure 3.1 for workflow). 
 
The pixels for each image were first selected as either “background” or those 
containing biological information using an automatic routine.  Selection criteria were 
employed using a deterministic approach to set a threshold IR signal; this was 
compared with the optical image to ascertain if only those pixels of biological relevance 
were selected.  The remaining pixels identified as “background” (or from sections of a 
second algal cell in the field of view) were set to zero in order to avoid any interference 
from these pixels which may lead to incorrect interpretation of the subsequent 
analyses.  Following the removal of the background pixels two main approaches were 
employed for the analysis of the spectral data.  Firstly, the spectra for each map were 
summed in order to provide a composite spectrum for each biological replicate, and 
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these composite spectra were used for subsequent multivariate analyses.  Secondly, 
functional group mapping was performed on the spectral maps to investigate the 
spatial distribution of selected functional groups and to gain further insight into the 
effects of the APIs on the algal cells. 
 
Once functional group mapping had been carried out, a threshold was set for the 
lipid:amide ratio maps.  All of the pixels above the chosen threshold were considered to 
be areas rich in lipids and those below the threshold were considered to be pixels rich 
in amide I.  The threshold was selected individually for each spectral map (biological 
replicate) in order to select the correct pixels for analysis (See Figure 3.1 for example).  
The spectral information for each of the pixels identified as rich in lipids or amide I were 
summed to form a composite spectrum for each of the biological replicates.   
 
The composite spectra were pre-processed prior to multivariate analysis.  Spectral 
regions which are dominated by CO2 vibrations arising from the atmosphere (2403 – 
2272 cm-1 and 683 – 656 cm-1) were removed and filled with a linear trend and the 
spectra were row normalised (centred about the mean and scaled to unit variance).  
These pre-processed spectra were used for subsequent multivariate analyses.  
Principal components analysis (PCA; (Jolliffe, 1986)) is an unsupervised method for 
reducing the dimensionality of multivariate data whilst preserving the variance; this 
transformation was performed prior to canonical variates analysis (CVA).  CVA is a 
supervised machine learning method that seeks to minimise within-group variance 
whilst maximising between-group variance, and can be used in conjunction with PCA to 
discriminate between groups on the basis of retained principal components (PCs), 
given a priori knowledge of group membership of the spectral replicates (Manly, 1994, 
Winder et al., 2004).  In this study, PC-CVA was performed on the composite spectra in 
order to investigate any phenotypic changes occurring in the algal cells when exposed 
to the APIs in their various enantiomeric ratios.  The PC-CVA models were constructed 
with a priori knowledge of the biological replicates.  In order to ensure these models 
were not over- or under-trained, validation was performed using the method of full 
cross-validation, where two of the biological replicates were used for model training 
with the third projected into the model for cluster validation purposes (Jarvis and 
Goodacre, 2004a).  Finally, CVA also allows statistical significance to be displayed on 
the scores plots and circles were used to represent the 95% χ2 confidence region 
constructed around each group mean based upon the χ2 distribution with two degrees 
of freedom (Krzanowski, 1988). 
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Principal component regression (PCR, (Gemperline et al., 1991)) is a supervised linear 
regression method and was used to ascertain if any linear relationships between the 
FT-IR spectra and the drug (R):(S) exposure existed.  In this approach PCA is first 
conducted and the PC scores regressed against the %(R)- enantiomer.  This process 
was again validated as detailed above as the optimal number of PCs (latent variables) 
against which to calibrate the model needs to be chosen.  
 
Functional group mapping is widely used in the analysis of spectroscopic maps.  It 
utilises the integrated peak area, intensity and position of FT-IR absorption bands 
attributed to specific functional groups and plots them as a function of X-Y position 
which can be laid over the optical image of the same sample area.  Thus revealing the 
spatial distribution of chemical constituents within a biological sample and providing 
information regarding a single peak (functional group) or a ratio of two peaks (McIntosh 
et al., 1999).  Table 3.2 highlights the major functional groups of interest.  The IR bands 
which are attributed to amide I and II are known to be sensitive to protein conformation 
(Fabian and Mäntele, 2002).  The amide I band corresponds to a high fraction of α-
helices compared to β-sheet secondary structure in the average protein content (Byler 
and Susi, 1986).  The most intense of the lipid absorptions are found at wavenumbers 
3000 – 2800 cm-1.  These bands are attributed to the symmetric and asymmetric 
stretching vibrations of CH3 and CH2 groups of the acyl chains.   
 
Functional group mapping was employed in order to investigate localised biochemical 
effects in the Micrasterias cellular components following exposure to the APIs.  The 
intensity and spatial distribution of amide I (1700 – 1600 cm-1) and lipids (3000 – 2800 
cm-1) within the algal cells, were analysed in order to obtain information regarding the 
specific effects of the APIs in the nucleus and chloroplasts respectively.  In addition, 
due to the high levels of amides observed throughout the algal cells, a ratio of 
lipid:amide mapping was employed in order to investigate those areas high in lipids.  
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Table 3.2:  FT-IR band assignments for the major regions of biological interest of the 
Micrasterias hardyi algal cell.  
Wavenumber (cm-1) range Dominant Compounds 
3000-2800 CHx stretches from Fatty acids 
  
1700-1500  
   (1700-1600) 
   (1600-1500)   
Proteins 
   C=O from Amide I 
   C-N and C-N-H from Amide II 
  
1450-1200 
 
   (1250-1200) 
Carboxylic groups of proteins, free amino acids, 
polysaccharides 
   P-O from RNA/DNA, phospholipids 
  
1200-900 C-O or O-H from Polysaccharides 
 
 
For each of the spectral maps the IR spectral intensity was converted into a colour 
code in which blue represents low IR absorbance and red represents high IR 
absorbance (see Figure 3.1 for example).  Gouraud shading is an interpolated shading 
function and was applied to the maps in order to reduce the appearance of pixilation 
(Gouraud, 1971).  It is piecewise bilinear, in which the value (i.e. colour) for each 
individual pixel varies linearly and interpolates with the values from the 8 pixels 
surrounding it. 
 
As described above, PCA reduces the dimensionality of multivariate data whilst 
preserving the variance.  PCA imaging transforms the data according to the variance 
within the dataset and constructs a map based on the PCA.  PCA imaging was 
performed on the spectral maps and the first principal component (PC) was plotted for 
each sample; lower PCs were also inspected but contained little additional knowledge.  
This provides a visualisation of the areas of the algal cells which account for the 
greatest variance within the analysis.  PCA imaging was employed in order to gain 
insight into the major spatial differences occurring within the cells when exposed to 
varying enantiomeric ratios of the APIs and the FT-IR bands related to these 
differences.  Most PCA images are constructed on single images and do not allow 
direct comparison between different images.  Therefore PCA was constructed from one 
alga and the FT-IR spectra from a different Micrasterias sample from the whole FPA 
was projected into its PC scores space.  Thus allowing direct comparison of the PC 
scores from image 1 with PC projected scores from a second image.  This method was 
performed in order to investigate the differences observed in algal cells exposed to 
differing enantiomeric ratios of the APIs and between the control and API exposed 
cells. 
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Figure 3.1:  Workflow showing the different steps and methods involved in the analysis of the 
FT-IR spectroscopy data. 
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3.4 Results and discussion 
3.4.1 Micrasterias hardyi 649/15 
 
 
Figure 3.2:  Photomicrograph image of Micrasterias hardyi 649/15 and the major cellular 
components.  
 
 
FT-IR microspectroscopic imaging is well suited to the spectral analysis of M. hardyi; a 
single-celled organism which has a depth of <12 µm, allowing for the collection of 
spectra without issues regarding over absorbance of the infrared light (Heraud et al., 
2005).  In addition M. hardyi has a large diameter (~80 – 200 µm), which permits 
imaging of the whole cell using a ×15 objective (Heraud et al., 2005, Patel et al., 2008).  
The algal cell consists of two semicells, each of which has four main lateral lobes and 
one larger polar lobe.  The semicells are connected by a central constriction termed the 
isthmus, which accommodates the nucleus.  Generally, one large chloroplast which 
extends into the lobes is found in each semicell (See Figure 3.2).  The chloroplasts 
enable photosynthesis and pyrenoids are highly differentiated areas of the chloroplasts 
which are surrounded by a thick sheath composed of starch.   
 
3.4.2 Investigating whether Atenolol or Propranolol exert a notable effect 
on the algal phenotype as judged by FT-IR spectroscopy 
Figure 3.3 shows average composite FT-IR spectra of the whole algal cells exposed to 
Atenolol and Propranolol, and cells not exposed to the APIs (i.e. control); the averages 
were calculated as detailed above and show information about the whole algal cells 
-
-
-
-
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D
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rather than any specific region.  The dominant spectral regions typify the patterns 
commonly associated with the FT-IR spectra of (micro)organisms, and the major 
spectral bands of biological interest are highlighted in Table 3.2 (Winder et al., 2004, 
Winder et al., 2006, Zhao et al., 2006, Naumann et al., 1991a).  There was no notable 
difference in the FT-IR spectrum of M. hardyi exposed to Atenolol compared to the 
control sample.  However, for cells exposed to Propranolol there appeared to be a 
reduction in the level of lipids within the algal cells (3000 – 2800 cm-1).  In addition a 
dominant peak was observed at 1500 – 1200 cm-1; a region typically associated with 
the carboxylic groups of proteins, free amino acids and polysaccharides (Winder et al., 
2004, Winder et al., 2006, Zhao et al., 2006, Naumann et al., 1991a).  The algal cells 
were washed during the harvesting stage and it is therefore unlikely that this peak is 
due to the presence of a contaminant from the Propranolol enantiomers.  Further 
inspection of the FT-IR spectra revealed this peak was only present in samples 
exposed to 25:75 and 75:25 ratios of (R):(S)- Propranolol and the (S)- enantiomer.  The 
intensity of the peak appeared to be higher in the algal cells exposed to the 
enantiomeric ratios of Propranolol compared to those exposed to the (S)- enantiomer; 
however there was no notable difference in the intensity of the peak between the 
enantiomeric ratios.  This peak was not observed in the spectra of cells exposed to (R)-
Propranolol and the racemate (Figure 3.4). 
 
PC-CVA was performed on the composite average spectra from each alga individually 
in order to investigate any phenotypic changes occurring within the cells when exposed 
to the APIs and their various enantiomeric ratios.  There was no notable phenotypic 
variation in the metabolic fingerprints of the samples exposed to the enantiomeric ratios 
of 30 µg mL-1 Atenolol (Figure 3.5a), because the different groups used by the CVA 
algorithm were not separated and the 95% χ2 tolerance regions overlap with those of 
the control samples.  This analysis clearly illustrates that no discrimination was 
observed between the control and Atenolol exposed conditions and suggests that 
Atenolol does not have a phenotypic effect on the algal cells detectable by FT-IR 
spectroscopy.  By contrast, Propranolol exposed samples separate from the control 
samples across PC-CV 1.  To further explore this separation, the Atenolol exposed 
samples were removed from the dataset and PC-CVA was carried out on the 
Propranolol exposed and control samples (Figure 3.5b).  In this model the Propranolol 
exposed samples clearly separate from the control samples across PC-CV 1.  As CVA 
uses a priori class knowledge (in this case pertaining to the different treatments) the 
model needs to be validated.  Therefore as described above, 2 of the 3 biological 
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replicates were used for calibration (shown in black) and the 3rd replicate (grey font) 
was projected into the model.  The majority of these projected data are grouped with 
the appropriate calibration samples indicating that the separation displayed in the 
model was valid.  Moreover, the 95% confidence intervals for the groups are also 
plotted showing that for the control samples there was a distinct separation in CVA 
scores space from the Propranolol exposed cultures indicating that Propranolol exerts 
a phenotypic effect on the algal cells.  It was perhaps unsurprising that the (R)- and (±)- 
exposed samples display some separation across PC-CV 2 as these samples are 
visibly distinct from the other enantiomeric ratios in the FT-IR spectra (Figure 3.4).  
However, the 95% confidence intervals for these samples indicated that the separation 
of these samples in this analysis was not wholly statistically significant.  Inspection of 
the loadings for this analysis (data not shown) revealed that this partial separation was 
due to vibrations at wavenumbers 1509 – 1478 cm-1 , which correlate with the dominant 
peak observed in the average spectra for the algal cells exposed to the (S)- 
enantiomer, and the enantiomeric ratios (25:75 and 75:25 of (R) : (S)- Propranolol) 
(Figure 3.4).  Previous studies have shown that (±)- Propranolol significantly altered the 
phenotype of M. hardyi during exposure to the API at 60 µg mL-1 (Patel et al., 2008).  
However, the effects of the enantiomers on the algae have not been studied previously, 
and to our knowledge the phenotypic effect of Atenolol has not been investigated in 
algae. 
 
3.4.3 Multivariate analysis of localised lipid and amide rich regions within 
the algae 
The multivariate analysis of the composite spectra from the whole algae revealed a 
phenotypic difference in the algal cells exposed to all of the enantiomeric ratios of 30 
µg mL-1 Propranolol.  In order to investigate any localised effects exerted on the M. 
hardyi cells following exposure to the APIs multivariate analysis was carried out on 
composite spectra taken from areas of the algal cells which had been identified as 
being rich in either lipids or amide I relating to the lobes and the central cellular region 
respectively.  Figure 3.6 shows the PC-CVA scores plots for the amide I and lipid rich 
regions of Micrasterias cells exposed to the enantiomeric ratios of 30 µg mL-1 Atenolol.  
It was clear from these plots that Atenolol exposed samples showed no separation 
from the control samples and this correlates with the PC-CVA results from the 
composite spectra of the whole algal cells.  In addition no notable phenotypic variation 
was observed in the metabolic fingerprints of these samples for any of the enantiomeric 
Monitoring the phenotypic and spatial effect of chiral pharmaceuticals on green algae 
using FT-IR microspectroscopy 
 
An environmental metabolomics investigation of the effects of chiral pharmaceuticals 
and environmental pollutants on microorganisms 
- 108 -   
ratios.  By contrast, Propranolol exposed samples showed a clear separation from the 
control samples across PC-CV 1 in both amide I and lipid regions (Figure 3.7).  As 
observed in the PC-CVA carried out on the composite spectra from the whole algal 
cells, the (R)- and (±)- Propranolol exposed samples show some separation across 
PC-CV 2 but this separation was also not considered to be statistically significant.  In 
addition, the loadings for these analyses demonstrated that the observed separation 
was attributable to vibrations at wavenumbers 1489 – 1478 cm-1.  The FT-IR spectra 
for both the amide I and lipid rich regions of the Propranolol exposed cells exhibited a 
similar phenotypic response, suggesting that the API does not exhibit a localised effect 
within the cellular components in the FT-IR spectra.   
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Figure 3.3:  Average FT-IR spectra for Micrasterias hardyi cells exposed to 30 µg mL-1 Atenolol 
and Propranolol, and those grown in the absence of API (Con = control).  The spectra are offset 
on the Y axis to allow easier visualisation, and the absorbance is relative. 
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Figure 3.4:  Average FT-IR spectra for Micrasterias hardyi cells exposed to varying ratios of 30 
µg mL-1 Propranolol, and those grown in the absence of API (i.e. control).  The spectra are 
offset on the Y axis to allow easier visualisation, and the absorbance is relative.  Ratios 100:0, 
75:25, 50:50, 25:75 and 0:100 (R) : (S) are represented by points R, R:s, ±, r:S and S 
respectively.  Control samples are labelled “Con”. 
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Figure 3.5:  PC-CVA scores plots for Micrasterias hardyi exposed to enantiomeric ratios of 30 
µg mL-1 Atenolol and Propranolol (a.) and Propranolol (b.).  Plots were constructed using the 
composite spectra for the whole algal cells.  Points shown in black represent the 2 biological 
replicates that were used to train the PC-CVA models.  Points shown in grey represent the third 
biological replicate which was used to validate the PC-CVA model.  Blue circles represent the 
95% confidence interval about the group centroid, and green circles the 95% confidence region 
about the group sample population.  Plots a and b were constructed using 5 and 3 PCs and 
account for 94.1 and 77.4 % explained variance respectively.  Points R, R:s, R:S, r:S, S and 
Con represent samples exposed to 100:0, 75:25, 50:50, 25:75, 0:100 (R) : (S) and control 
samples respectively. 
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Figure 3.6:  PC-CVA scores plots for amide (LHS) and lipid rich (RHS) regions of Micrasterias 
hardyi exposed to enantiomeric ratios of 30 µg mL-1 Atenolol.  Points shown in black represent 
the 2 biological replicates used to train the PC-CVA models.  Points shown in grey represent the 
third biological replicate which was used to validate the PC-CVA model.  Blue circles represent 
the 95% confidence interval about the group centroid, and green circles the 95% confidence 
region about the group sample population.  The plots were constructed using 3 PCs and 
account for 86.2 and 92.7 % explained variance respectively (LHS and RHS).  Points R, R:s, 
R:S, r:S, S and Con represent samples exposed to 100:0, 75:25, 50:50, 25:75, 0:100 (R) : (S) 
and control samples respectively. 
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Figure 3.7:  PC-CVA scores plots for amide (LHS) and lipid rich (RHS) regions of Micrasterias 
hardyi exposed to the enantiomeric ratios of 30 µg mL-1 Propranolol.  Plots were constructed 
using the composite spectra for the whole algal cells.  Points shown in grey represent the third 
biological replicate which was used to validate the PC-CVA model.  Blue circles represent the 
95% confidence interval about the group centroid, and green circles the 95% confidence region 
about the group sample population.  The plots were constructed using 4 PCs and account for 
93.6 and 88.0 % explained variance respectively (LHS and RHS).  Points R, R:s, R:S, r:S, S 
and Con represent samples exposed to 100:0, 75:25, 50:50, 25:75, 0:100 (R) : (S) and control 
samples respectively. 
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3.4.4 Investigating supervised learning for quantification of the 
enantiomer effect of the APIs 
As described above principal component regression (PCR) is a supervised learning 
method that effects quantitative analysis and was carried out in order to investigate the 
relationship between the percentage of enantiomer to which the algae had been 
exposed to and the phenotypic response.  PCR was trained to quantify the percentage 
of (R)- enantiomer to which the samples had been exposed and the control samples 
were removed from the dataset prior to analysis in order to prevent any subsequent 
bias within the analyses.  The PCR results (Figure 3.8) appeared to show some 
correlation, however the errors for these models were rather high.  The root mean 
squared (RMS) errors for the Atenolol and Propranolol exposed cells were +/- 83.48 
and +/- 99.54 respectively demonstrating that it was not possible to predict the ratio of 
enantiomers to which the algal cells had been exposed for either of the APIs from the 
FT-IR spectroscopy data.  In addition PCR was also carried out on the composite 
spectra of the amide I and lipid rich regions of the cells exposed to Atenolol and 
Propranolol (data not shown).  However, the results were consistent with those from 
the whole algal cells and it was not possible to model the relationship between the ratio 
of enantiomers to which the algal cells had been exposed and the phenotypic response 
for either of the APIs.  PCR is capable of modelling linear relationships and therefore it 
was not perhaps surprising that a correlation was not observed in these analyses as 
this would rely on a mainly linear relationship between enantiomeric ratio and 
phenotypic response within the algal cells.  Therefore a correlation would presume that 
the majority of the biological effect exerted on the algae was due to one of the 
enantiomers.  Whilst it is known that the (S)- enantiomer of Propranolol exerts the 
majority of the β-blocking effect in man, the effects of this API and its enantiomers have 
not previously been studied in algae (Barrett and Cullum, 1968, Walle et al., 1984).  
The multivariate data analyses indicated that both of the Propranolol enantiomers exert 
a phenotypic effect on M. hardyi, and appeared to exert differing phenotypic effects.  
Therefore, the PCR algorithm may not be able to model such complex phenotypic 
variations.  In addition, the initial results from the PC-CVA suggested that Atenolol did 
not exert a noticeable phenotypic effect on the composite spectra of the algal cells and 
it is therefore unlikely that a linear relationship between %(R)- enantiomer and 
phenotypic response may be modelled for Atenolol. 
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Figure 3.8:  Principal component regression (PCR) carried out on composite spectra from 
whole Micrasterias hardyi cells exposed to varying ratios of 30 µg mL-1 Atenolol (a.) and 
Propranolol (b.).  The models were built using two out of the three biological replicates and were 
given knowledge of the percentage of the (R)- enantiomer to which the algal cells had been 
exposed.  The model for Atenolol and Propranolol were built using 5 and 7 PCs and had errors 
of +/- 83.48 and +/- 99.54 respectively.  
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3.4.5 Investigating whether the APIs effect the distribution and 
concentration of the chemical constituents within the algal cells 
FT-IR microspectroscopy was carried out on whole algal cells exposed to the 
enantiomeric ratios of 30 µg mL-1 Atenolol or Propranolol in order to investigate any 
potential spatial effects on M. hardyi.  Spectral maps were constructed for the total IR 
signal absorbed by the Micrasterias cell at wavenumbers 4000 – 900 cm-1.  In addition, 
functional group mapping was carried out on these spectral maps in order to provide a 
visualisation of the spatial distribution of the chemical constituents of the algal cells 
when exposed to the APIs and their enantiomeric ratios.  Maps were constructed for 
the integrated peak areas under the amide I peak at wavenumbers 1700 – 1600 cm-1 
and the lipid peak at wavenumbers 3000 – 2800 cm-1.  In addition, due to the high 
levels of amides observed throughout the algal cells, a ratio of lipid:amide I was 
employed in order to normalise to the same protein level.  Finally, maps were 
constructed for the integrated peak areas under the peak observed at wavenumbers 
1500 – 1200 cm-1 for the Propranolol exposed cells.  Figure 3.9 and Figure 3.10 show 
the functional group maps for a selection of samples exposed to the enantiomeric 
ratios of 30 µg mL-1 Atenolol and Propranolol respectively and Figure 3.11 shows the 
functional group maps for the Propranolol exposed cells at wavenumbers 1500 – 1200 
cm-1.  
 
The morphological components of the algal cells can be clearly observed in the total 
signal maps of the Micrasterias control cells (Figure 3.9a).  These relate well to the 
relevant photomicrograph images and previous reports which have shown FT-IR 
microspectroscopy to be capable of resolving these cellular components (Heraud et al., 
2005, Patel et al., 2008).  Integration of the amide I band revealed a high concentration 
of amides throughout the centre of the cell and partially extending into the lobes.  A 
particularly high intensity of the amide I band was observed in the isthmus, the region 
in which the nucleus is found (Meindl et al., 1994, Heraud et al., 2005).  This correlates 
with the known composition of the nucleus, which has high levels of histones and low 
levels of lipids (Laskowski et al., 1997, Heraud et al., 2005).  The presence of amides 
in the semi-cells extending into the lobes may be attributed to the presence of the 
chloroplasts, in particular the pyrenoids which are highly differentiated areas of the 
chloroplast responsible for the fixation of CO2.  Pyrenoids are known to contain high 
levels of ribulose-1,5-bisphosphate carboxylase/oxygenase (RubisCO); the key 
enzyme of the Calvin Cycle which is the main process for carbon fixation in plants, 
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algae and photosynthetic bacteria (Laskowski et al., 1997, Venter et al., 2004).  Both 
RubisCO and histones are known to contain a high proportion of α-helices within their 
structure, and it is therefore likely that the intense amide I bands observed in the region 
of the chloroplasts and nucleus respectively was due to the presence of these proteins 
(Laskowski et al., 1997).  High levels of lipids are also observed throughout the control 
cells particularly within the centre of the semicells in the region in which the 
chloroplasts are observed.  It has been suggested that this may be attributed to the 
closely packed membranes termed thylakoids found within the chloroplasts (Meindl, 
1993, Heraud et al., 2005).  The spectral maps demonstrating the lipid:amide I ratio 
display highly differentiated areas in the end of the lobes which contain high 
concentrations of lipids, and have previously been suggested to be lipid storage bodies 
(Heraud et al., 2005). 
 
The photomicrograph images for Micrasterias exposed to the enantiomeric ratios of 30 
µg mL-1 Atenolol do not reveal a notable difference in the appearance of the algal cells 
when compared to the control cells.  This was reflected in the maps of the total FT-IR 
signal which appear similar to those of the control cells for all of the ratios.  In addition 
the functional group maps for the integration under the amide I and lipid peaks do not 
display a difference from the control cells (Figure 3.9).  This was not unexpected as the 
multivariate analysis did not show a difference between the Atenolol exposed and the 
control cells based on the composite spectra.  Figure 3.10 shows the photomicrograph 
images and the functional group maps for M. hardyi control cells and a selection of 
those exposed to the enantiomeric ratios of 30 µg mL-1 Propranolol.  It is clear from the 
photomicrograph images that Propranolol exerts a notable effect on the algal cells.  
The cells appear to be chlorotic following exposure to all of the selected enantiomeric 
ratios.  In addition, the maps of the total FT-IR signal display a general reduction in 
intensity for all of the enantiomeric ratios, which was not surprising given the 
appearance of the algal cells.  This trend was also observed for the amide I band which 
exhibits a dramatic reduction in amides throughout the Propranolol exposed cells 
compared to the control cells and corresponded to the chlorotic appearance of the algal 
cells.  The Micrasterias cells exposed to the racemate (Figure 3.10d) display the 
greatest reduction in amide I.  Although Figure 3.10 only displays one of the replicates 
from each of the experimental conditions, these trends are consistent throughout all of 
the replicates.  The functional group mapping for the lipid:amide I ratio also reveals a 
notable effect in the Propranolol exposed cells.  A general reduction of lipids was 
observed in the lipid storage bodies found at the end of the lobes in the algal cells 
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(Heraud et al., 2005).  Microalgae are well known for the production of lipids under 
stress conditions (Torres et al., 2008), however Propranolol is a lipophilic compound 
(Lemmer et al., 1985, Westerlund, 1985) and it was not surprising to note that it 
interacts with the lipid components of the M. hardyi cells.  The reduction of lipids in 
these areas was particularly noticeable in the Micrasterias cells exposed to both (R)- 
and (±)- Propranolol (Figures Figure 3.10b and Figure 3.10d respectively).  This 
observation was consistent with earlier analyses as these samples were notably 
different in the FT-IR spectra and showed some separation from the remaining 
samples in the PC-CVA carried out on the composite spectra for the whole algal cells.  
In addition, the photomicrograph images appear to reflect this enhanced effect on the 
algal cells by (R)- and (±)- Propranolol in comparison with the other enantiomeric 
ratios.  The (R)- enantiomer is known to have a predominantly membrane stabilising 
effect in man, whilst (S)- Propranolol accounts for the majority of the β-blocking effect 
(Barrett and Cullum, 1968, Potter and Sweetland, 1967, Hanna and Evans, 2000, 
Walle et al., 1984).  It is therefore likely that the enhanced effect on the lipids may be 
due to interactions with the algal membrane and the lipid components.  In addition the 
racemate possesses differing physical properties from the enantiomers and it may be 
expected that it could produce different effects in biological systems (Chickos et al., 
1981, Secor, 1963). 
 
The FT-IR spectra of cells exposed to the (S)- enantiomer and the enantiomeric ratios 
(25:75 and 75:25 of (R) : (S)- Propranolol), compared to the (R)- enantiomer and the 
racemate, revealed an additional feature at 1500 – 1200 cm-1 (Figure 3.4) which was 
also observed from the PC-CVA (Figure 3.5b).  Therefore in order to investigate this 
further, functional group maps for M. hardyi control cells and a selection of those 
exposed to the enantiomeric ratios of 30 µg mL-1 Propranolol for the total signal and the 
region at wavenumbers 1500 – 1200 cm-1 were constructed (Figure 3.11).  The IR 
signal for this peak was most intense in the centre of the cells, the region in which the 
chloroplasts and the nucleus are located.  The maps correspond to those for the amide 
I, lipid and lipid: amide I ratios maps (Figure 3.10) and show that Propranolol exerted a 
notable effect on the algal phenotype.  Comparing the series of Propranolol exposures 
as the amount of (S)- enantiomer it was not readily possible to determine any 
differential effect on the algal cells when exposed to the pure enantiomers and the 
various enantiomeric ratios.  However, on closer inspection it was possible to see that 
the overall signal strength for the integration between 1500 – 1200 cm-1 in the central 
region of the cells decreased as the (S) : (R) ratio increased, which may suggest  that  
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the (S)- enantiomer had a more profound effect on the chloroplast or nucleus of the 
algae. 
Monitoring the phenotypic and spatial effect of chiral pharmaceuticals on green algae 
using FT-IR microspectroscopy 
 
An environmental metabolomics investigation of the effects of chiral pharmaceuticals 
and environmental pollutants on microorganisms 
- 118 -   
Total Signal
4000 – 900 cm-1
Amide I
1700 – 1600 cm-1
Lipid
3000 – 2800 cm-1
Lipid : Amide I
a.
b.
c.
d.
e.
f.
 
Figure 3.9:  Photomicrograph images and functional group maps for Micrasterias hardyi cells 
exposed to varying ratios of 30 µg mL-1 (R) : (S)- Atenolol.  Row a. shows results for control 
cells.  Rows b-f represent cells exposed to 100:0, 75:25, 50:50, 25:75, 0:100 (R) : (S) 
respectively. 
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Figure 3.10:  Photomicrograph images and functional group maps for Micrasterias hardyi cells 
exposed to varying ratios of 30 µg mL-1 (R) : (S)- Propranolol.  Row a. shows results for control 
cells.  Rows b-f represent cells exposed to 100:0, 75:25, 50:50, 25:75, 0:100 (R) : (S) 
respectively. 
 
Monitoring the phenotypic and spatial effect of chiral pharmaceuticals on green algae 
using FT-IR microspectroscopy 
 
An environmental metabolomics investigation of the effects of chiral pharmaceuticals 
and environmental pollutants on microorganisms 
- 120 -   
a.
d.
e. f.
b.
c.
 
Figure 3.11:  Functional group maps for Micrasterias hardyi cells exposed to varying ratios of 
30 µg mL-1 (R) : (S)- Propranolol.  Maps for the total IR signal are shown on the left and 
functional group maps for the peak found at wavenumbers 1500-1200 cm-1 are shown on the 
right hand side.  Control samples are represented by (a.).  Samples b-f represent cells exposed 
to 100:0, 75:25, 50:50, 25:75, 0:100 (R) : (S)- Propranolol respectively. 
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3.4.6 PCA Mapping 
Functional group mapping was employed to investigate the phenotypic effects of the 
APIs on specific regions of the FT-IR spectra.  Therefore, in order to investigate the 
whole spectrum rather than specific regions PCA mapping was performed where PCA 
was conducted on the whole algae and the first PC score plotted on the chemical map.  
As the scores may have a different scale these were all normalised to lie within the 
same range.  However, on inspection of the PCA chemical maps it was clear that there 
was no obvious visual difference between the controls and any of the Atenolol exposed 
cells (Figure 3.12).  By contrast, for the Propranolol treated cells the overall ‘intensity’ 
of the maps was generally lower in the treated cells compared to the controls, but no 
specific differences could be observed in the PC loadings matrices (Figure 3.13).  
Therefore, chemical mapping using PCA did not bring anything more to the 
investigation compared to functional group mapping. 
 
Projections were used to highlight differences from controls and API exposed cells. In 
this process PCA was constructed on one alga and spectra from other algae were 
projected into this PCA space.  The idea behind this is that if there is a phenotypic 
difference between the algae then the spectra will also be different and so when 
projected into the PCA space these projected scores should fall outside the PC scores 
range.  This was tested within a replicate group; i.e. PCA was conducted on one of the 
control algae and the other two replicates projected in.  The images (data not shown) 
were equivalent, showing that there was no phenotypic difference.  However, when an 
alga treated with Atenolol or Propranolol was projected in it also looked very similar to 
the control.  Thus the project routine also did not identify any enantiomeric specific 
changes. 
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Figure 3.12:  PCA maps for Micrasterias hardyi cells exposed to varying enantiomeric ratios of 
30 µg mL-1 Atenolol.  PCA was carried out on the whole algal cells and the first PC is plotted for 
each sample.  Samples exposed to 100:0, 75:25, 50:50 25:75 and 0:100 (R) : (S)- Atenolol are 
labelled R, R:s, ±, r:S and S respectively. 
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Figure 3.13:  PCA maps for Micrasterias hardyi cells exposed to varying enantiomeric ratios of 
30 µg mL-1 Propranolol.  PCA was carried out on the whole algal cells and the first PC is plotted 
for each sample.  Samples exposed to 100:0, 75:25, 50:50 25:75 and 0:100 (R) : (S)- 
Propranolol are labelled R, R:s, ±, r:S and S respectively. 
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3.5 Conclusions 
The Propranolol racemate has previously been shown to exert phenotypic effects on M. 
hardyi at 30 µg mL-1.  In this investigation FT-IR microspectroscopy was employed to 
investigate the chirality specific effects of the enantiomeric ratios of the APIs 
Propranolol and Atenolol on the total cellular fingerprints of the algal cells.  In addition 
the spatially localised effects of the APIs and their enantiomer ratios on the biochemical 
components of the algal cells were also investigated.   
 
No notable difference was observed in M. hardyi exposed to Atenolol compared to the 
control samples as analysed by FT-IR spectroscopy.  The spectra appeared to be 
indistinguishable from those of the control when subjected to multivariate analyses.  In 
addition, the functional group mapping did not reveal any localised phenotypic 
differences in the Atenolol exposed cells for any of the enantiomeric ratios.   
 
By contrast, as observed previously, a phenotypic effect on the algal cells was 
observed when exposed to Propranolol.  A clear difference was observed in the FT-IR 
spectra of the algal cells exposed to 30 µg mL-1 Propranolol at all of the enantiomeric 
ratios and a dominant peak was observed in the FT-IR spectra at wavenumbers 1500 - 
1200cm-1 which was not observed in cells exposed to (R)- Propranolol or the 
enantiomer.  Inspection of the photomicrographs and functional group maps revealed 
that the algal cells exposed to (R)- and (±)- Propranolol were particularly affected by 
the API.  However, these samples were not satisfactorily separated from the remaining 
Propranolol exposed samples in the multivariate analysis of the spectral data.   
 
The greatest reduction in the amide region of the FT-IR spectra was observed in cells 
exposed to the racemate.  However, it was not possible to determine any specific 
localised effects in the algal cells relating to the cellular components.  Analysis of both 
the lipid rich (lobes) and amide I rich (centre of cell housing the nucleus and 
chloroplasts) areas did not reveal significantly different responses from those observed 
throughout the cell.  It is therefore likely that Propranolol exerts a general effect on the 
whole algal cell.  
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4.1 Abstract 
A number of methods are employed in the removal of harmful substances both from 
domestic and industrial wastewaters prior to the release of effluents into the aquatic 
environment.  These include chemical and physical remediation processes such as 
ozonation, and biological processes such as biofilm and membrane bioreactors and 
activated sludge systems.  In this investigation we acquired activated sludge from an 
industrial bioreactor capable of degrading phenol.  The sludge was incubated in the 
laboratory and monitored for the phenotypic effects exerted on the sludge by a range of 
environmental pollutants over a 48 h period.  Multiple samples were taken across the 
time course and analysed by Fourier transform infrared (FT-IR) spectroscopy.  FT-IR 
spectroscopy was employed as a whole organism fingerprinting approach to monitor 
biochemical changes in the bacterial cells during exposure to the chosen compounds.  
The ability of the activated sludge to degrade these compounds during the time course 
was also investigated.  The microbial community was able to degrade 5 mM phenol 
within 36 h and this was accompanied by a detectable biochemical change in the FT-IR 
fingerprint related to the cellular phenotype of the microbial community.  However, no 
notable phenotypic effect was observed in the microbial community when exposed to 
toluene, Atenolol and Propranolol.  FT-IR spectroscopy, when combined with 
chemometric analysis is a very useful high-throughput screening approach for 
assessing the metabolic capability of complex microbial communities.  The study 
demonstrates that the acquired ability of the microbial community is specific to phenol 
and it is not transferable to degrade compounds of a similar structure.  
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4.2 Introduction 
The release of effluents containing harmful chemicals into receiving waters may cause 
long term effects in aquatic biota and the occurrence and fate of environmental 
contaminants such as aromatic hydrocarbons, personal care products and 
pharmaceuticals in the aquatic environment has drawn increasing attention over the 
last decade (Daughton and Ternes, 1999, Jjemba, 2006, Alvarez and Vogel, 1991, 
Nahar et al., 2000, Ternes, 1998, Halling-Sørensen et al., 1998, Kümmerer, 2009).  
However, little is currently known about the fate of these compounds following their 
intended use (Kolpin et al., 2002) and there are a number of concerns regarding the 
presence of these compounds in the environment.  These concerns include risks to 
physiological and reproductive processes (Huggett et al., 2002, Kime and Nash, 1999, 
Purdom et al., 1994, Larsson et al., 1999), the development of antibiotic-resistance in 
bacteria (Khachatourians, 1998, Smith et al., 1999, Gilliver et al., 1999), and the likely 
increase in the toxicity of chemical mixtures (Abuhamed et al., 2004, Sumpter and 
Jobling, 1995).  For numerous substances, the potential effects on both man and 
aquatic ecosystems are not fully understood (Ayscough et al., 2000, Halling-Sørensen 
et al., 1998, Daughton and Ternes, 1999).  A number of harmful compounds have been 
indentified as causing undesirable effects in aquatic organisms.  For example the 
synthetic oestrogen ethinyloestradiol and the β-blocking agent Propranolol have been 
shown to exert a significant risk to reproduction in fish (Huggett et al., 2002, Kime and 
Nash, 1999, Larsson et al., 1999, Purdom et al., 1994).  In addition phenol has been 
shown to produce detrimental effects in aquatic organisms (Kühn et al., 1989).   
 
A number of methods are employed in the removal of harmful substances both from 
domestic and industrial wastewaters prior to the release of effluents into the aquatic 
environment.  These include chemical and physical remediation processes such as 
ozonation (Huber et al., 2003, Ternes et al., 2003, Ahmaruzzaman and Sharma, 2005, 
Vázquez et al., 2007, Qian et al., 1994), and biological processes such as biofilm and 
membrane bioreactors (Jeong and Chung, 2006, Morper and Wildmoser, 1990, 
Zuehlke et al., 2003, Kloepfer et al., 2004) and activated sludge systems (Sutton et al., 
1999, Suzuki et al., 2002, Fent et al., 2006).  Activated sludge systems are employed 
worldwide for the treatment of wastewaters and offer an effective alternative to the 
traditional chemical and physical methods which are known to produce hazardous by-
products (Singleton, 1994, Suzuki et al., 2002).  A key characteristic of the activated 
sludge process is the recycling of a large proportion of the biomass, resulting in a 
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significant community of microorganisms capable of efficiently processing wastewaters 
to degrade hazardous contaminants (Bitton, 2005).  The use of activated sludge has 
been shown to be more efficient than other methods for the removal of environmental 
pollutants such as pharmaceuticals (Drewes et al., 2002, Quintana et al., 2005), 
personal care products and aromatic hydrocarbons such phenols and toluene 
(Singleton, 1994, Sutton et al., 1999, Tisler et al., 1999) from wastewaters.   
 
FT-IR spectroscopy is a phenotyping technique which has previously been used to 
generate informative metabolic fingerprints from biological material (Johnson et al., 
2004, Winder et al., 2007).  Previous studies have also proved its applicability to 
biological systems by successfully demonstrating the discrimination of bacteria to sub-
species level (Winder et al., 2006, Timmins et al., 1998, Naumann et al., 1991a) but 
only when combined with chemometrics (Goodacre et al., 1998).  In addition, the 
combination of FT-IR and trajectory analysis has proved successful in the identification 
of metabolic changes in natural multi-organism fermentations (Johnson et al., 2004).  
FT-IR is particularly useful in gaining insight into complex biological problems as an 
initial screening method because it is high-throughput with analysis times of 10-60s per 
sample, requires minimal sample preparation, and is automated and relatively 
inexpensive.  
 
In this investigation we aim to explore the phenotypic effects exerted on an activated 
sludge community when exposed to a range of environmental pollutants.  The activated 
sludge community selected for investigation originated from an industrial steelworks 
where it was used in the degradation of phenol from coking effluents.  The activated 
sludge was monitored for the phenotypic effects and potential degradation of phenol, 
the structurally similar aromatic hydrocarbon toluene, and the β-blocking agents 
Atenolol and Propranolol over a 48 h period using FT-IR spectroscopy and HPLC 
analysis.  Through the comparison of the phenotypic changes with the degradation 
data, we aim to develop an understanding of the effects exerted on the activated 
sludge community by these environmental pollutants. 
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4.3 Materials and methods 
4.3.1 Activated sludge 
Activated sludge was collected from a bioreactor at an industrial wastewater treatment 
plant (Corus Steelworks, Scunthorpe, UK) and transported at room temperature 
immediately back to the laboratory where it was subsequently stored at 4°C until further 
use.  This microbial community was stored for 1 day prior to supplementation with any 
of the chosen compounds.   
 
4.3.2 Incubation conditions 
Prior to the addition of the chosen pollutants the activated sludge samples (150 mL) 
were incubated aerobically for 2 h at 25 °C at 150 r.p.m. in a Multitron (INFORS HT, 
Switzerland) orbital shaker.  Triplicate samples (so called biological replicates) were 
supplemented with the environmental pollutants 5 mM phenol, 1 mM toluene, 0.17 mM 
Propranolol, or 0.18 mM Atenolol, all of which have been shown to exert undesirable 
effects on aquatic organisms (vide supra).  Additional triplicate control samples were 
incubated without the addition of any pollutant and were used to monitor the activity of 
the activated sludge during incubation under laboratory conditions.  The activated 
sludge samples were maintained aerobically at 25 °C with 150 r.p.m. shaking 
throughout the incubation and sampling periods (Manefield et al., 2002).  Hourly 
samples were taken over a 10 h period (including t = 0 h and t = 15 min) and 
subsequently at 15, 20, 24, 36 and 48 h for analysis with FT-IR spectroscopy.  An 
aliquot (1 mL) was centrifuged for 6 min at 16089 g and the supernatant was removed 
for quantitative analysis of the pollutant with HPLC or a colorimetric assay.  The cell 
pellets were stored at -80 °C until required. 
 
4.3.3 Phenol quantification 
Quantification of phenol was performed using a colorimetric assay in which a red 
antipyrine dye is produced (King et al., 1991).  During this assay condensation of 4-
aminoantipyrine with phenol in the presence of alkaline oxidising agents produces a 
red antipyrine dye (AAPPC) in what is known as the Emerson reaction (Emerson, 
1943, Emerson and Kelly, 1948).  It is known that this assay has a greater sensitivity 
than other colorimetric assays of phenol (Svobodová and Gasparič, 1971).  The assay 
is most sensitive in the range of 0.002 – 0.02 mM.  It was therefore necessary to dilute 
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the phenol samples from early time-point determinations with sterile H2O in order to 
achieve the most sensitive assay.  The colour develops within 2 min, and changes with 
time, but it does not significantly change within 1 h (Martin, 1949).  The colorimetric 
assay is influenced by such factors as concentration of the reagents in relation to 
phenol concentration (Gasparic et al., 1974, Svobodová and Gasparič, 1971) the pH at 
which the assay is performed (7.5 – 9.5) and the order in which the reagents are 
added.  It is also considered necessary to have a least a 10-fold excess of 4-
aminoantipyrine and the oxidising agent relative to phenol (Svobodová and Gasparič, 
1971).  For this reason, a blank was run with each series of determinations by mixing 
4-aminoantipyrine, buffer, and the oxidising agent with sterile H2O.  The reagents and 
phenol standards were prepared just prior to their use. 
 
The aliquots (1 mL) were filtered (0.22 µm, MilliporeTM) and treated with 25µL of 0.5 M 
NH4OH and adjusted to pH 7.9 with 22.5 µL of phosphate buffer (0.5M KH2PO4, 0.6M 
K2HPO4).  Samples were treated with 10 µL of 100mM 4-aminoantipyrine and 10 µL of 
250 mM potassium ferricyanide.  The samples were allowed to react for 5 min, and the 
reaction products were determined in triplicate against a blank for each replicate with a 
BioMate™ 5 (Thermo Electron Corporation) spectrophotometer at 500 nm.  Phenol 
concentrations were calculated from standard curves prepared in parallel.   
 
4.3.4 HPLC analysis 
Concentrations of toluene, Atenolol and Propranolol were determined by HPLC (Agilent 
1100 series).  The supernatant samples were allowed to thaw at room temperature and 
were filtered (0.22 µm, MilliporeTM) in order to remove any microbial cells remaining in 
the medium.  Aliquots (25 µL) were injected onto the HPLC column in a randomised 
order.  Each sample was injected three times during the analysis, resulting in three 
analytical replicates for each biological sample.  The HPLC system was equipped with 
a Chirobiotic V2 column (250 mm × 4.6 mm i.d.), particle size 5 µm (ASTEC, 
Whippany, NY, USA) and a UV detector operating at a wavelength of 230 nm.  The 
column was eluted with an isocratic mixture of methanol and water (90:10, v/v) and 
1.0% triethylamine acetate (TEAA) buffer, pH 5.0.  The pH of the buffer was adjusted 
with acetic acid prior to the addition of methanol.  The measurements were carried out 
a 25 ± 1 °C at a flow rate of 1 mL min-1 (Bosakova et al., 2005).  
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4.3.5 FT-IR spectroscopy 
A 96-well zinc selenide plate was rinsed with analytical grade 2-propanol and deionised 
water and allowed to dry at room temperature (Winder et al., 2006).  The dry cell 
pellets stored at -80 °C were allowed to thaw at room temperature and washed in order 
to remove any traces of phenol.  Ice cold sterile water (2 mL) was added to each 
sample and vortexed.  The samples were centrifuged for 10 mins (0 °C, 16089 g), and 
the supernatant was discarded.  This cycle was repeated 3 times.  A final aliquot of 100 
µL sterile water was added to each sample and the solution was vortexed.  Aliquots (20 
µL) of each resuspended sample were applied to the ZnSe plate and oven dried at 50 
°C for 10 min.  Drying was used to avoid absorption of water in the mid-IR region which 
may mask biologically important chemical information in the spectra.  Three replicates 
of each of the samples were randomly applied to the ZnSe plates and triplicate spectra 
were obtained from different positions of each well, a total of nine spectra (so called 
technical replicates) were collected per sample.  The plate was loaded onto a 
motorised microplate module HTS-XT under the control of a computer programme with 
OPUS software version 4 (Winder et al., 2006).  Spectra were collected using an 
Equinox 55 FT-IR spectrometer (Bruker Optics Ltd), in transmission mode using the 
deuterium triglycine sulphate (DTGS) detector over the wavelength range of 4000-600 
cm-1 and with a resolution of 4 cm-1.  In order to improve the signal to noise ratio, 64 
spectra were co-added and averaged.  The spectra are displayed in terms of 
absorbance (see Figure 4.2 for typical example spectra). 
 
4.3.6 Data analysis 
The ASCII data were imported into Matlab version 7.1 (The MathWorks, Inc., Natick, 
MA, USA) and as an initial step CO2 vibrations arising from the atmosphere (2403 – 
2272 cm-1 and 683 – 656 cm-1) were removed and filled with a linear trend.  The 
spectra were then corrected using extended multiplicative scatter correction (EMSC) 
which normalises and smoothes the spectra by application of a polynomial smoothing 
function (Martens et al., 2003).  These pre-processed spectra were used for 
subsequent multivariate analyses. 
 
Principal components analysis (PCA; (Jolliffe, 1986)) is an unsupervised method for 
reducing the dimensionality of multivariate data whilst preserving the variance.  This 
transformation was performed prior to canonical variates analysis (CVA).  CVA is a 
supervised learning method that seeks to minimise within-group variance whilst 
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maximising between-group variance, and can be used in conjunction with PCA to 
discriminate between groups on the basis of retained principal components (PCs), 
given a priori knowledge of group membership of the spectral replicates (Manly, 1994, 
Winder et al., 2004).  PC-CVA models were constructed with a priori knowledge of the 
biological replicates.  In order to make sure these PC-CVA score plots were not over- 
or under-trained, these models were trained (constructed) with two of the biological 
replicates and cross-validated using the third biological replicate as detailed in (Jarvis 
and Goodacre, 2004a).  Finally, CVA also allows statistical significance to be displayed 
on the scores plots and circles were used to represent the 95% χ2 tolerance region 
constructed around each group mean by the χ2 distribution of two degrees of freedom 
(Krzanowski, 1988). 
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4.4 Results and discussion 
4.4.1 Quantification of the environmental pollutants 
The concentration of the environmental pollutants remaining in the activated sludge 
samples was monitored during the 48 h incubation period.  A colorimetric assay was 
used to determine levels of phenol in the supernatant for all of the experimental 
conditions.  Figure 4.1 shows the quantification results for the phenol supplemented 
and control activated sludge samples.  The activated sludge samples contained 
residual levels of approximately 0.22 mM phenol which was gradually degraded by the 
microbial community within 48 h.  Activated sludge samples supplemented with 5 mM 
phenol displayed a notable degradation of the phenol within 2 h and complete 
degradation was achieved within 36 h.   
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Figure 4.1:  Quantification of phenol remaining in the supernatant of phenol supplemented and 
control samples during the 48 h incubation period.  Data are averaged from 3 biological 
replicates and error bars show standard deviation. 
 
 
Quantification of phenol in the activated sludge samples supplemented with toluene, 
Atenolol and Propranolol corresponded with the control data; containing a residual 
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concentration of approximately 0.22 mM phenol remaining in the activated sludge 
following collection from the industrial steelworks.  This residual phenol was fully 
degraded by the activated sludge community within the 48 h incubation period and 
these samples were not supplemented with additional phenol.  Unfortunately, due to 
the complex nature of the activated sludge samples, it was not possible to quantify the 
levels of the other environmental pollutants with HPLC.  The samples produced high 
levels of background noise and as a result it was not possible to resolve the 
compounds using this method. 
 
4.4.2 Effects of the environmental pollutants on the FT-IR metabolic 
fingerprints 
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Figure 4.2:  Average FT-IR spectra for activated sludge samples following 48 h incubation at 25 
°C in the presence of the phenol, toluene, Propranolol and Atenolol.  Samples are labelled Phe, 
Tol, Prop and Aten for samples exposed to phenol, toluene, Propranolol and Atenolol 
respectively.  Control samples are labelled “Con”.  The spectra are offset on the Y axis to allow 
easier visualisation, and the absorbance is relative. 
 
 
Typical FT-IR spectra of the activated sludge samples incubated with phenol, toluene, 
Propranolol or Atenolol and samples incubated without any supplementary compounds 
are shown in Figure 4.2.  FT-IR spectroscopy results in the production of a composite 
spectrum that is representative of a wide range of endogenous and exogenous 
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metabolites.  The resultant spectrum is therefore highly complex and not open to direct 
interpretation of individual compounds of interest (See section 1.4.1, page 33).  On 
initial inspection a dominant peak was observed in all of the spectra at wavenumbers 
2120 - 2000 cm-1, which is not typically observed in the FT-IR spectra of bacterial 
samples (Winder et al., 2006), and there are very few functional groups that vibrate in 
this area of the infrared spectrum.  The most common are S-O from sulphates, C≡N 
from unsaturated N compounds, C-C stretching vibrations of alkynes and S=C=N from 
thiocyanates (Degen, 1997, Peoples et al., 1987).  It is known however, that phenol 
and thiocyanates are the two primary pollutants in coking effluent (Jeong and Chung, 
2006, Prater and Fisher, 1991, Manefield et al., 2005) and furthermore the effluent from 
the industrial plant in which the samples originate is known to contain thiocyanates at 
concentrations as high as 2.4 mM (Manefield et al., 2005).  It is therefore likely that this 
peak was attributable to the presence of thiocyanates within the activated sludge 
samples.  The remaining spectral regions typify the patterns commonly associated with 
the FT-IR spectra of microorganisms.  Many of the spectral bands have previously 
been assigned to functional groups of biological interest (Fabian and Mäntele, 2002, 
Lasch et al., 2002, Schultz et al., 1999, Winder et al., 2006).  The spectra for all of the 
experimental conditions appear to be dominated by the amide I and amide II functional 
group bands at wavenumbers 1700 – 1600 cm-1 and 1600 – 1500 cm-1 respectively.  
The band at 1200 – 900 cm-1 is attributed to C-O or O-H from polysaccharides.  In 
addition, the absorptions at wavenumbers 3000 – 2800 cm-1 are attributed to lipids; in 
particular, the symmetric and asymmetric stretching vibrations of the CH, CH2 and CH3 
groups of the acyl chains (Lorin-Latxague and Melin, 2005, Udelhoven et al., 2000, 
Patel et al., 2008).  
 
Due to the complex nature of the FT-IR dataset multivariate analysis (MVA) methods 
were employed to investigate the relationship between the bacterial communities from 
their FT-IR data.  PC-CVA was employed to investigate the phenotypic effect of the 
compounds on the activated sludge during incubation at 25 °C over a 48 h period.  Due 
to the large number of groups within the FT-IR dataset (5 experimental conditions x 17 
time points x 3 biological replicates x 9 analytical replicates) and in order to aid 
visualisation of the general trends within the data, a subset of samples were selected 
for multivariate analysis with PC-CVA.  Figure 4.3 shows the PC-CVA scores and 
loadings plots for the FT-IR data of the activated sludge communities supplemented 
with phenol, toluene, Atenolol or Propranolol and those not supplemented with any 
additional compounds (i.e., the control samples) at 0, 4, 8, 15, 20, 24 and 48 h.  The 0 
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h samples were collected just prior to the addition of any compounds for all of the 
experimental conditions and therefore as expected, all of the samples for this time point 
clustered with the control.  A clear separation was observed across the first canonical 
variate (PC-CV 1) which correlated to the time of sampling.  The activated sludge 
samples supplemented with phenol displayed a distinct separation from the remaining 
samples across PC-CV 2 following the 15 h time point.  This separation demonstrates 
a clear phenotypic difference in the activated sludge samples when supplemented with 
phenol; a finding which was not perhaps surprising, as the activated sludge community 
selected for investigation was employed for the degradation of phenols in the coking 
effluent (Manefield et al., 2005).  It is probable that the observed change in the 
phenotype of the sludge was directly related to the time at which the community was 
actively degrading phenol, and this will be investigated further.  By contrast, samples 
supplemented with toluene, Atenolol and Propranolol displayed no notable separation 
from the control samples, as the 95% χ2 tolerance regions around the group means 
overlap.  Visual inspection of the PC-CVA loadings plot for this analysis (Figure 4.3b) 
provides information relating to which spectral features are important for this 
separation.  In these analyses the 95% χ2 confidence band is represented as a green 
ellipse, such that any spectral features which are positioned outside of this region are 
considered significant in the PC-CV loadings plot.  The separation across PC-CV 1 
appeared to be due to variation in the FT-IR spectra at wavenumbers 2125 – 2055 cm-
1
.  As described above this peak was likely to be due to the presence of thiocyanates 
within the samples.  A number of studies have investigated the degradation of 
thiocyanates in coking effluent by activated sludge communities (Paruchuri et al., 1990, 
Shieh and Richards, 1988, Hung and Pavlostathis, 1997, du Plessis et al., 2001, Staib 
and Lant, 2007).  Thiocyanates are employed as a growth substrate by the activated 
sludge and whilst it is known that phenol does not affect this process, the presence of 
cyanides within the effluent have been shown to significantly inhibit thiocyanate 
degradation (Staib and Lant, 2007).  Furthermore the degradation of thiocyanates 
within activated sludge communities has been reported to be much slower than that of 
phenol and cyanide (Staib and Lant, 2007).  Thus it is likely that the changes in this 
peak of the FT-IR spectra for the control samples may be due to the degradation of 
thiocyanates by the activated sludge during the incubation period.   
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Figure 4.3:  PC-CVA scores (a.) and loadings (b.) plots for FT-IR spectra of activated sludge 
samples supplemented with phenol, toluene, Atenolol and Propranolol for 0, 4, 8, 15, 24 and 48 
h at 25 °C.  Samples supplemented with phenol, toluene, Atenolol and Propranolol are labelled 
“S”, “T”, “A” and “P” respectively.  Control samples are represented by “C”.  PCs 1-8 were 
employed by the CVA algorithm with the a priori knowledge of the biological replicates and 
accounts for 98.9% explained variance.  In the scores plot points shown in black represent the 2 
biological replicates used to train the PC-CVA models.  Points shown in grey represent the third 
biological replicate which was used to validate the PC-CVA model.  Black circles represent the 
95% confidence interval about the group centroid, and grey circles the 95% confidence region 
about the group sample population.  For the loadings biplot (b.), contiguous spectral regions 
falling beyond 2 standard deviations from the mean are encoded by colours and symbols 
detailed in the legend. 
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The greatest variance observed in the PC-CVA of all of the experimental conditions 
was between the samples with / without supplementary phenol.  Therefore, the data for 
each of the experimental conditions was analysed individually with the control samples 
in order to investigate any more subtle phenotypic changes in these communities when 
exposed to the chosen compounds.  As described above, a subset of samples was 
selected for analysis in order to allow visualisation of the strongest trends within the 
dataset.  The full datasets were also analysed (data not shown) to ensure that the 
trends observed in the selected samples represent the trends observed in the entire 
dataset.  Figure 4.4a and Figure 4.4b show the PC-CVA scores and loadings plots for 
the activated sludge samples at 0, 24 and 48 h following the addition of phenol, and the 
control samples.  As observed in the analysis of the whole dataset (Figure 4.3a) the 
samples for the 0 h time point clustered together and those supplemented with phenol 
at 24 and 48 h show a distinct separation from the control samples across PC-CV 1.  
The PC-CVA loadings plot (Figure 4.4b) demonstrates that this separation was due to 
changes in the FT-IR spectra at wavenumbers 1755 – 1718 cm-1 which is most 
commonly associated with the C=O stretching vibrations of esters, aldehydes or 
ketones.  In addition the separation across PC-CV 1 was also shown to be due to 
changes at wavenumbers 1199 – 1178 cm-1, most often associated with the C-N 
stretching vibrations of amines and the C-O stretching vibrations of alcohols, ethers 
and esters.  Some separation of the 24 and 48 h phenol supplemented samples is 
observed across PC-CV 1, however, the 95% confidence regions overlap and therefore 
the separation is not considered significant for this analysis.  The control communities 
display separation across PC-CV 2 according to the time of sampling.  Inspection of the 
PC-CVA loadings plot for this analysis indicated that this separation was due to 
variation at wavenumbers 2123 – 2047 cm-1 corresponding with the analysis carried out 
on the whole dataset (Figure 4.3b).  The observed separation of the control samples 
according to the time of sampling indicates a phenotypic change within the activated 
sludge community during the incubation period. 
 
The PC-CVA scores and loadings plots for activated sludge samples for 48 h with and 
without the addition of toluene are shown in Figure 4.4c and Figure 4.4d respectively.  
As described above, the 0 h samples displayed no separation in this analysis, whilst a 
clear separation between the 24 and 48 h time points from the 0 h samples was 
observed across PC-CV 1.  However, no notable difference was observed between the 
control and toluene supplemented samples indicating that there was no phenotypic 
difference in the toluene supplemented and non-supplemented sludge samples, 
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despite toluene’s somewhat close structural similarity to phenol.  The loadings plot for 
this analysis demonstrates that the separation of samples across PC-CV 1 was due to 
changes at wavenumbers 2121 – 2084 cm-1, 1036 – 1018 cm-1 and 1651 – 1618 cm-1 
which are associated with the S=C=N from thiocyanates, the C-O stretching vibrations 
of alcohols and the C=C stretch of aromatic rings respectively.  The presence of 
aromatic rings within the activated sludge samples was not unexpected as the 
chemical structures of phenol (residual levels of phenol in the activated sludge 
samples) and toluene both contain an aromatic ring (Figure 4.5).  Unfortunately, due to 
the high levels of background noise from the supernatant it was not possible to use 
HPLC to quantify levels of toluene remaining in the medium following the incubation 
period.  However, the phenotypic response appears dramatically different in samples 
actively degrading phenol and that of the activated sludge community supplemented 
with toluene appears to mimic the control communities suggesting that it did not exert a 
great phenotypic response in the activated sludge community.  This was rather 
surprising as toluene is very similar in structure to phenol (Figure 4.5).  In addition it is 
known that a number of microorganisms are capable of degrading both toluene and 
phenol, however; there have been no reports on the ability of the activated sludge used 
in this investigation to degrade toluene (Kahng et al., 2001, Kukor and Olsen, 1990, 
Nelson et al., 1987).  The first step in the degradation pathways for both of these 
compounds is a monooxygenase and it has been shown that the monooxygenase 
employed in the degradation of toluene has close homology with that of the phenol 
degradation pathway (Shingler et al., 1992, Yen et al., 1991, Nordlund et al., 1990).  A 
number of the same enzymes are employed for the degradation of both of these 
compounds in P. putida F1 (Reardon et al., 2000, Spain et al., 1989).  Furthermore, 
Rogers and Reardon demonstrated the simultaneous degradation of toluene and 
phenol showing that the same pathway was utilised in the degradation of both of the 
compounds in Burkholderia sp. (Rogers and Reardon, 2000).  The activated sludge 
was exposed to a relatively low concentration of toluene (1mM) in comparison with the 
concentration of phenol (5mM) to which it was exposed.  It is therefore possible that 
some degradation of toluene did occur within the activated sludge community that may 
have not been detectable with FT-IR spectroscopy due to the low levels of toluene with 
which is was exposed.  However, it is not possible to investigate this further without the 
relevant toluene quantification data. 
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Figure 4.4:  PC-CVA scores (LHS) and loadings (RHS) plots for FT-IR spectra of activated 
sludge samples supplemented with phenol (a and b) and toluene (c and d) for 0, 24 and 48 h at 
25 °C.  Samples supplemented with phenol and toluene are labelled “S” and “T” respectively.  
Control samples are represented by “C”.  PCs 1-5 were employed by the CVA algorithm with the 
a priori knowledge of the biological replicates and account for 97.7% and 98% explained 
variance respectively.  In the scores plots points shown in black represent the 2 biological 
replicates used to train the PC-CVA models.  Points shown in grey represent the third biological 
replicate which was used to validate the PC-CVA model.  Black circles represent the 95% 
confidence interval about the group centroid, and grey circles the 95% confidence region about 
the group sample population.  For the loadings biplots (RHS), contiguous spectral regions falling 
beyond 2 standard deviations from the mean are encoded by colours and symbols detailed in 
the legend. 
 
 
 
Phenol Toluene
 
Figure 4.5:  The chemical structures of the aromatic hydrocarbons phenol and toluene. 
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PC-CVA was also carried out on the FT-IR spectra of activated sludge samples 
incubated in the presence of the APIs Atenolol and Propranolol.  Figure 4.6 shows the 
PC-CVA scores and loadings plots for this analysis.  As noted for the toluene 
‘supplementation’ no notable difference was observed in samples supplemented with 
Atenolol from the control samples (Figure 4.6a).  As described above, the samples 
separate across PC-CV 1 according to the time point in the incubation period.  
However, the samples supplemented with Atenolol co-cluster with the control samples, 
indicating that the API did not exert a phenotypic effect on the activated sludge 
community.  In addition, Propranolol did not appear to exert an effect on the phenotypic 
fingerprint of the activated sludge community (Figure 4.6c).  A separation of the 0 h 
samples from the 24 and 48 h samples was observed across PC-CV 1, but there was 
no observable separation between the control and API supplemented samples for both 
Atenolol and Propranolol.  The PC-CVA loadings for these analyses (Figure 4.6b and 
Figure 4.6d) show similarities in the wavenumbers responsible for the separation 
observed in both of the PC-CVA scores plots.  For example the majority of the 
separation observed across PC-CV 1 for samples supplemented with Atenolol was due 
to wavenumbers 2115 – 2080 cm-1.  The differences observed between control 
samples and those supplemented with Propranolol is due to changes in the FT-IR 
spectra at wavenumbers 2124 – 2078 cm-1 and as described above, this falls within the 
region which is associated with the S=C=N vibrations from thiocyanates (Peoples et al., 
1987).  Again it was not possible to quantify the concentration of Atenolol and 
Propranolol remaining in the supernatant following the 48 h time course.  This was due 
to the complex nature of the samples which masked the presence of the APIs in the 
HPLC analysis.  However, since the activated sludge samples supplemented with 
Atenolol or Propranolol did not display any phenotypic variation from the control 
samples in the analysis of the FT-IR data it was unlikely that any degradation of the 
APIs occurred.   
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Figure 4.6:  PC-CVA scores (LHS) and loadings (RHS) plots for FT-IR spectra of activated 
sludge samples supplemented with Atenolol (a and b) and Propranolol (c and d) for 0, 24 and 
48 h at 25 °C.  Samples supplemented with Atenolol and Propranolol are labelled “A” and “P” 
respectively.  Control samples are represented by “C”.  PCs 1-5 were employed by the CVA 
algorithm with the a priori knowledge of the biological replicates and account for 97.5% and 
98.4% explained variance respectively.  In the scores plots points shown in black represent the 
2 biological replicates used to train the PC-CVA models.  Points shown in grey represent the 
third biological replicate which was used to validate the PC-CVA model.  Black circles represent 
the 95% confidence interval about the group centroid, and grey circles the 95% confidence 
region about the group sample population.  For the loadings biplots (RHS), contiguous spectral 
regions falling beyond 2 standard deviations from the mean are encoded by colours and 
symbols detailed in the legend. 
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4.5 Conclusions 
In this investigation activated sludge was acquired from an industrial bioreactor capable 
of degrading phenol.  The sludge was incubated in the laboratory and monitored for the 
phenotypic effects exerted on the sludge by a range of environmental pollutants over a 
48 h period.  Multiple samples were taken across the time course and analysed by FT-
IR spectroscopy.  FT-IR was employed as a whole organism fingerprinting approach to 
monitor biochemical changes in the bacterial cells during exposure to the chosen 
compounds.  We also investigated the ability of the activated sludge to degrade these 
compounds during the time course.  The phenol quantification data obtained from 
samples supplemented with 5 mM phenol showed that the activated sludge community 
was capable of degrading 5 mM phenol in 36 h, and it was evident from the FT-IR data 
that a metabolic effect was exerted on the microbial cells.  However, no notable 
phenotypic effect was observed in the microbial community when exposed to toluene, 
Atenolol or Propranolol and this was likely to be because this complex microbial 
community had been selected to degrade phenol rather than its close analogue toluene 
or the two structurally diverse APIs.   
 
Phenotypic differences were observed in the control cells during the time course and 
we hypothesise that this effect may be attributed to the presence of thiocyanates.  
However, further investigation is required to confirm these observations.  In conclusion, 
high-throughput metabolic fingerprinting with FT-IR spectroscopy has been used to 
monitor phenotypic shifts within complex microbial communities when exposed to a 
range of environmental pollutants.  This investigation demonstrates that FT-IR 
spectroscopy when combined with chemometric analysis is a very useful high-
throughput screening approach for assessing the metabolic capability of complex 
microbial communities.  
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5.1 Abstract 
The coking process produces great volumes of wastewater contaminated with 
pollutants such as cyanides, sulphides and phenolics.  Chemical and physical 
remediation of this wastewater removes the majority of these pollutants; however, 
these processes do not remove phenol and thiocyanate.  The removal of these 
compounds has been effected during bioremediation with activated sludge containing a 
complex microbial community.  In this investigation we acquired activated sludge from 
an industrial bioreactor capable of degrading phenol.  The sludge was incubated in our 
laboratory and monitored for its ability to degrade phenol over a 48 h period.  Multiple 
samples were taken across the time course and analysed by Fourier transform infrared 
(FT-IR) spectroscopy.  FT-IR spectroscopy was employed as a whole organism 
fingerprinting approach to monitor biochemical changes in the bacterial cells during the 
degradation of phenol.  We also investigated the ability of the activated sludge to 
degrade phenol following extended periods (2-131 days) of storage in the absence of 
phenol.  A reduction was observed in the ability of the microbial community to degrade 
phenol and this was accompanied by a detectable biochemical change in the FT-IR 
fingerprint related to cellular phenotype of the microbial community.  In the absence of 
phenol a decrease in thiocyanate vibrations was observed, reflecting the ability of these 
communities to degrade this substrate.  Actively degrading communities showed an 
additional new band in their FT-IR spectra that could be attributed to phenol 
degradation products from the ortho- and meta-cleavage of the aromatic ring. We 
believe that FT-IR spectroscopy when combined with chemometric analysis is a very 
useful high-throughput screening approach for assessing the metabolic capability of 
complex microbial communities.  
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5.2 Introduction 
Phenolic compounds are ubiquitous in the environment due to their release from both 
industrial and natural processes.  The accumulation of phenolic compounds comprises 
an environmental hazard, and the removal of these pollutants is required prior to the 
release of wastewater from such industrial processes (Environment Agency, 1995, 
Whiteley and Bailey, 2000).  The coking process produces great volumes 
(approximately 1,800 L min-1) of wastewater contaminated with pollutants such as 
cyanides, sulphides, thiocyanates and phenolics (Patterson, 1985, Manefield et al., 
2002, Neufeld and Valiknac, 1979, Philp et al., 2003, Vázquez et al., 2006).  Chemical 
and physical remediation of this wastewater removes the majority of these pollutants 
(Vázquez et al., 2007, Ahmaruzzaman and Sharma, 2005, Minhalma and de Pinho, 
2002, Minhalma and de Pinho, 2004, Qian et al., 1994, Vázquez et al., 2006).  
However, these processes do not remove phenol and thiocyanate, and the removal of 
these compounds takes place during bioremediation with activated sludge (Manefield 
et al., 2005).  
 
The use of microorganisms in the bioremediation of phenols produced during industrial 
processes is widespread (Sutton et al., 1999, Tisler et al., 1999).  However, until the 
development of RNA stable isotope probing (RNA-SIP), the composition of the 
microbial communities specifically degrading phenolics within activated sludge was 
largely speculative and based upon the presence of phenolic degradation pathways 
within isolates cultured axenically from the system under study (Whiteley and Bailey, 
2000).  In order to target the key degraders directly, Manefield et al. (2002) applied 
RNA-SIP on the activated sludge utilised in this investigation, to identify the dominant 
members of this community responsible for the degradation of phenol.  Bacterial 
genera found to dominate the acquisition of carbon from phenol, through cellular 
isotopic labelling after 13C labelled phenol degradation, included members of the β-
Proteobacteria, including the Thauera and Acidovorax genera, and the α-
proteobacterial Rhodopseudomonas genus.  All of the phenol degrading 
microorganisms highlighted by this study have previously been isolated when aromatic 
compounds such as phenol, benzoate, or toluene were used as the sole source of 
carbon (Tschech and Fuchs, 1987, Harwood and Gibson, 1988).  However, whilst 
members of the Thiobacillus and Acidobacterium genera were also found to be 
dominant within this activated sludge community, these species do not assimilate 
carbon from phenol (Manefield et al., 2002). 
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Whilst there has been considerable interest in characterising the members of the 
complex microbial community involved in biodegradation, little attention has been 
directed towards the metabolic pathways utilised in the degradation of phenol.  In this 
investigation we have employed Fourier transform infrared (FT-IR) spectroscopy as a 
phenotypic typing technique which has previously been used to generate informative 
metabolic fingerprints from biological material (Johnson et al., 2004, Winder et al., 
2006).  Previous studies have also proved its applicability to biological systems by 
successfully demonstrating the discrimination of bacteria to sub-species level (Winder 
et al., 2006, Timmins et al., 1998, Naumann et al., 1991a) but only when combined with 
chemometrics (Goodacre et al., 1998).  In addition, the combination of FT-IR and 
trajectory analysis has proved successful in the identification of metabolic changes in 
natural multi-organism fermentations (Johnson et al., 2004).  FT-IR spectroscopy is 
particularly useful in gaining insight into complex biological problems as an initial 
screening method because it is high-throughput with analysis times of 10-60s per 
sample, requires minimal sample preparation, is automated and relatively inexpensive.  
 
In this study three objectives were investigated to provide insight into the process of 
phenol degradation by an activated sludge community previously developed for the 
degradation of phenol in coking effluent.  In the first instance, biochemical changes in 
the activated sludge community were monitored during the degradation of phenol over 
a 48 h period through the use of FT-IR spectroscopy.  In addition we determined the 
effect of storing the activated sludge for extended periods of time, (without added 
phenol) to understand the ability of this microbial community to degrade phenol and 
investigated the phenotypic changes by FT-IR analysis.  In addition, GC-MS was 
employed for metabolite profiling of the activated sludge community in order to monitor 
the changes in the meta-metabolome during the active degradation of phenol. 
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5.3 Materials and methods 
5.3.1 Sample Information 
The overall workflow for this series of experiments is detailed in Figure 5.1.  Activated 
sludge was obtained from a bioremediation system at an industrial steelworks where it 
was employed in the degradation of phenol in coking effluent (Manefield et al., 2005, 
Manefield et al., 2002, Whiteley and Bailey, 2000).  As described above, coking 
effluents also typically contain pollutants such as sulphides, cyanides and thiocyanates.  
The activated sludge was collected and transported immediately back to the laboratory 
(Manchester University) at room temperature where it was stored at 4°C until further 
use.  Activated sludge was stored for 2, 9, 16 and 131 days prior to any 
supplementation with phenol.  This ageing of the samples was carried out in order to 
assess the phenol degrading capabilities of the activated sludge following extended 
storage periods, during which no additional phenol was added to the samples. 
 
5.3.2 Laboratory Microcosms 
Prior to the addition of phenol the activated sludge samples (150 mL) were incubated 
aerobically for 2 h at 25 °C at 150 r.p.m. in a Multitron (INFORS HT, Switzerland) 
orbital shaker.  Triplicate samples (so called biological replicates) were supplemented 
with 5 mM phenol as the sole carbon source.  Additional triplicate control samples were 
incubated without added phenol, and were used to monitor the activity of the activated 
sludge during incubation under laboratory conditions.  All of the activated sludge 
samples were maintained aerobically at 25 °C with 150 r.p.m. shaking throughout the 
incubation and sampling periods (Manefield et al., 2002).  Hourly samples were taken 
over a 10 h period (including t = 0 h and t = 15 min) and subsequently at 15, 20, 24, 36 
and 48 h for the quantification of phenol and analysis with FT-IR spectroscopy.  For FT-
IR spectroscopy a 1 mL aliquot was centrifuged for 6 min at 16089 g, the supernatant 
was removed and the cell pellets were stored at -80 °C until required.  Cell pellets were 
stored so that all of the activated sludge samples may be analysed by FT-IR 
spectroscopy at the same time, in order to reduce any minor instrument variation within 
the dataset.   
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Figure 5.1:  Experimental workflow showing the different steps between collection of the 
activated sludge samples, incubation with phenol and phenol quantification and FT-IR 
spectroscopy. 
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5.3.3 Assay for Phenol Quantification 
The phenol concentration at each sampling point was determined by the Emerson 
reaction; a colorimetric assay in which a red coloured antipyrine dye (AAPPC) is 
produced through the condensation of 4-aminoantipyrine with phenol in the presence of 
alkaline oxidising agents (King et al., 1991).  The assay has a greater sensitivity than 
other colorimetric assays of phenol (Svobodová and Gasparič, 1971) and is most 
sensitive in the range of 0.002 – 0.02 mM.  The colour develops within 2 min, and 
changes with time, but it does not significantly change within 1 h (Martin, 1949, 
Gasparic et al., 1974, Svobodová and Gasparič, 1971).  The reagents and phenol 
standards were prepared just prior to their use. 
 
Sample supernatants generated by centrifugation as detailed above (1 mL) were 
filtered (0.22 µm, MilliporeTM) and treated with 25 µL of 0.5 M NH4OH and adjusted to 
pH 7.9 with 22.5 µL of phosphate buffer (0.5 M KH2PO4, 0.6 M K2HPO4).  Samples 
were treated with 10 µL of 100 mM 4-aminoantipyrine and 10 µL of 250 mM potassium 
ferricyanide.  The samples were allowed to react for 5 min, and the reaction products 
were determined in triplicate against a blank (4-aminoantipyrine, buffer, and the 
oxidising agent was mixed with sterile H2O) for each replicate with a BioMate™ 5 
(Thermo Electron Corporation) spectrophotometer at 500 nm.  Phenol concentrations 
were calculated from standard curves prepared in parallel.  The samples were diluted 
with sterile deionised water when not in the sensitive range of the assay (i.e. 0.002 – 
0.02 mM).   
 
5.3.4 Analysis of microbial cells by FT-IR spectroscopy 
Fingerprint analysis using FT-IR spectroscopy (Maquelin et al., 2002) was performed 
on all of the activated sludge samples, taken from each of the four time delayed 
experiments at the same time in order to reduce any minor instrument variation within 
the dataset.  FT-IR spectroscopy is a whole organism fingerprint analysis approach and 
analyses the total complement of the (bio)chemical components from bacterial cells 
(Goodacre et al., 1998, Magee, 1993); this includes lipids, sugars, nucleic acids as well 
as proteins (Helm and Naumann, 1995).  A 96-well zinc selenide plate was rinsed with 
2-propanol and deionised water and allowed to dry at room temperature (Winder et al., 
2006).  The dry cell pellets stored at -80 °C were allowed to thaw at room temperature 
and washed in order to remove any traces of phenol.  Ice cold sterile water (2 mL) was 
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added to each sample and vortexed.  The samples were centrifuged for 10 mins (0 °C, 
16089 g), and the supernatant was discarded.  This cycle was repeated 3 times.  A 
final aliquot of 100 µL sterile water was added to each sample and the solution was 
vortexed.  Aliquots (20 µL) of each resuspended sample were applied to the ZnSe 
plate and oven dried at 50 °C for 10 min.  Drying was used to avoid absorption of water 
in the mid-IR region which may mask biologically important chemical information in the 
spectra.  Three analytical replicates of each of the samples were randomly applied to 
the ZnSe plates and triplicate spectra were obtained from different positions within 
each well, a total of nine spectra (so called analytical replicates) were collected per 
biological sample.  For subsequent multivariate models one biological sample (i.e. 
biological replicate) is represented by nine FT-IR spectra.  The plate was loaded onto a 
motorised microplate module HTS-XT under the control of a computer programme with 
OPUS software version 4 (Winder et al., 2006).  Spectra were collected using an 
Equinox 55 FT-IR spectrometer (Bruker Optics Ltd), in transmission mode using the 
deuterated triglycine sulphate (DTGS) detector over the wavelength range of 4000-600 
cm-1 and with a resolution of 4 cm-1.  In order to improve the signal to noise ratio, 64 
spectra were co-added and averaged.  The spectra are displayed in terms of 
absorbance. 
 
5.3.5 Metabolite profiling with GC-MS 
In order to quench metabolism, activated sludge samples (2 mL) were plunged rapidly 
into an equal volume of 60% aqueous methanol solution (−48 °C).  The quenched 
biomass was centrifuged for 10 min (3,000 g, −9 °C) and the supernatant was 
removed.  The biomass pellets were stored at −80 °C for further analysis (Winder et al., 
2008).  
 
For metabolite extraction, the biomass pellets were suspended in 550 µL of 80% 
aqueous methanol solution (−48 °C), frozen in liquid nitrogen, and allowed to thaw on 
dry ice.  The freeze thaw cycle was carried out three times in order to permeabilise the 
cells and allow leakage of the metabolites into the supernatant.  The suspensions were 
centrifuged for 7 min (16,060g, −9 °C) and the supernatant was retained and stored on 
dry ice.  An additional aliquot (550 µL) of 80% aqueous methanol solution was added 
to the biomass pellet and the procedure was repeated.  The second aliquot of the 
supernatant was combined with the first and the sample was stored on dry ice for 
further analysis (Winder et al., 2008).  In order to prepare the metabolite extracts for 
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GC-MS analysis, aliquots (1 mL) of each extract was spiked with 100 µL of internal 
standard solution (0.19 mg mL-1 succinic-d4 acid, 0.27 mg mL-1 malonic-d2 acid, 0.22 
mg mL-1 glycine-d5 in HPLC-grade water) and lyophilised (HETO VR MAXI vacuum 
centrifuge attached to a HETO CT/DW 60E cooling trap; Thermo Life Sciences, 
Basingstoke, U.K.) (Winder et al., 2008).   
 
Samples were subsequently derivatised in two stages.  An aliquot (40 µL) 20 mg mL-1 
O-methylhydroxylamine solution in pyridine was added and heated at 40 °C for 80 min 
followed by addition of 40 µL of MSTFA (N-acetyl-N-(trimethylsilyl)-trifluoroacetamide) 
and heating at 40 °C for 80 min.  A retention index solution was added for 
chromatographic alignment (20 µL, 0.6 mg mL-1 C10/C12/C15/C19/C22 n-alkanes).  
 
The gas chromatography time-of-flight mass spectrometry (GC-TOF-MS) method used 
to analyse the metabolites is suitable for detection and semi-quantification of a wide 
range of metabolite classes as detailed in available mass spectral / retention index 
libraries (Kopka et al., 2005) or genome-scale reconstructions of metabolic networks 
(Feist et al., 2007)  Samples were analysed in a random order employing GC-TOF-MS 
(Agilent 6890 GC coupled to a LECO Pegasus III TOF mass spectrometer) and using 
the optimal settings determined previously for yeast analysis (O'Hagan et al., 2004).  
The raw data were processed using LECO ChromaTof v2.12 and its associated 
chromatographic deconvolution algorithm, with the baseline set at 1.0, data point 
averaging of 3, and average peak width of 2.5.  A reference database was prepared 
which incorporated the mass spectrum and retention index of all metabolite peaks 
detected in a random selection of samples in order to allow the detection of all 
metabolites present.  Each metabolite peak in the reference database was searched 
for in each sample, and if matched, the peak area was reported and the response ratio 
relative to the internal standard was calculated (Winder et al., 2008).   
 
5.3.6 Data analysis 
The IR data were imported into Matlab version 7.1 (The MathWorks, Inc., Natick, MA, 
USA) and as an initial step CO2 vibrations arising from the atmosphere (2403 – 2272 
cm-1 and 683 – 656 cm-1) were removed and filled with a linear trend using a protocol 
we have developed previously (Alsberg et al., 1998).  The spectra were then corrected 
using extended multiplicative scatter correction (EMSC) which normalises and 
smoothes the spectra by application of a polynomial smoothing function (Martens et al., 
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2003).  EMSC was employed as a baseline correction technique and was carried out 
on the entire dataset such that unavoidable baseline variations were removed; visible 
inspection of this processing step was used to check for the inclusion of any artefacts 
and these were not seen.  Other potential pre-processing methods were assessed 
empirically and we found EMSC to correct for the non-linear background most 
effectively, when compared against basic scaling and normalisation functions.  The 
pre-processed spectra were used for subsequent multivariate analyses. 
 
Principal components analysis (PCA; (Jolliffe, 1986)) is an unsupervised multivariate 
projection method employed as a data reduction strategy in which principal 
components (PCs) are derived that explain the majority of the variance within a 
complex dataset.  The aim of the data compression is to obtain a set of novel PCs 
which describe as much of the variance in the original dataset as possible.  This 
transformation was performed prior to canonical variates analysis (CVA).  CVA is a 
supervised learning method that seeks to minimise within-group variance whilst 
maximising between-group variance, and can be used in conjunction with PCA to 
discriminate between groups on the basis of retained principal components (PCs), 
given a priori knowledge of group membership of the spectral replicates (Manly, 1994, 
Winder et al., 2004).  In these analyses, a priori knowledge of class structure of the 
biological replicates was employed to achieve the supervision of the algorithm (Windig 
et al., 1983, MacFie et al., 1978, Goodacre et al., 1998).  In order to make sure these 
PC-CVA score plots were not over- or under-trained, the models were trained 
(constructed) with two of the biological replicates and cross-validated using the third 
biological replicate as detailed in (Jarvis and Goodacre, 2004a). 
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5.4 Results and discussion 
Phenol quantification data (Figure 5.2) indicated that the fresh activated sludge was 
capable of degrading 5 mM phenol within 48 h.  When aged for 2 d, a notable 
degradation of phenol by the microbial community was observed within 2 h, and 
complete degradation of 5 mM phenol was achieved within 36 h.  By contrast, the 
microbial community aged for 9 d did not exhibit a noticeable degradation of phenol 
until after an 8 h lag period and complete degradation occurred within 48 h.  In 
contrast, activated sludge samples which were aged for 16 and 131 d were not able to 
degrade 5 mM phenol within the 48 h period, indicating a gradual loss in the ability of 
the activated sludge community to degrade phenol effectively during the ageing 
process; a finding which has not previously been noted.   
 
Typical FT-IR spectra of the activated sludge samples incubated with / without 5 mM 
phenol as the sole carbon source are shown in Figure 5.3.  FT-IR spectroscopy results 
in the production of a composite spectrum that is representative of a wide range of 
endogenous and exogenous metabolites.  The resultant spectrum is therefore highly 
complex and not open to direct interpretation of individual compounds of interest (See 
section 1.4.1, page 33).  On initial inspection of the spectra a dominant peak is 
observed in both spectra at wavenumbers 2124.6 - 2082.2 cm-1, this is not observed in 
the FT-IR spectra of bacterial samples (e.g., see Winder et al., 2006), and there are 
very few functional groups that vibrate in this area of the infrared spectrum.  The most 
common are S-O from sulphates, C≡N from unsaturated N compounds, C-C stretching 
vibrations of alkynes and S=C=N from thiocyanates (Degen, 1997, Peoples et al., 
1987).  It is known however, that phenol and thiocyanates are the two primary 
pollutants in coking effluent (Neufeld and Valiknac, 1979, Patterson, 1985, Vázquez et 
al., 2006, Jeong and Chung, 2006, Prater and Fisher, 1991, Manefield et al., 2005) and 
furthermore the effluent from the industrial plant in which our samples originate is 
known to contain thiocyanates at concentrations as high as 2.4 mM (Manefield et al., 
2005).  It is therefore likely that this peak is attributable to the presence of thiocyanates 
within the activated sludge samples.  In order to confirm this we obtained the FT-IR 
spectrum from potassium thiocyanate (see Figure 5.4) and the 2050 cm-1 vibration from 
S=C=N is clearly observed.  The remaining spectral regions typify the patterns 
commonly associated with the FT-IR spectra of bacteria, and the major spectral bands 
of biological interest are highlighted in Table 5.1 (Winder et al., 2004, Winder et al., 
2006, Zhao et al., 2006, Naumann et al., 1991a). 
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Figure 5.2:  Phenol quantification data (black symbols and lines) with the ratio of COOH and 
thiocyanate peak areas (1754.5 - 1710.2 cm-1 / 2124.6 - 2082.2 cm-1) shown in green.  Data for 
all ageing experiments are shown (2, 9, 16 and 131 days; a, b, c and d respectively). Samples 
supplemented with 5 mM phenol are depicted on the left hand side and samples incubated in 
the absence of phenol (control) are on the right hand side. 
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Figure 5.3:  Typical FT-IR spectra of activated sludge samples incubated (a) without phenol 
and (b) in the presence of 5 mM phenol, both maintained at 25 °C for 48 h.  Grey spectra 
indicate samples taken after 15 min of incubation and black offset spectra incubated for 48 h.  
The major spectral regions of biological interest are highlighted for both plots (See Table 5.1 for 
details).  The arrow highlights shoulder due to carbonyl vibration from COOH. 
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Table 5.1:  Major spectral regions of biological interest. 
 Wavenumber (cm-1) range Dominant Compounds 
A 3000-2800 CHx stretches from Fatty acids 
   
B 2130-2085 S-O  
C≡N from unsaturated N compounds 
C=N=S from isothiocyanates 
   
C 1700-1500  
   (1700-1600) 
   (1600-1500)   
Proteins 
   C=O from Amide I 
   C-N and C-N-H from Amide II 
   
D 1450-1200 
 
   (1250-1200) 
Carboxylic groups of proteins, free amino acids, 
polysaccharides 
   P-O from RNA/DNA, phospholipids 
   
E 1200-900 C-O or O-H from Polysaccharides 
   
F <900 Unassigned 
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Figure 5.4:  FT-IR absorbance spectrum of potassium thiocyanate.  An asterisk is used to 
highlight the main vibration feature at 2050 cm-1 which arises from S=C=N. 
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Due to the large dimensionality and qualitative similarity observed in these spectra, 
multivariate analysis (MVA) methods were employed to interrogate the data, as 
described above.  The full dataset comprised 1836 spectra (4 experiments x 17 time 
points x 3 biological replicates x 9 analytical replicates) and PC-CVA on this whilst 
possible would be very difficult to visualise.  Therefore to allow a general visualisation 
of the phenotypic changes between the control and phenol supplemented samples 
across the total experimental time course, the analytical replicates from each sample 
condition were averaged (so that the 3 biological replicates for every time point within 
the ageing conditions each represented 9 FT-IR spectra) prior to PC-CVA.  The PC-
CVA scores plot (Figure 5.5) was constructed using the first 9 PCs (which accounts for 
99.95 % of the total explained variance) with the a priori knowledge of the biological 
replicates (i.e., 68 (4 ageing experiments x 17 time points) groups).  In Figure 5.5 the 
arrows indicate the general trends observed within the FT-IR spectra with respect to 
time; both in terms of storage time and experimental sampling time supplemented (or 
not) with phenol.  It can be observed that all of the samples exhibit a strong trend with 
relation to the time of sampling across the first canonical variate (PC-CV 1).  It can also 
be observed that the two experimental conditions cluster together to left of the origin 
which corresponds to samples either not being exposed to phenol or being exposed 
but not yet degrading phenol.  By contrast, samples to the right of the origin bifurcate in 
PC-CV 2; those that continue on a horizontal trajectory are samples not supplemented 
with phenol, and those that increase in PC-CV 2 are now metabolically active with 
respect to phenol and are able to degrade it.  This separation suggests that there is a 
strong phenotypic difference between the samples supplemented with 5 mM phenol as 
the sole carbon source and those maintained without the addition of phenol.  Moreover, 
this PC-CVA scores plot indicates when the bacteria become metabolically active and 
able to degrade phenol.  This activity appeared different and reflected the various 
storage conditions. 
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Figure 5.5:  PC-CVA scores plot performed on averaged FT-IR data (from the 3 biological 
replicates at each of the 17 time points) from all of the “time-delay” experiments (2, 9, 16 and 
131 days).  PCs 1-9 were employed by the CVA algorithm with the a priori knowledge of the 
biological replicates (64 classes; 3 experiments (biological replicates) x 17 time points).  The 
black triangles represent the samples incubated in the presence of 5 mM phenol and the green 
circles represent the samples incubated in the absence of phenol.  The arrows illustrate a 
general trend with respect to time (including storage and time during incubation) and hold no 
statistical significance.  (Note that unfortunately the 48 h time point for the 16 day storage 
sample was lost during storage). 
 
 
 
Monitoring the phenotypic changes in complex bacterial communities capable of 
degrading phenol 
 
An environmental metabolomics investigation of the effects of chiral pharmaceuticals 
and environmental pollutants on microorganisms 
- 160 -   
Since a strong phenotypic difference was observed in the PC-CVA for the entire 
dataset, further PC-CVA was carried out for each of the time-separated investigations 
(Figure 5.6).  This strategy was used in order to observe the effects of extended 
storage periods or “ageing” in the absence of phenol on this activated sludge, which 
may affect the metabolic potential of the community.  
 
The analysis of the spectral data obtained from the investigation carried out on 
activated sludge samples aged for 2 d shows a strong trend with respect to time across 
PC-CV 1 (Figure 5.6a).  Both the control samples and those supplemented with 5 mM 
phenol as the sole carbon source cluster together until 15 h, after which point the 
samples supplemented with phenol separate from the control samples across PC-CV 
2.  The trends observed here are also observed in the PC-CVA of the samples aged for 
9 d (Figure 5.6b).  The separation of the samples after 15 h suggests that the activated 
sludge communities phenotype changes significantly during the degradation of phenol.  
Moreover, these data support the general trends observed in the PC-CVA scores plots 
for the complete FT-IR dataset (Figure 5.5).  
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Figure 5.6:  PC-CVA scores (left hand side) and loadings plots (right hand side) performed on 
FT-IR data from each of the “time-delay” experiments individually (2-131 days; (a) – (d) 
respectively).  PCs 1-7 were employed by the CVA algorithm with the a priori knowledge of the 
biological replicates (17 classes for each experiment, representing the 17 time points).  In the 
scores plots (LHS) the time at which each sample was taken following the addition of phenol is 
represented by a grey-scale in which the intensity decreases as the time of sampling increases.  
The arrows illustrate the trend with respect to time and hold no statistical significance.  For the 
loadings biplots (RHS), contiguous spectral regions falling beyond 2 standard deviations from 
the mean are encoded by colours and symbols detailed in the legend. 
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Visual inspection of the PC-CVA loadings plots for these analyses (Figure 5.6a and 
Figure 5.6b, RHS) provides information relating to which spectral features are 
important for this separation.  In this plot a boundary of 2 standard deviations from the 
loadings centroid was used to give a non-statistical approximation of a 95% confidence 
interval (this aid to visualisation highlights bands which are changing the most).  The 
PC-CVA loadings plot for the activated sludge samples aged for 2 d (Figure 5.6a) 
shows that the separation of the samples supplemented with phenol at 15 h is due to a 
new peak occurring at 1754.5 - 1710.2 cm-1 in the samples supplemented with phenol 
(highlighted in Figure 5.3 by an arrow), and a concomitant increase in the thiocyanate 
peak (2124.6 - 2082.2 cm-1) in the control samples.  In order to highlight this further we 
generated an FT-IR difference spectrum by subtracting the (average control spectrum 
at time=48) from (average phenol spectrum at time=48), and this also highlighted the 
band at 1754.5 - 1710.2 cm-1 as being important (see Figure 5.7).  Note that vibrations 
from phenol itself did not appear to be of importance upon inspection of the PC-CVA 
loadings.  Closer inspection of the FT-IR spectra for the control samples showed that 
the thiocyanate peak broadens over time, accounting for the observed increase in the 
peak area during the incubation period.  The PC-CVA loadings plot for the activated 
sludge aged for 9 d (Figure 5.6b) shows a very similar effect as described above.  The 
fact that those activated sludge samples supplemented with 5 mM phenol are clearly 
separated across PC-CV 2 in both the PC-CVA scores plots (Figure 5.6a and Figure 
5.6b) when these activated sludge communities are actively degrading phenol (Figure 
5.2a and Figure 5.2b) supports the hypothesis that a strong phenotypic change is 
observed in the FT-IR spectra of the whole bacteria (i.e. the total biological 
components of the bacterial cells), and FT-IR spectroscopy has been used to follow 
metabolic events in complex microbial communities (Huang et al., 2005, Huang et al., 
2006).   
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Figure 5.7:  FT-IR difference spectrum of: (average phenol IR spectrum at t=48) minus 
(average control IR spectrum at t=48).  The peak highlighted with an asterisk is the carbonyl 
stretch at 1754.5 - 1710.2 cm-1 which increases following supplementation with phenol. 
 
 
 
This change in the FT-IR spectra for communities actively degrading phenol (Figure 
5.2) is likely to be due to the community altering its metabolic potential as it induces 
gene transcription to produce enzymes capable of catabolising phenol and its 
byproducts (Agarry et al., 2008).  The degradation process is generally initiated by a 
monooxygenase phenol hydroxylase which produces catechol.  Subsequently, one of 
two metabolic pathways may be employed.  The ortho pathway results in the formation 
of succinyl Co-A and acetyl Co-A, and the meta pathway produces pyruvate and 
acetaldehyde (Schlegel, 1993, Agarry et al., 2008, Leonard and Lindley, 1998, Paller et 
al., 1995, Zhao and Ward, 1999).  The initial intermediates of these pathways are 
detailed in Figure 5.8 and Figure 5.9. 
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Figure 5.8:  Ortho cleavage of the aromatic ring and the 3-oxoadipate pathway.  Adapted from 
Schlegel (1993). 
Enzymes involved: (1) catechol 1,2-dioxygenase; (2) muconate cycloisomerase; (3) 
muconolactone isomerase; (4) protocatecuate-3,4-dioxygenase; (5) 3-carboxymuconate 
cycloisomerase; (6) 4-carboxymuconolactone decarboxylase; (7) 4-oxoadipatenollactone 
hydrolase; (8) 3-oxoadipate-succinyl-CoA transferase; (9) 3-oxoadipyl-CoA thiolase. 
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Figure 5.9:  Meta cleavage of the aromatic ring.  Adapted from Schlegel (1993). 
Enzymes involved: (1) metapyrocatechae (catcechol-2,3-dioxygenase); (2) protocatcechuate-
4,5-dioxygenase. 
 
 
Unfortunately these metabolite intermediates from the ortho- or meta-cleavage of the 
aromatic ring in catechol are not available for FT-IR analysis.  However, immediately 
downstream of catechol these products contain carboxylic acid groups (-COOH) and in 
addition to these moieties mucono-lactone and 4-oxoadipate enol-lactone also have a 
lactone ring that may constrain the carbonyl group (C=O) vibration.  The region 
highlighted at 1754-1710 cm-1 increased after 15 h only in activated sludge samples 
exposed to phenol that are actively degrading it.  This region is due to the carbonyl in 
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the COOH group.  Moreover, we have also observed previously constrained carbonyl 
vibrations in penicillin due to its β-lactam ring that when cleaved by the enzyme β-
lactamase resulted in a shift from 1767 cm-1 to ca. 1740 cm-1 (Winson et al., 1997) 
providing further evidence for the detection of phenol degradation products by FT-IR 
spectroscopy.  If the sequences of these genes are known then a targeted 
transcriptomics and proteomics analysis, while the sludge community is actively 
degrading phenol, may provide further information.  This type of analysis is rather 
difficult in complex microbial communities particularly in communities which contain 
bacteria with unsequenced genomes.  However, a number of methods have been 
developed in recent years for the proteomic analysis of complex communities (Lacerda 
et al., 2007, Lacerda and Reardon, 2009, Ram et al., 2005, Valenzuela et al., 2005).  
 
The PC-CVA scores plots for the samples aged for 16 d and 131 d can be seen in 
Figure 5.6c and Figure 5.6d.  Whilst a trend with respect to time can be observed 
across PC-CV 1 and PC-CV 2 in both plots, there is no noticeable separation of the 
control samples and those supplemented with phenol.  This observation is supported 
by the phenol quantification data (Figure 5.2c and Figure 5.2d) which show a visible 
reduction in the ability of the bacterial community to degrade phenol.  Interestingly, the 
PC-CVA loadings plots (Figure 5.6c and Figure 5.6d) show the separation of samples 
according to time, irrespective of phenol degrading ability, is due to an increase in the 
thiocyanate peak (2122.7 – 2082.2 cm-1 for 16 d and 2126.5 – 2061.0 cm-1 for 131 d), 
an effect which was observed in the control samples for earlier ageing periods.  This 
indicates that whilst the activated sludge community has lost the ability to degrade 
phenol during the extended storage periods, it appears to still be equivalent at the 
phenotypic level to the control samples stored for 2 and 9 d; a result that is also clear 
from the analysis of the whole dataset (Figure 5.5).  This suggests that the bacterial 
community is still metabolically active despite the loss of phenol degrading ability.  
 
As detailed above, the PC-CVA highlighted two major differences in the FT-IR spectra 
between actively degrading phenol communities and non-supplemented controls or 
non-degrading communities.  These differences were due to changes in the peaks at 
wavenumbers 1754.5 - 1710.2 cm-1 (from the -COOH on metabolites in the phenol 
degradation pathways) and 2124.6 - 2082.2 cm-1 (from thiocyanates).  In order to 
investigate this further and determine any time-related or phenol-degradation related 
trends, the phenol quantification data were plotted with a ratio of these peak areas 
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(1754.5 - 1710.2 cm-1 / 2124.6 - 2082.2 cm-1) calculated from the raw spectra against 
time (Figure 5.2).   
 
The phenol quantification and FT-IR peak area ratios for activated sludge samples 
aged for 2, 9, 16 and 131 d can be seen in Figure 5.2 (and also see Figure 5.10 for the 
areas under carbonyl peak).  The control samples did not contain phenol (with the 
exception of a possible residual amount (~0.1 mM) in the 2 d old samples) and the ratio 
of the COOH / thiocyanate vibrations more-or-less follows the same trend and 
decreases with respect to time (clearly with different rates).  By contrast the ratio 
increases in samples that are actively degrading phenol; for 2 d old activated sludge 
samples this occurs after 8 h and for 9 d is after 24 h, a possible trend was also 
observed at the 36 h time point in the 16 d aged sample, although this was less 
obvious than in the previous samples.  For the 131 d aged activated sludge the ratio 
follows the same trend as the control experiments, and with the exception of the 36 h 
time point so do the 16 d stored samples.  Inspection of the peak areas alone (Figure 
5.10 and Figure 5.11) indicate that the COOH vibration also increases when the sludge 
is actively degrading phenol.  This is not surprising given the complex biological 
processes involved in the degradation of phenol as discussed above (Agarry et al., 
2008).   
 
It is likely that the community structure of the activated sludge changes during the 
degradation of phenol (Manefield et al., 2005, Manefield et al., 2002, Whiteley and 
Bailey, 2000).  Changes in the structure of the bacterial community may be 
investigated with RNA stable isotope probing (SIP) (Manefield et al., 2002, Madsen, 
2006, Dumont and Murrell, 2005, Whiteley et al., 2006).  This data combined with 
metabolomic analyses may provide valuable insight into the principal bacterial species 
and metabolic pathways employed by the activated sludge community during the 
degradation of phenol, and this will be an area of future work.  
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Figure 5.10:  Phenol quantification data (black symbols and lines) plotted with the COOH band 
(1754.5 - 1710.2 cm-1); FT-IR peak areas shown in green.  Data for all ageing experiments are 
shown (2, 9, 16 and 131 days; a, b, c and d respectively).  Samples supplemented with 5 mM 
phenol are shown on the left hand side and samples incubated in the absence of phenol 
(control) are on the right hand side. 
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Figure 5.11:  Phenol quantification data (black symbols and lines) plotted with the thiocyanate 
band (2124.6 - 2082.2 cm-1); FT-IR peak areas shown in green.  Data for all ageing experiments 
are shown (2, 9, 16 and 131 days; a, b, c and d respectively).  Samples supplemented with 5 
mM phenol are shown on the left hand side and samples incubated in the absence of phenol 
(control) are on the right hand side. 
 
Monitoring the phenotypic changes in complex bacterial communities capable of 
degrading phenol 
 
An environmental metabolomics investigation of the effects of chiral pharmaceuticals 
and environmental pollutants on microorganisms 
- 169 -   
Metabolite profiling by GC-MS was employed in order to investigate the metabolic 
changes occurring in the activated sludge community during the degradation of phenol.  
Parallel samples were supplemented with 5 mM of either 12C-phenol or 13C6-phenol and 
monitored during a 48 h period, for the degradation and possible degradation products 
of phenol within the metabolite profiles.  From the GC-MS data two pairs of metabolite 
peaks were identified as a mix of 12C and 13C analogues, thus indicating uptake of 13C 
from the labelled phenol.  The metabolite peaks were identified as the amino acids 
glycine and glutamic / pyroglutamic acid.   
 
The multivariate analysis method PC-DFA was employed in order to provide a 
visualisation of the general trends in the metabolic profiles during the time course.  
Figure 5.12 shows the PC-DFA scores plot (PC-DF 1 vs. PC-DF 2) for the 12C and 
13C6-phenol supplemented activated sludge samples during the 48 h time course.  A 
general trend was observed across PC-DF 1 according to the time of sampling.  These 
findings corresponded with those of the FT-IR spectroscopy analyses (Figure 5.6) and 
indicated a strong metabolic response to the phenol supplement within the activated 
sludge community.  There was a clear separation across PC-DF 2 and this appeared to 
be due to the presence of an outlier (labelled P24).  Therefore, the scores for PC-DF 1 
vs. PC-DF 3 were plotted (Figure 5.13) in order to investigate any further changes 
within the metabolic profiles of the activated sludge communities during the 
degradation of phenol.  The samples displayed a clear separation across PC-DF 1 
according to the time of sampling until the 24 h time point, after which, the samples at 
36 and 48 h appeared to co-cluster.  It is likely that this was due to a reduction in the 
metabolic activity of the activated sludge following the depletion of phenol, as it was 
shown above that following phenol supplementation it was significantly removed by the 
community in the first 20 h.  Some separation between the 12C-phenol and 13C6-phenol 
supplemented samples between 1-10 h was observed across PC-DF 3.   
 
 
Monitoring the phenotypic changes in complex bacterial communities capable of 
degrading phenol 
 
An environmental metabolomics investigation of the effects of chiral pharmaceuticals 
and environmental pollutants on microorganisms 
- 170 -   
-30 -20 -10 0 10 20 30
-25
-20
-15
-10
-5
0
5
10
P0 P0 P0 P1 P1 P1 
P4 P4 P4 
P8 P8 P10P10P10 P15
P15P15
P24
P24
P24
P36P36
P36P36P48P48
P48P48P48
E  E0 
E1 
 
E4 E4 E4 
E8 E8 
E8 
E10E10
E10
E15 E15E15
E24E24
E24
E36E36E366E36
E48 EE48
E4848
Discriminant function 1    
D
is
cr
im
in
an
t f
u
n
ct
io
n
 
2 
 
 
 
D
is
cr
im
in
an
t f
u
n
ct
io
n
 
2 
 
 
 
 
Figure 5.12:  PC-DFA scores plot for the metabolic profile data of activated sludge 
supplemented with 5 mM phenol (12C or 13C6) over 48 h.  PCs 1-20 were employed by the DFA 
algorithm with the a priori knowledge of the biological replicates.  Points labelled P are those 
supplemented with 12C phenol, and those labelled E were supplemented with 13C labelled 
phenol.   
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Figure 5.13:  PC-DFA scores plot for the metabolic profile data of activated sludge 
supplemented with 5 mM phenol (12C or 13C6) over 48 h.  PCs 1-20 were employed by the DFA 
algorithm with the a priori knowledge of the biological replicates.  Points labelled P are those 
supplemented with 12C phenol, and those labelled E were supplemented with 13C labelled 
phenol.  The trends are highlighted with red and blue arrows, which represent 12C-phenol and 
13C6-phenol respectively. 
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Kruskal-Wallis analysis was carried out in order to determine any significant changes in 
the levels of metabolites during the time course.  A total of 23 metabolite peaks were 
found to display significant changes of which 16 could be identified by means of 
matching to authentic standards by retention time and mass spectrum, or by the mass 
spectrum only (Winder et al., 2008).  Comparison of the 12C-phenol and 13C6-phenol 
supplemented samples with Kruskal-Wallis analysis did not find any significant 
changes in the metabolic profiles and it is therefore unlikely that the observed 
separation across PC-DF 3 in the PC-DFA scores plot (Figure 5.13) was due to a small 
contaminant within the activated sludge samples and may be due to the quantification 
ion used for defining the chromatographic peak.   
 
Phenol was not detected by the GC-MS analysis and it is likely that it was lost during 
the sample preparation due to its high volatility.  However a number of aromatic 
hydrocarbons (including fluoranthene and pyrene, see Figure 5.14) were detected and 
it is likely that these were hydrocarbons present in the activated sludge from the coking 
effluent.  In addition, the presence of aromatic hydrocarbons within the activated sludge 
samples may be due to degradation products of phenol.  It was observed that the 
levels of these aromatic hydrocarbons reduced during the time course, thus indicating 
degradation by the activated sludge.  In addition, a number of sugars were detected in 
the metabolic profiles of the activated sludge, some of which decreased significantly 
during the incubation period and others displayed a significant increase in 
concentration during the time course.  It was not possible to provide definitive 
identification for these sugars.  The amino acids cysteine and glutamine were found to 
increase significantly in the 36 and 48 h time points (Figure 5.15).  In addition, the 
carboxylic acid malonic acid was found to gradually reduce in concentration during the 
time course.  
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Figure 5.14:  Box and whisker plots showing the changes in metabolite levels during the 48 h 
time course.  d represents definitive identification by means of matching to authentic standard by 
retention time and mass spectrum.  p represents putative identification by mass spectrum only.  
Classes 1-9 represent the sampling time points during the incubation period at 0, 1, 4, 8, 10, 15, 
24, 36 and 48 h. 
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Figure 5.15:  Box and whisker plots showing the changes in metabolite levels during the 48 h 
time course.  d represents definitive identification by means of matching to authentic standard by 
retention time and mass spectrum.  p represents putative identification by mass spectrum only.  
Classes 1-9 represent the sampling time points during the incubation period at 0, 1, 4, 8, 10, 15, 
24, 36 and 48 h. 
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5.5 Conclusions 
The phenol quantification data obtained from samples aged for 2 and 9 d show that the 
activated sludge community is capable of degrading 5 mM phenol in 48 h, and it is 
evident from the FT-IR data that this has a metabolic effect on the microbial cells since 
vibrations that are non-phenol related are clearly important.  The results also show that 
the activated sludge community loses its ability to degrade phenol when aged for 
extended periods of time (16 and 131 d), and it is likely that this is due to a phenotypic 
adaptation from long storage in a phenol-free medium.  The increase in the area of 
COOH vibration (C=O at 1754.5 - 1710.2cm-1) during the degradation of phenol 
suggests that FT-IR spectroscopy is detecting the products of phenol degradation.  
Further analyses could target key enzymes involved in the degradation of phenol, such 
as monooxygenase phenol hydroxylase and catechol-2, 3- dioxygenase.  However, this 
is rather difficult in complex communities.  GC-MS analysis was able to detect 
significant changes in a number of metabolites during the degradation of phenol and 
shows the power of employing mass spectrometry-based metabolomics approaches 
(Dunn et al., 2005, Goodacre, 2004, Winder et al., 2008) for the analysis of activated 
sludge samples exposed to 5 mM phenol.  In conclusion, high-throughput metabolic 
fingerprinting with FT-IR spectroscopy has been used to monitor phenotypic shifts 
within complex microbial communities, and this snapshot of biochemical changes 
supports the further investigation of this important bioremedial process using mass 
spectrometry-based metabolomics and this is an area of current study.  
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6 Conclusions and Future Work 
Active pharmaceutical ingredients and their metabolites are ubiquitous in the 
environment and their occurrence in the aquatic environment is of growing concern.  
However, despite the fact that these may cause harmful effects in organisms found 
within this niche, little is currently known about the effects of APIs in the aquatic 
environment.  Chiral pharmaceuticals are of particular concern as the enantiomers may 
be metabolised differently, with the potential for the production of an array of harmful 
compounds.  There are many racemic APIs for treating human and animal conditions, 
and even in these target organisms the pharmacodynamic effects of the enantiomers 
are not always known.  Within recent years the importance of the interactions of these 
compounds within the aquatic environment has been realised and information 
regarding the fate and biodegradation of such environmental pollutants is of great 
importance.  The advent of post-genomic technologies has proved advantageous in the 
study of the effects of these environmental pollutants.  The aim of this study was 
therefore, to investigate the effects of chiral APIs and other environmental pollutants on 
environmentally relevant microorganisms and the metabolic pathways in which these 
pollutants undergo degradation at the metabolome level.  
 
The effects of the chiral APIs Atenolol and Propranolol were investigated in a number 
of prokaryotic and eukaryotic systems in order to provide a comprehensive study of the 
effects of the APIs in the aquatic environment.  FT-IR spectroscopy was employed in 
the first instance as a metabolic fingerprinting tool for the phenotypic analysis of a 
range of environmentally relevant bacteria.  In addition, FT-IR microspectroscopy was 
employed for the investigation of the phenotypic and localised effects of chiral APIs in a 
eukaryotic system.   
 
Initially the selected bacteria were exposed to a range of concentrations of the pure 
enantiomers and the racemate for each of the APIs.  FT-IR spectra were acquired for 
these exposures and a range of multivariate analysis methods were employed in the 
analysis of these data.  Initial results showed that the data reduction strategy PCA 
followed by the clustering method CVA was sufficient to characterise the metabolic 
effects exerted on the bacteria from the FT-IR spectra.  Propranolol was found to have 
a notable effect on the bacterial phenotype, whilst Atenolol did not appear to have a 
considerable phenotypic effect.  The regression method PLSR was employed in the 
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quantification of the metabolic effects exerted on P. putida KT2440 when exposed to 
increasingly large concentrations of (±)- Propranolol and the algorithm was able to 
model and predict these effects successfully.  In particular the pseudomonads 
employed in this study displayed differing phenotypic effects when exposed to 
Propranolol and were thus selected for exposure to a range of enantiomeric ratios of 
the API at a fixed concentration.  Analysis of the FT-IR spectra revealed chiral-specific 
effects when the bacteria were exposed to the various enantiomeric ratios of 
Propranolol.  Any potential degradation of the APIs during the growth period was 
investigated with HPLC.  However, the results indicated that degradation of the APIs 
did not occur and it was therefore not possible to link the differential phenotypic effects 
observed in the bacterial cells to the degradation of the APIs.  It was concluded that the 
observed phenotypic effects were more likely to be a secondary effect of the API and it 
is likely that this was due to interactions of Propranolol with the bacterial cell 
membranes.  Further work could aim to provide more accurate quantification of the 
APIs both in the remaining supernatant and the within the bacterial cells. 
 
It was important to consider the metabolic effects of the APIs in both prokaryotic and 
eukaryotic microorganisms and therefore, the green alga Micrasterias hardyi was 
selected for investigation of the chiral specific effects of Atenolol and Propranolol.  
Previous reports have demonstrated that Propranolol exerts a phenotypic effect on the 
green alga (Patel et al., 2008).  However, the effects of Atenolol in the alga have not 
previously been reported, and the chiral specific effects of Propranolol were unknown 
for M. hardyi.  FT-IR microspectroscopy was employed to generate chemical maps in 
order to monitor the general phenotypic effects throughout the whole cell and within 
localised areas of the algal cells.  A wide range of multivariate analysis methods were 
employed in order to analyse both the general and localised effects of the APIs.  No 
observable difference was reported for the algal cells exposed to Atenolol and this 
finding corresponded with that of the prokaryotic systems (Chapter 2).  By contrast, 
noticeable differences were observed in the FT-IR spectra of the Propranolol exposed 
cells.  PC-CVA revealed a significant phenotypic difference in cells exposed to 
Propranolol; however, the algorithm was not able to differentiate between the 
enantiomeric ratios.  Functional group mapping was successfully employed to 
investigate the localised effects of the APIs within the algal cells.  In addition, an 
enhanced metabolic effect was reported for the cells exposed to the (R)- enantiomer 
and the racemate, an effect which was not noted in the bacterial species exposed to 
the APIs.  PCA mapping was able to analyse the entire FT-IR spectrum in a spatially 
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relevant manner, and was employed in order to explore the localised phenotypic effects 
within the algal cells further.  However, this method was unable to differentiate any 
significant difference in the algal cells according to the experimental conditions.  It was 
concluded that Atenolol did not exert a detectable phenotypic effect in the algal cells.  
Whilst Propranolol exerted a significant phenotypic effect on M. hardyi and all of the 
bacterial species studied, and a notable phenotypic effect was observed between the 
enantiomeric ratios.   
 
As changes in the FT-IR spectra suggested that lipids were being altered then future 
work could concentrate on this and combine a GC-MS approach for exploring central 
metabolism with LC-MS for the analysis of the lipids.  Particular attention could be paid 
to the difference observed in the cells exposed to the (R)- enantiomer and the 
racemate in comparison to the remaining (R) : (S) ratios. 
 
The greatest phenotypic effect observed in all of the microorganisms studied was in the 
pseudomonads following exposure to Propranolol.  GC-MS was therefore employed for 
the metabolic profiling of the two pseudomonads following growth in the presence of a 
range of enantiomeric ratios of Propranolol at a fixed concentration.  Initial results 
demonstrated a clear phenotypic difference between the bacterial species.  In addition 
chiral specific metabolic effects were observed for both pseudomonads when exposed 
to the enantiomeric ratios of Propranolol, corresponding with the results of the FT-IR 
spectroscopy.  In particular P. aeruginosa PA14 displayed a different metabolic 
response to each of the enantiomeric ratios of (R)-:(S)- Propranolol.  The multivariate 
and univariate analyses of the GC-MS data highlighted significant differences in a 
number of metabolites between the varying enantiomeric ratios which could not be 
identified.   
 
Further work should aim to provide identification of these metabolites.  In addition, 
complementary techniques such as LC-MS could be employed in order to provide a 
comprehensive analysis of the metabolic effects of these APIs in aquatic 
microorganisms.  The enantiomers of the APIs are likely to be present in the 
environment as a range of concentrations and therefore a range of enantiomeric ratios.  
Further work may investigate the more subtle differences observed by GC-MS in the 
bacterial cells exposed to the 75:25 and 25:75 ratios (R)- : (S)- Propranolol in order to 
provide a more detailed characterisation of the metabolic effects of the Propranolol 
enantiomers.  In addition, the methods employed here may be further developed to 
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analyse mixed culture samples which are more representative of the aquatic 
environment and samples from an aquatic environment known to contain API 
pollutants.  
 
Aromatic hydrocarbons represent another important class of environmental pollutants.  
The phenotypic effects of the aromatic hydrocarbons phenol and toluene and the chiral 
APIs Atenolol and Propranolol were investigated in more complex biological 
communities.  Activated sludge previously developed for the degradation of phenol in 
coking effluent was employed (Manefield et al., 2005, Manefield et al., 2002) and FT-IR 
spectroscopy was utilised to monitor the phenotypic effects of the environmental 
pollutants during a 48 h period.  In addition HPLC was employed to quantify the 
pollutants remaining in the supernatant following incubation.  However, HPLC did not 
successfully quantify the pollutants due to the complex nature of the community flocs.  
FT-IR spectroscopy was only able to monitor the phenotypic effects occurring in the 
microbial community supplemented with phenol and results from the multivariate 
analyses suggested that these changes were due to shifts in the levels of thiocyanates 
found within the activated sludge, and this was further explored with a range of ageing 
experiments and metabolic fingerprinting (Chapter 5).  By contrast, no notable 
difference was observed in the communities exposed to the other environmental 
pollutants.  In contrast to the findings presented in Chapter 2 and Chapter 3, the APIs 
did not appear to exert a phenotypic effect on the activated sludge community.  In 
addition, no detectable phenotypic effects were observed in the FT-IR analysis of the 
activated sludge following exposure to the aromatic hydrocarbon toluene. 
 
Whilst this complex microbial community had been previously investigated using 
molecular approaches for the identification of the main phenol degrader (Manefield et 
al., 2005, Manefield et al., 2002), little is known regarding the changes in the 
community phenotype that may occur within the activated sludge when it is actively 
degrading phenol.  FT-IR spectroscopy was employed in a temporal manner to monitor 
the community phenotype during phenol degradation.  Phenol consumption was 
confirmed using a colorimetric assay for phenol and degradation took ca. 36 h but only 
in ‘young’ cultures compared to communities that had been allowed to age for between 
16 and 131 days.  Multivariate analyses of the FT-IR spectra showed different 
phenotypic trajectories depending on whether the community was able to degrade 
phenol or whether this metabolic potential was lost. 
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During incubation changes in the FT-IR spectra of the control samples were dominated 
by changes in the levels of thiocyanates.  By contrast, a new peak was only observed 
in the FT-IR spectra of the phenol supplemented communities and this could be 
attributed to a COOH group vibration that was likely due to phenol degradation 
products from either the ortho- or meta-cleavage pathways.  Armed with this 
knowledge the activated sludge community was monitored during the active 
degradation of phenol with the use of GC-MS.  Further work could target these 
pathways and monitor the activated sludge for the production of these intermediates.  It 
would be particularly interesting to see if changes in the community structure occur 
during phenol degradation as this may provide evidence of cross-feeding, and this 
could be achieved using the RNA-SIP molecular methods detailed in Manefield et al., 
(2002). 
 
This work demonstrated the utility of FT-IR spectroscopy to investigate the phenotypic 
variations in complex biological communities during exposure to environmental 
pollutants.  Further work in this area should develop the methods presented here for 
monitoring phenotypic changes in complex communities.  In addition alternative 
methods for quantifying the remaining levels of the pollutants should be explored, 
which may involve specific solvent extractions.   
 
In conclusion, the work presented in this thesis has shown for the first time that 
metabolomics allows subtle phenotypes in microorganisms to be revealed when they 
are exposed to chiral forms of APIs which are commonly found in the environment.  
Despite these APIs not being designed for any interaction with bacteria and aquatic life 
in general these are significant findings and may have implications as more and more 
APIs become detectable and concentrated in the environment due to continued use in 
man and indeed animals or aquaculture.  I believe that metabolomics will play an 
important role in toxicological studies, in understanding pollutant-species interactions, 
and should become an important tool for environmental monitoring. 
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